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Abstract
Tissue-Specific H2Bub1 is Required for Cardiomyocyte Development
Syndi Marissa Barish
2021
Currently, the most common birth defect is congenital heart disease (CHD).
Whole-exome sequencing of CHD patients identified variants affecting chromatin
modifier genes, which contribute to 2.3% of CHD. De-novo mutations affecting the core
complex (RNF20, RNF40 and UBE2B) required for the monoubiquitination of H2B on
K120 (H2Bub1) are enriched in CHD patients. This complex has many cellular roles,
such as stem cell differentiation, but no described role in cardiac morphogenesis. This
body of work describes the role of H2Bub1 in heart development in vivo in mice and in
vitro in human induced pluripotent stem cell (iPSC)-derived cardiomyocytes.
The patient variant in RNF20 was an early stop codon in a single allele,
suggesting haploinsufficiency for RNF20, so we first analyzed Rnf20+/- mice. Unlike the
patients, these mice have no discernible cardiac abnormalities. Additionally, the Rnf20-/mice are pre-implantation lethal. Therefore, we created cardiac specific deletions of
Rnf20, using both Nkx2.5-Cre and Isl1-Cre to analyze its role in the first and second heart
fields respectively. The Rnf20fl/-::Nkx2.5-Cre+ mice are e12.5 lethal, and have incomplete
septation and decreased compact myocardium, while the Rnf20fl/-::Isl1-Cre+ mice survive
until adulthood and appear morphologically normal. We further investigated the Rnf20fl/::Nkx2.5-Cre+ mice and determined that they have disorganized cardiac sarcomeres
lacking an H zone and decreased expression of calcium signaling genes. We conclude
that Rnf20 is necessary for embryonic viability and normal cardiac structure formation.

I

Given the myocardial phenotype, we investigated H2Bub1 during cardiomyocyte
development by in vitro differentiation of human iPSCs into cardiomyocytes. ChIP-seq
for H2Bub1 in iPSC-derived cardiomyocytes demonstrates that H2Bub1 is dynamically
regulated during differentiation: there are abundant genes with H2Bub1 marks in iPSCs
and mesoderm, but only a few genes maintain H2Bub1 during the transition from cardiac
mesoderm to cardiac progenitors. The set of selectively maintained genes is strongly
enriched for sarcomeric calcium genes, and 10/11 of these calcium genes are associated
with cardiomyopathy. There are conflicting published data about whether H2Bub1 is an
activating or repressive mark. Our data suggest that H2Bub1 is selectively maintained on
tissue-specific genes to promote their expression. These data support the mouse data by
also showing a link between H2Bub1, calcium signaling, and cardiomyopathy.
We then tested the effect of downregulation of RNF20-complex components on
cardiomyocyte differentiation. Haploinsufficiency for RNF20 arrests differentiation into
cardiac mesoderm. Notably, decreased RNF20 leads to a paradoxical increase in H2Bub1
at chromatin modifier genes. The lack of concordance of the decrease in RNF20 and the
resulting increase in total H2Bub1 levels suggests that H2Bub1 deposition efficiency may
reflect the ratios of the RNF20-complex components. Depletion of another RNF20complex component, UBE2B, results in either beating cardiomyocytes (which seem
indistinguishable from wild-type) or failure to differentiate into cardiac mesoderm. RNAseq shows decreased expression of sarcomere and calcium genes. These data demonstrate
that H2Bub1 levels need to be tightly regulated for normal heart development.
We then determined that H2Bub1 preferentially marks tissue-specific long genes.
We first compared H2Bub1-ChIP-seq data between the multiciliated oviduct and the

II

nonmulticiliated liver, and identified enrichment in cilia genes among the genes that have
increased occupancy in oviducts. Interestingly, cilia genes have long transcripts.
Published data indicate a link between H2Bub1 and transcriptional elongation, but there
is disagreement as to whether H2Bub1 has a positive or negative effect. Thus, we
hypothesized that that preferential marking of tissue-specific long genes by H2Bub1 is
related to transcriptional elongation. We next compared the shape of the H2Bub1 signal
between wild-type and UBE2B-/- cardiomyocytes in long genes and short genes. While
short genes give the predicted profile, long genes have a vastly different profile.
Interestingly, we identified tissue-specific UBE2B-dependent H2Bub1 accumulation near
the center of long genes, which correlates with efficient transcriptional elongation.
Finally, we compared the shape of the H2Bub1 signal between mouse embryonic
fibroblasts and mouse embryonic stem cells. These data also show H2Bub1 accumulation
near the center of tissue-specific genes. Therefore, our data suggest that H2Bub1
positively regulates transcriptional elongation on long tissue-specific genes.
In summary, our data show that the RNF20-complex is required for cardiac
development. Mice with cardiac-specific deletion of Rnf20 have structural heart defects;
human iPSCs with RNF20 and UBE2B mutations cannot efficiently differentiate into
cardiomyocytes. In both mice and iPSC-derived cardiomyocytes, sarcomere and calcium
signaling gene expression is dependent on normal H2Bub1 levels. We also identify
tissue-specific UBE2B-dependent H2Bub1 accumulation in cardiomyocytes and MEFs
that corresponds to transcriptional efficiency. Thus, normal H2Bub1 distribution is
required for cardiac development, and H2Bub1 accumulation may act as a general
mechanism for tissue-specific regulation of transcriptional elongation efficiency.
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Part I: Introduction and Literature Review

Chapter 1: Heart development and congenital heart disease
1.1 Congenital heart disease
It is not surprising that the heart is the first functional organ to develop in an
embryo given its importance in sustaining life. However, its development is a very
complicated, regulated, and precise process. At any stage in heart development,
numerous cellular processes can go wrong, resulting in congenital heart disease (CHD).
CHD is the most frequent birth defect in live births, affecting one percent of live born
infants, and is the most common cause of mortality from congenital defects (van der
Linde et al. 2011). This disease is largely genetic in nature; the genetic contribution is
likely 90%, and there are more than 400 genes identified that likely contribute to CHD
(Jin et al. 2017; Homsy et al. 2015; Zaidi et al. 2013). Of the 90% that is genetic, ~3% is
caused by transmitted mutations, ~8% is caused by de-novo mutations, ~13% is caused
by aneuploidies, ~10% is caused by copy number variants, and the remaining ~56% is of
unknown cause. The 10% that is not genetic is thought to be due to environmental causes,
such as in-utero alcohol exposure and pre-gestational diabetes (Fig. 1.1). As indicated in
figure 1.1, the most significant class of genes amongst de-novo mutations that contribute
to CHD is chromatin modifiers, which will be described in more detail in chapter 2.
Many different types of chromatin modifiers are implicated in CHD (Fig. 1.2) (Diab et al.
2021). The purpose of this chapter is to review the mechanisms by which the heart
normally develops. The following sections of this chapter will address the developmental
progression of heart structures, calcium signaling, and sarcomeres. Chapter 4 provides the
experimental detail for the necessity for RNF20, a gene with a known CHD variant, in
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Figure 1.1 Congenital heart disease etiology. Pie chart showing the CHD etiologies and
their contribution to CHD (Diab et al. 2021). No permission needed to reproduce.

3

Figure 1.2 Chromatin remodeling genes in congenital heart disease (CHD). Genes
with an asterisk (*) next to them are statistically significant. Color coding for the figure is
in panel (A) (Diab et al. 2021). No permission needed to reproduce.
(A) Chromatin remodeling genes implicated in CHD that interact with Histone H1.
(B) Chromatin remodeling genes implicated in CHD that modify the tails of one of the
four core histones (H2A, H2B, H3, or H4) and the residue of modification. H2Bub1
machinery is in a red box.
(C) Chromatin remodeling genes implicated in CHD that have non-specific activity.
4

mouse heart development, and chapters 6 and 7 detail the necessity for the RNF20complex in normal cardiomyocyte differentiation.
1.2 Overview of stage-specific changes in heart structures
Heart development begins when cells migrate away from the primitive streak and
form the cardiac crescent at mouse embryonic day 7.5 (e7.5) (Tam et al. 1997) (Fig. 1.3a,
1.3b). By e8.0, the cardiac crescent has formed a linear tube, which beats (Fig. 1.3c). It
then starts to loop and expand (e8.5) (Fig. 1.3d). At this stage, it has two layers: the
endocardium (the endothelial cells that line the lumen of the heart) on the inside and the
myocardium on the outside (Kaufman and Navaratnam 1981). The myocardium is made
up of cardiomyocytes, which are the heart muscle cells. Like other muscle cells, these
cells contain actin and myosin filaments arranged in a regular pattern called sarcomeres,
which allow the heart to beat. These structures arise from premyofibrils at e8.5 (or
earlier), which are like stress-fibers, contained in the cardiomyocytes (see section 1.5 for
more detail) (Hirschy et al. 2006; Sanger et al. 2005). By e10.5, the heart has four
chambers that are starting to septate and the epicardium is starting to form (Fig. 1.3e).
Unlike the myocardium and the endocardium, the epicardium is derived from the
proepicardium, which is located near the venous poles of the heart. The proepicardial
cells begin to migrate towards the heart at e10.5, first covering the ventricular wall, and
then extending cranially and caudally. By e14.5, the epicardium is fully formed and the
heart has undergone septation (Fig. 1.3f) (Ho and Shimada 1978; Manasek 1969;
Komiyama, Ito, and Shimada 1987; Savolainen, Foley, and Elmore 2009). Even though
heart development occurs in a short time frame in mice, the process is very complex.
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Figure 1.3 Heart development. Adapted from (Brade et al. 2013). Copyright Cold
Spring Harbor Laboratory Press. Reproduced with permission.
(A) At e6.5, mesodermal progenitors ingress through the primitive streak, and then
migrate towards the heart field.
(B) At e7.5, the cardiac crescent has formed, with the first heart field anterior to the
second heart field.
(C) At e8.0, the cardiac crescent turns into a linear heart tube that beats.
(D) At e8.5, the heart tube loops and expands.
(E) At e10.5, the proepicardial cells migrate into the heart to start forming the
epicardium. Additionally, the heart now has four chambers that are beginning to septate.
(F) At e14.5, the epicardium is fully formed and septation is complete.
AA, Aortic arch; ant, anterior; AO, dorsal aorta; CNCC, cardiac neural crest cells; do,
dorsal; EPI, epicardium; FHF, first heart field; HF, headfolds; IVS, interventricular
septum; L, left; LA, left atrium; LV, left ventricle; OFT, outflow tract; PE,
proepicardium; PhA, pharyngeal arch; PLA, primitive left atrium; post, posterior; PRA,
primitive right atrium; PS, primitive streak; PT, pulmonary trunk; R, right; RA, right
atrium; RV, right ventricle; SHF, second heart field; ven, ventral.
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Mouse heart development and human heart development are comparable with
minor differences. The main difference is the timeframe of events. Mouse heart
development occurs from e7.5 until e14.5 (7 days), while human heart development
occurs from 7 weeks until 9 weeks (14 days). The mouse heart then grows in size for the
remaining week until birth, while the human heart grows in size for about another 30
weeks. There are also some minor differences in ventricular morphology, particularly in
the valve morphology (Krishnan et al. 2014). Thus, mouse and human heart development
morphology is remarkably similar. Based on morphology alone, mice are a good model
system for studying human heart development (see section 1.6 for a complete discussion
on the differences between mice and humans).
1.3 Origins of cardiac cells
At the onset of gastrulation, cardiac precursor cells express MESP1, an early
cardiac transcription factor. MESP1 is required for cardiac precursor cells to leave the
primitive streak, formation of a single heart tube, exit from pluripotency, and
cardiovascular specification (Saga et al. 1999; Lescroart et al. 2018). Thus, MESP1 is not
just the earliest marker of cardiac cells, but it is also functionally important for normal
heart development. Since it is the earliest marker of cardiac cells, MESP1+ cells give rise
to the majority of the heart cells (epicardial, myocardial, and endocardial). Later in
development, at e7.5, these MESP1+ cardiac precursor cells begin to express another
marker of cardiac cells, the homeobox gene NKX2.5 (Lints et al. 1993). Thus, expression
of MESP1 commits cells to a cardiac fate, and causes the cells to eventually express the
rest of the cardiac gene expression program.
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Originally, it was thought that all heart progenitor cells were the same. It is now
known that there are two types of cells that contribute to the heart (both derive from the
MESP1+ and NKX2.5+ precursor cells at e7.5), the first and second heart fields (FHF and
SHF) (Fig. 1.4). The existence of the SHF was postulated when it was determined that
the FHF does not contribute to the outflow tract (Mjaatvedt et al. 2001; Waldo et al.
2001). The SHF was later identified, and it is marked by the LIM homeodomain protein,
ISL1, while the FHF is marked by the ion channel, HCN4 (Liang et al. 2013; Spater et al.
2013; Cai et al. 2003). Thus, NKX2.5 is expressed in every cell and then cells turn on
either HCN4 or ISL1. It is hypothesized that cells are not both ISL1+ and NKX2.5+ for
long. In other words, once a cell is expressing the SHF markers, it no longer expresses
NKX2.5 (Jia et al. 2018; Prall et al. 2007). Therefore, over time NKX2.5 becomes
restricted to the FHF (Moses et al. 2001). It follows that later in development, the FHF is
marked by NKX2.5 and the SHF is marked by ISL1.
It was determined that the FHF and SHF cells can be broken down even further
into subtypes. This analysis determined that the FHF cells tend to be associated with
myogenic differentiation, while the SHF cells tend to be associated with maintaining
progenitor cells (Jia et al. 2018). A more exact break down of which structures each heart
field contributes to was determined using lineage tracing with the FHF marker, HCN4.
The FHF generates mostly cardiomyocytes and minimal endothelial cells. More
specifically, the FHF generates some cardiac conduction cells, the majority of the left
ventricular cardiomyocytes, and some atrial cardiomyocytes (Liang et al. 2013; Spater et
al. 2013). In conclusion, even though both FHF and SHF cells contribute to the heart,
they express different genes and preferentially integrate into different parts of the heart.
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Figure 1.4 First and second heart fields. The contribution of the first heart field (red)
and the second heart field (green) to the different components of the heart over
developmental time. This illustrates the main heart field that contributes to a given area.
In the embryo, the contribution of first heart field and second heart field cells to a given
area is not as well-defined. Ao, aorta; LA, left atrium; LV, left ventricle; OFT, outflow
tract; RA, right atrium; RV, right ventricle. Adapted from (Zaffran, Robrini, and Bertrand
2014). No permission needed to reproduce.

9

1.4 Calcium signaling and heart development
Cardiomyocyte contraction in embryos, which begins at mouse embryonic day 8
(e8) and corresponds with heartbeat onset, is accomplished by calcium channels, located
on the plasma membrane (voltage-gated channels and NCX (a sodium/calcium
exchanger)) and on the sarcoplasmic reticulum (RyR (Ryanodine Receptor), IP3R
(calcium release channel), and SERCA (calcium release pump)), changing calcium
concentrations (Brade et al. 2013; Rapila, Korhonen, and Tavi 2008). In embryos, this
contraction is started by calcium released by IP3R and amplified by RyRs (Rapila,
Korhonen, and Tavi 2008). Excess calcium in the cell, caused by IP3R and the RyRs,
triggers calcium removal by NCX and SERCA, which results in current (Reppel et al.
2007). Inward current then activates voltage dependent sodium and calcium channels
(such as CACNA1C), which causes an action potential (Rapila, Korhonen, and Tavi
2008). Thus, CACNA1C and RyRs are responsible for increasing calcium levels in the
cell, and NCX and SERCA are responsible for decreasing calcium levels in the cell.
Since embryos lack many adult structures, such as pacemaker cells, they are reliant on
these spontaneous contractions for their heart to beat. In contrast, adult cardiomyocytes
are less dependent on these spontaneous contractions and become more dependent on
pacemaker cells (Louch, Koivumaki, and Tavi 2015). Calcium signaling must have a
critical role in embryonic function, since an initial framework is set-up early on to allow
it to occur before all of the structures are made.
Cacna1c is a L-type calcium channel that is expressed in many tissues, but is the
main L-type calcium channel in the heart (Takimoto et al. 1997). Thus, it is unsurprising
that Cacna1c knockouts in mouse or fish result in cardiomyocytes exhibiting abnormal
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beating and lethality by e14.5 (Rottbauer et al. 2001; Seisenberger et al. 2000). Likewise,
embryos cultured with the calcium blockers nifedipine and verapamil have cardiac
abnormalities (large left ventricle, no right ventricle, and a thin outflow track) and
abnormal expression of cardiac genes: Gata4 and Mylpc (Porter, Makuck, and Rivkees
2003). Thus, calcium signaling, particularly by CACNA1C, is so important in embryonic
function that mice cannot live without it. However, by doing a full embryo knockout or
knockdown, these studies are incorporating the non-cardiac effects of Cacna1c. Another
study made adult cardiomyocyte-specific knockouts, which resulted in cardiomyopathy
or cardiac hypertrophy (Goonasekera et al. 2012; Blaich et al. 2012). Similarly, variants
in human calcium channel genes lead to cardiomyopathies (Boczek et al. 2015; Kepenek
et al. 2020; Xu et al. 2018). These studies more definitively link normal Cacna1c
expression with normal heart development. Given its importance in heart development, it
is not surprising that there are several transcription factors that regulate its expression,
such as NFAT5. When Nfat5 is knocked-down, it phenocopies the effect of the Cacna1c
knockout (Li et al. 2016). Thus, CACNA1C is a calcium channel that is necessary for
embryonic function and cardiac development.
While there are three RyR proteins, Ryr2 is a calcium release channel mainly
expressed in cardiomyocytes. Similar to Cacna1c mutants, mice that lack Ryr2 are e10
lethal and have abnormal sarcoplasmic reticulums in their heart tubes. While mouse
hearts can beat without RYR2, the cardiomyocytes exhibit calcium transients, but have
no response to caffeine, an activator of RyRs. Thus, RYR2 is important for calcium
transients, but it is not the only factor that contributes to heart contraction (Takeshima et
al. 1998; Takeshima 2002). In addition to mouse studies, RYR2 has been studied in cell
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culture, which makes it easier to discern the role of RYR2 in an individual cell type.
Ryr2-/- embryonic stem cells are able to differentiate into beating cardiomyocytes, but the
beating rate is decreased. While the amplitude of the calcium transients is the same with
or without Ryr2, the transients without Ryr2 are less frequent (Fu et al. 2006; Yang et al.
2002). The cell culture and mouse experiments come to the same conclusion that RYR2
is important for certain aspects of calcium transients and is not critical to produce heart
beats. Therefore, Cacna1c loss has more morphological abnormalities than Ryr2 loss.
Given the weaker phenotype of Ryr2 mutants compared to Cacna1c mutants, it is not
surprising that calcium transients are minimally affected by sarcoplasmic reticulum
inhibitors, but abolished by L-type calcium channel blockers. This indicates that Cacna1c
is the primary channel used in embryonic calcium signaling (Liu et al. 2002). Even
though Cacna1c is the primary calcium channel, Ryr2 is necessary for normal embryonic
calcium signaling and embryonic viability.
SERCA and NCX are calcium pumps responsible for returning the calcium levels
back to homeostatic levels after an action potential. SERCA2A, the cardiac and skeletal
muscle isoform, is a calcium pump that pumps calcium back into the sarcoplasmic
reticulum, which causes muscle relaxation (Lytton et al. 1989). NCX is a sodium-calcium
exchanger that regulates intracellular calcium in the heart (Cho et al. 2000). Similar to
Cacna1c-/- and Ryr2-/- mice, Serca2a-/- mice and Ncx-/- mice are embryonic lethal. The
main phenotypes of Ncx-/- mice are weak heart contractions and growth retardation.
Interestingly, Serca2a+/- mouse hearts have a phenotype: reduced calcium uptake in the
sarcoplasmic reticulum and reduced cardiovascular performance (Periasamy et al. 1999;
Cho et al. 2000). There was a debate in the field as to whether both of these calcium
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pumps, particularly SERCA2A, function in embryos. Interestingly, calcium transients
occur and are rapidly decayed even in the absence of Ncx. This suggests that SERCA2A
actively removes calcium in embryos (Conway et al. 2002). However, if Ncx-/- hearts are
stressed (stimulated at a higher frequency or in the presence of caffeine), diastolic
calcium levels increase. This phenotype in the presence of Serca2a indicates that
SERCA2A and NCX may serve distinct roles in calcium removal. Strikingly, SERCA2A
is not upregulated to compensate in Ncx-/- hearts, but instead is also downregulated. Since
Ncx-/- hearts having fewer sarcomeres, the sarcomeric protein SERCA2A is also
decreased (Reuter et al. 2003). Therefore, NCX and SERCA2A serve essential, nonredundant roles in calcium removal after an action potential in embryonic hearts.
1.5 Cardiac sarcomeres
An important component of the heart and skeletal muscle is the sarcomere, which
is the contractile unit of cardiomyocytes. The sarcomere is composed mainly of actin,
actinin, myosin, and titin in a well-defined lattice structure. It can be further divided into
regions: Z-band, I-band, A-band, H-zone, and M-band (Fig. 1.5). The Z-bands are the
electron dense regions that form vertical lines in electron microscopy images. In fact, a
sarcomere is defined as the region between two Z-bands. The I-band is the region
adjacent to the Z-band that contains no myosin filaments, while the A-band is the region
containing the myosin filaments. The H-zone is the region that contains no actin
filaments, and the M-band is at the center of it (Henderson et al. 2017). In the rest of this
section, we will explore the protein components and the regions in more detail.
While the A-band and the I-band are important, we will focus on the Z-band and
the M-band. Both the Z-band and the M-band anchor the sarcomeric components in
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Figure 1.5 Schematic of a sarcomere. The sarcomere is mainly made up of actin
(green), actinin (black), myosin (purple), titin (red), and myomesin (blue). A sarcomere is
defined as the region between two Z bands. The I band is the region that contains no
myosin filaments, only actin filaments. The A band is the region that contains myosin
filaments. The H zone is the region that contains no actin filaments, only myosin
filaments. The M Band is the center of the H Zone that contains myomesin.
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place. Given the high amounts of force exerted on the components by contraction,
ensuring that the sarcomere does not lose its rigid structure is critical. The Z-band, which
contains actinin, is the location where the actin and titin filaments are anchored. The Mband, which contains myomesins, physically attaches the myosins to each other
(Henderson et al. 2017; Grove et al. 1984). It functions to balance out the forces caused
by contraction (Agarkova and Perriard 2005). Further, by locking the myosins in place,
the M-band organizes the myosins into A-bands. The M-band becomes more prominent
over development, as the component composition changes over time. For example, the
embryonic splice variant of myomesin has an elastic domain in the middle, so it is not
able to be seen on TEM (Agarkova et al. 2000). The M-band is important for sarcomere
function, since when it is absent (by deleting obscurin), mice have reduced endurance.
Obscurin, a component of the M-band, is also important for A-band formation, myosin
incorporation, and attaching the sarcomere to the sarcoplasmic reticulum (Lange et al.
2009; Kontrogianni-Konstantopoulos et al. 2006; Randazzo et al. 2017). Given the
importance of the M-band in the sarcomere, it is not surprising that there are many
regulatory mechanisms in place to ensure the normal expression of the M-band
components. Two such proteins that regulate Myomesin and Titin, M-band components,
are the RNA splicing factors RBM20 and RBM24 (Yang et al. 2014; Schneider et al.
2020; Cai et al. 2019). Thus, the M-band and the Z-band have critical roles in allowing
the sarcomeres to function normally.
Titin is a unique protein in that it spans half of the sarcomere, and is therefore in
each of the regions of the sarcomere. Since titin is a very large protein, it contains many
domains and has unique properties in each region. One of the roles of titin is to act as a
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molecular spring, which gives the sarcomere is mechanical properties (Henderson et al.
2017). Additionally, there is a lot of evidence to support that titin acts as a molecular
ruler; it is hypothesized that the length of titin is proportional to the length of the
sarcomere. It is thought that titin ensures correct sarcomere length by acting as a template
for myosin fibers to form along. This is supported by the fact that titin is always half the
size of the sarcomere, even though different types of sarcomeres are different lengths.
Also, when titin is genetically manipulated to be smaller by deleting domains, the
sarcomere shrinks proportionally (Bennett, Rees, and Gautel 2020; Tonino et al. 2017). A
third role of titin in the sarcomere is to attach to the myosin and keep them at the center
of the sarcomere, to ensure equal forces are received from both sides of the sarcomere
(Nayak and Amrute-Nayak 2020). Thus, titin plays several crucial roles in the sarcomere.
It is also hypothesized that titin functions in the formation of the sarcomere,
which is referred to as sarcomerogenesis. This hypothesis is supported by sarcomere
disassembly occurring when certain exons of titin are conditionally deleted in the heart
(Gotthardt et al. 2003; Mayans et al. 1998). Sarcomerogenesis begins early in
development and continues until adulthood. While the myofibrils (contractile subunits of
the sarcomere) form early on, the sarcomeres get remodeled as the heart develops. How
this process occurs is not agreed upon, as there are several models that have been
proposed. The most accepted model, the premyofibril model, is the one that will be
discussed here. According to this model, stress fiber-like structures form containing
actinin, actin, and non-muscle myosin-II (NMM-2). Over time, as muscle myosin begins
to replace NMM-2, these structures become nascent myofibrils. Once these structures no
longer contain NMM-2 and only contain muscle myosin, they are referred to as mature
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myofibrils (Rhee, Sanger, and Sanger 1994). This model is supported by knockout
models of Nmm-2 failing to form the stress fiber-like structures, providing evidence that
incorporation of NMM-2 in stress fibers is necessary for their formation. Additionally,
knockout models of Nmm-2 result in mice with structural heart defects, providing
evidence that NMM-2 is necessary for sarcomere formation (Swailes et al. 2006; Duan
and Gallagher 2009; Tullio et al. 1997). While these are the agreed upon components to
form a sarcomere, there are a few other factors that are not as solidified. For example,
obscurin may be necessary for initiating normal structural organization (Borisov et al.
2006). Additionally, for these myofibrils to form mature Z-bands and normal myosin
organization, muscle contraction is required. Thus, if there is a mutation that prevents
contraction, the sarcomeres will not form correctly (Geach, Hirst, and Zimmerman 2015).
In summary, sarcomerogenesis is a multistep process that is critical for normal embryo
function.
The end result of sarcomerogenesis is functional contracting sarcomeres.
Contraction occurs as the myosin proteins attach to the actin filaments and pull the Zband towards the M-band (Henderson et al. 2017). It is regulated by the troponin
complex, which consists of troponin C, troponin I, and troponin T. Troponin T binds
tropomyosin, which attaches the troponin complex to actin. In the absence of calcium,
troponin I is positioned in such a way that myosin cannot bind actin. Thus, the troponin
complex keeps tropomyosin on actin, preventing contraction. However, when calcium
levels increase, troponin C undergoes a conformational change, which repositions
troponin I so that myosin is able to bind actin. By repositioning troponin I, tropomyosin
is able to relocate to its preferred position, which allows contraction to occur. This
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regulatory role of troponin is essential for normal cardiac and embryonic development. In
tnnt2 (a cardiac troponin) morphant zebrafish, myofibrillogenesis is abnormal due to loss
of actin-myosin activity regulation (Ferrante et al. 2011; Sweeney and Hammers 2018).
Further, Tnnt2-/- mice are embryonic lethal and do not have cardiac contractions (Nishii et
al. 2008; Ahmad et al. 2008). Thus, regulating contractions is not just necessary to
prevent too many contractions to occur, but it is also required for normal heart
development.
Now that regulation of contraction has been described, how the actin and myosin
fibers work together to cause the sarcomere to contract will be discussed. How the actin
and myosin are positioned relative to each other changes in a cyclic manner and causes
contraction. Muscle contraction is an active process, so ATP is consumed. The stage of
the ATP cycle drives the actin-myosin interactions by changing the conformation of the
myosin heads. At low levels of calcium, the troponin complex and tropomyosin prevent
interaction between actin and myosin. Thus, the myosin heads are at the surface of the
thick filament. At this stage (called super relaxed), the myosin filaments are bound by
ADP and inorganic phosphate. When calcium levels increase, actin is no longer blocked
by troponin and tropomyosin, so the myosin heads interact with the actin. Myosin
initially weakly binds to actin through electrostatic interactions. Over time, these
interactions become stronger, as hydrogen bonds form. Force occurs when myosin
changes positions, releasing the inorganic phosphate. This is called the power stroke.
After this stage, ADP is released from the myosin head and ATP binds in its place. ATP
decreases the affinity of myosin for actin, causing myosin to detach from actin. Once this
occurs, ATP is hydrolyzed into ADP and inorganic phosphate. The myosin heads return
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to the super relaxed state and the cycle starts over. Since each myosin undergoes the
cycle asynchronously, the sarcomere is able to contract (Sweeney and Hammers 2018;
Powers et al. 2021). Contracting sarcomeres in cardiomyocytes are very important for the
development and survival of higher-order animals, since it allows for nutrient and gas
exchange to occur in organisms too large for mere diffusion to accomplish this.
1.6 Studying heart development
There has been a lot of knowledge gained on heart development through mouse
studies. Mice are a great model system for many reasons, such as their short lifespan and
evolutionary closeness to humans (Vandamme 2014). However, there are known speciesspecies differences, particularly in epigenetic marks, that have functional effects (Hanna,
Demond, and Kelsey 2018). To study heart development without the interspecies
differences, there have been efforts to develop protocols to be able to differentiate human
pluripotent stem cells (hPSCs) into heart cells. Another advantage to this system is by
working with only one cell type, it is easier to determine the role of a given protein in a
given cell type. Initial efforts to differentiate hPSCs into cardiomyocytes and epicardium
were done using embryoid bodies, which is inefficient and produces variable results
(Kehat et al. 2001; Witty et al. 2014). Alternatively, monolayer-based differentiation
protocols have been developed, which yield more than 80% cardiomyocytes and 90%
epicardium. The methods involve modulating Wnt at precise times in the differentiation
protocol as well as adding insulin after the cardiac progenitor stage (Lian et al. 2013;
Bao, Lian, et al. 2017). The protocols for endocardium are not as well developed, since
they yield only 2% endocardial cells (Bao, Bhute, et al. 2017). A lot of progress has been
made to create model systems to study heart development.
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Even though these hPSC differentiation models are made from human cells, they
are just in vitro models. Using the above cardiomyocyte differentiation protocol, the fully
differentiated cardiomyocytes are approximately equivalent to e11.5 mouse
cardiomyocytes. Thus, neonatal or adult cardiomyocytes cannot be studied. Unfortunately
by using these systems, the cells are taken out of their native environment and may
behave differently because of their monolayer configuration and/or the lack of other cell
types. For example, cardiomyocyte differentiation ability in vitro is highly dependent on
cell cycle stage at the start of differentiation (Laco et al. 2018). It is unlikely that this
dependency occurs in vivo. While some progress has been made to make these in vitro
differentiated cardiomyocytes more like in vivo cardiomyocytes by forming tissues from
the cardiomyocyte cells, they are still not equivalent to in vivo hearts (Schwan et al.
2016). It is thus likely advantageous to use both the in vitro model to get the benefits of
working with human cells and the in vivo model to understand how the cardiomyocytes
work with the other cell types. Combining both models is exactly what this study does. In
chapter 4, the mouse model is used, and in chapters 5 and 6 the hPSC model is used. In
this case, the two models complement each other very nicely, as the results support each
other.
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Chapter 2: The role of epigenetics in heart development
2.1 Chromatin modifiers
Chromatin modifiers regulate transcription by controlling access to the DNA.
Since the addition and removal of chromatin modifications change DNA compactness,
proper control during development is critical. Chromatin modifications, such as
acetylation, methylation, and ubiquitination, occur on the four core histones (H2A, H2B,
H3, and H4) (Tan et al. 2011; Kouzarides 2007) (Fig. 2.1). Traditionally, chromatin
modifications were characterized as either transcriptionally activating, such as the trimethylation of histone 3 at lysine 4 (H3K4me3) or transcriptionally repressing, such as
the tri-methylation of histone 3 at lysine 27 (H3K27me3) (Cao et al. 2002; Bernstein et
al. 2005). However, it is becoming increasingly clear that many marks can be activating
and repressing, depending on the context of the surrounding marks (Berger 2007). Since
chromatin modifiers regulate the transcription of many genes, they have pleiotropic
effects on the developing embryo (Van Laarhoven et al. 2015). The purpose of this
chapter is to review the role of epigenetics in development. The following sections of this
chapter will address the role of epigenetic marks on development in general and the role
of epigenetic marks on heart development. Chapters 4-7 provide evidence to support the
role of H2Bub1, an understudied epigenetic mark, on in vivo cardiac development and in
vitro cardiomyocyte differentiation.
2.2 Role of the polycomb repressive complex on development
A theme of developing systems is changes in the epigenetic landscape over time.
A canonical example of epigenetics affecting development is the polycomb repressive
complexes. Polycomb repressive complex 1 (PRC1) and polycomb repressive complex 2
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Figure 2.1 Schematic of a nucleosome. Schematic of the four core histones (H2A, H2B,
H3, and H4) and some of the residues along their tails that can be modified by chromatin
modifiers (Roelen and Lopes 2008). Reproduced with permission.
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(PRC2) function together in long-term gene silencing (Simon and Tamkun 2002; Francis
and Kingston 2001). Even though the complexes work together, PRC1 is dependent on
PRC2 to function (Rastelli, Chan, and Pirrotta 1993). PRC2 was first identified in
Drosophila where it was determined that the repression is due to its histone
methyltransferase activity with specificity towards lysine 9 and lysine 27 of histone H3
(Czermin et al. 2002; Muller et al. 2002). The human homologue of PRC2 was isolated
and it contained EED, SUZ12, RbAp46, and RbAp48. Just like the Drosophila complex,
this complex has histone methyltransferase activity with specificity for K9 and K27 of
histone H3 (Kuzmichev et al. 2002; Cao et al. 2002). While PRC2 can act on both sites,
its activity on K27 is much stronger. Thus, PRC2 is usually studied in the context of K27.
One key question is how the addition of three methyl groups to a lysine leads to
repression. It is hypothesized that the epigenetic silencing is achieved in a multi-step
fashion. First, the PRC2 complex deposits H3K27me3. Since PRC1 binds H3K27me3, it
is predicted that H3K27me3 recruits PRC1. Given the large size of PRC1, it likely
sterically prohibits chromatin remodeling factors from binding to that region and opening
the chromatin (Shao et al. 1999). Thus, the region is closed because it cannot be opened.
Another key question is what guides the PRC2 complex to the correct spot to deposit
H3K27me3. There are many factors that contribute, such as non-core PRC2 subunits,
RNA molecules, and another histone mark, monoubiquitination of histone 2A on lysine
119 (H2AK119ub1) (Laugesen, Hojfeldt, and Helin 2019; Blackledge et al. 2014). The
concept of histone marks interacting with each other will be further discussed in section
3.3. Now that we have discussed how PRC2 functions, we will discuss its role in
development.
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In the mouse, all three components of the PRC2 complex (EZH2, SUZ12, and
EED) are essential for embryonic development. While the rest of this section will focus
on specific examples of certain PRC2 components affecting individual tissues, it is
important to note that this list is not exhaustive of all of the developmental functions of
PRC2 components, as all PRC2 complex components likely affect the development of
many tissues. One aspect of development that all PRC2 components are necessary for is
gastrulation. Additionally, EZH2 is necessary for skeletal muscle differentiation, SUZ12
is necessary for normal differentiation, and EED is necessary for generating a normal
amount of mesoderm (Pasini et al. 2007; O'Carroll et al. 2001; Caretti et al. 2004; Faust
et al. 1998). Thus, repressing certain genes at precise times is necessary for normal
development. For example, EED is necessary to repress neuronal genes in embryonic
stem cells (ESC) (Azuara et al. 2006). The reason these proteins are so crucial for early
development is in part due to their role in Hox gene regulation. Hox genes are regulated
by the balance between H3K4me3 (activating mark) and H3K27me3. Initially,
H3K27me3 covers the entire Hoxd gene cluster and it is transcriptionally silent.
Gradually, H3K27me3 marks are removed and the genes are expressed. At the same time,
H3K4me3 marks are added. However, the H3K4me3 markings are sometimes added
before the gene is active. Thus, in this case, H3K4me3 is pre-marking genes to be
activated (Soshnikova and Duboule 2009). In conclusion, regulation of H3K27me3 in
development is a well characterized system that serves as a nice example for illustrating
the essential nature of epigenetic marks in allowing the organism to develop normally.
The subsequent sections will focus on other epigenetic marks and their role in heart
development.
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2.3 Role of histone methylation on heart development
In the previous section, the essential nature of chromatin modifiers in
development was established; chromatin modifiers are also essential in heart
development. A study profiled various histone marks, H3K27me3, H3K4me3, H3K4me1,
and H3K27ac, throughout development and identified dynamic chromatin patterns
throughout cardiac lineage commitment. The correlation of chromatin patterns with
stage-specific gene expression suggests that normal regulation of chromatin
modifications is important for cardiomyocyte development. Additionally, since these
marks are spatially and temporally dependent, this highlights the importance of
investigating different developmental time points in just one type of cell (Wamstad et al.
2012). That is exactly what this body of work does. In chapter 5, H2Bub1 is characterized
in just cardiomyocytes throughout cardiomyocyte differentiation.
In addition to profiling histone marks, functional analyses with histone modifier
knockouts were performed. For example, it was determined that KMT2D, a H3K4
methyltransferase, is important for depositing activating marks (H3K4me1 and
H3K4me2) on ion transport and cell cycle regulation genes in cardiomyocytes. Its
absence in the whole embryo and in several cardiac specific knockouts results in
embryonic lethality (Ang et al. 2016). Thus, histone methylation on H3K4 is essential in
mouse development and mouse cardiac development. H3K4 methylation was further
investigated in zebrafish using mutants in both Kmt2d and a H3K4 demethylase, Kdm6a.
It was determined that the correct deposition of these marks is important for normal heart
morphology and looping (Van Laarhoven et al. 2015). Thus, both too little and too much
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H3K4 methylation results in abnormal cardiac development, so precise regulation of
H3K4 methylation is necessary.
While H3K4 is one of the more well-studied residues for histone methylation, it is
not the only residue that can be methylated. H3K27 is another residue that can be
methylated, as described in section 2.2. PRC2 is necessary for heart development, as
heart-specific knockouts of PRC2 components leads to hypertrabeculation, less compact
myocardium, and ventricular septal defects (Ai et al. 2017). Thus, PRC2 is not just
necessary for early embryonic development, but it is also required for normal cardiac
development. H3K79 is another such residue, and the methylation is catalyzed by
DOT1L, a histone methyltransferase. DOT1L deposits activating marks on genes
essential for mesoderm development, such as Brachyury, and pre-marks genes essential
for cardiac commitment, such as Tnni3 (a cardiac troponin) (Cattaneo et al. 2016).
Similar to the other histone methylation sites, H3K79me2 plays an essential role in
creating a normal heart. Therefore, precise regulation of histone methylation at numerous
residues is not only required for embryonic viability, but also for normal heart
development and function.
2.4 Role of histone acetylation on heart development
Another group of histone modifiers that are well-studied in heart development is
the histone acetyltransferases. Unlike methylation that can be activating or repressive
depending on the residue, acetylation is typically activating. Acetylation loosens the
chromatin, which opens up the DNA, making it more accessible to be transcribed
(Clayton, Hazzalin, and Mahadevan 2006). As with the histone methyltransferases, there
are many sites along the tails of the histones that can be acetylated. H3K9 acetylation,
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catalyzed by MOZ (a histone acetyltransferase), is required for normal aortic arch
development and septation. In fact, if Moz is deleted, the result is embryonic lethality.
One site that MOZ deposits an acetyl group is at the Tbx1 locus, which is a key cardiac
transcription factor. In fact, the phenotype resulting from a Moz mutant is rescued by a
Tbx1 transgene. It was determined that MOZ is essential in the mesoderm for normal
cardiac development to occur (Voss et al. 2012; Vanyai, Thomas, and Voss 2015). Thus,
MOZ and H3K9ac are essential for normal cardiac development and embryonic survival.
Unlike methyltransferases, there are some generic acetyltransferases and
deacetylases that act on all four histone tails. The P300/CREBBP complex contains two
such acetyltransferases. When the histone acetyltransferase P300 is knocked-out, it leads
to pericardial effusions, fewer trabeculations, and less myosin heavy chain positive
cardiomyocytes (Yao et al. 1998). Even if P300 is haploinsufficient, cardiac defects, such
as edemas, less compact myocardium, ventricular septum closure defects, and abnormal
valve leaflets arise (Shikama et al. 2003). When P300 and other acetyltransferases are
inhibited using the drug curcumin, there are cardiac morphological defects and
dysregulation of important heart genes (such as Gata4 and Nkx2.5) throughout
development (Sun et al. 2014). Thus, the precise dosage of P300 is critical for heart
development, since any amount less than the optimal amount of P300 has adverse effects.
When the histone acetyltransferase Crebbp is knocked-out, embryos die around e9.5.
Similar to the P300 mutants, mice that are heterozygous for Crebbp also have a cardiac
phenotype. Most of the mice with cardiac defects have ventricular septal defects (Oike et
al. 1999). Therefore, altering the composition of the P300/CREBBP complex results in
embryonic lethality and gross cardiac malformations.
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In addition to acetyltransferases, histone deacetylases regulate heart development.
A double cardiac specific knockout of histone deacetylases 1 and 2 (Hdac1 and Hdac2)
causes cardiac morphological defects, cardiac arrhythmias, and cardiac stress
(Montgomery et al. 2007). Thus, as with histone acetyltransferases, HDACs are also
important for normal heart development. A drug that inhibits several histone deacetylases
prevents heart looping from occurring. Interestingly, HDACs promote heart looping by
activating Wnt/β-catenin signaling and increasing expression of genes required for heart
valve formation (Kim et al. 2012). This illustrates a major point of section 2.1; while
HDACS usually inhibit expression, chromatin marks are highly context dependent and
HDACs can activate expression. Regardless as to whether HDACs inhibit or promote
expression of genes, HDACs are critical for normal heart development and function. In
conclusion, histone modifiers play a critical role in ensuring that the heart develops
normally.
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Chapter 3: The monoubiquitination of H2B (H2Bub1)
3.1 H2Bub1 is evolutionarily conserved
Now that an introduction on histone modifications was provided (see chapter 2),
this section will focus on a particular understudied histone modification, the
monoubiquitination of H2B on K120 (H2Bub1). This modification is added by RNF20,
RNF40, and UBE2B (referred to as the RNF20-complex), and is removed by USP44
(Kim, Hake, and Roeder 2005; Fuchs et al. 2012; Kim et al. 2009) (Fig. 3.1). The
RNF20-complex components are evolutionarily conserved from yeast to human, but
unlike higher-order animals where the ubiquitin is added to the K120 residue, the
ubiquitin is added to the K123 residue in yeast (Robzyk, Recht, and Osley 2000; Wood et
al. 2003). Thus, H2Bub1 is an ancient histone modification with only slight changes over
time. Its conservation throughout evolution likely implies that it has an important role in
gene regulation. Surprisingly, this is an understudied mark with little definitively known
about it. The dearth of information about H2Bub1 is not only impeding knowledge about
a basic biological process, but it is also negatively impacting human patients, as variants
affecting H2Bub1 machinery have been linked to CHD (Robson et al. 2019). The purpose
of this chapter is to review what is known (and what is unknown) about H2Bub1. The
following sections of this chapter will address the components that deposit it, its
interactions with other histone modifications, its basic cellular functions, and its
connection with CHD. The role of H2Bub1 in heart development in vivo (chapter 4) and
in vitro (chapter 5), as well as a potential mechanism by which H2Bub1 functions
(chapters 6 and 7) will be discussed in future chapters.
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Figure 3.1 Schematic of the RNF20-complex. RNF20, RNF40, and UBE2B form a
complex, which adds a ubiquitin to the K120 residue of H2B. USP44 removes the
ubiquitin.
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3.2 The biochemistry and biophysics of the RNF20-Complex
Typically, ubiquitin is added to a protein to degrade it. However, if only one
ubiquitin is added to a histone, it modulates the activity of the neighboring genomic
region. Ubiquitin is added by the E1, E2, and E3 classes of enzymes, which activate the
ubiquitin and conjugate it to its substrate. The E1 protein activates the ubiquitin and
transfers it to the E2 protein. This protein forms a covalent bond between itself and the
ubiquitin. The E3 protein then catalyzes the transfer of the ubiquitin from the E2 protein
to the substrate on a lysine residue (Hershko and Ciechanover 1998). Since this is a
complex task, many E3 ligases form dimers; one ligase binds the E2 ligase, and the other
binds the ubiquitin (Budhidarmo, Nakatani, and Day 2012; Plechanovova et al. 2012;
Dou et al. 2012). There are many different classes of E3 proteins, and the RING (really
interesting new gene) class is the largest (Dye and Schulman 2007). Thus, the addition of
ubiquitin occurs through a sequential process and involves many proteins.
The RNF20-complex consists of an E2 ligase and two E3 ligases that dimerize.
The RNF20-complex components were first discovered in yeast; H2Bub1 is deposited by
Bre1, an E3 ubiquitin ligase, Rad6, an E2 ubiquitin-conjugating enzyme, and Lge1, a
scaffolding protein (Robzyk, Recht, and Osley 2000; Wood et al. 2003; Kim et al. 2018).
In mammals, these correspond to RNF20 and RNF40, UBE2B, and WAC, respectively
(Kim, Hake, and Roeder 2005; Kim et al. 2009; Zhang and Yu 2011; Gallego et al.
2020). It is of interest that yeast contain a single E3 ligase, while mammals contain two.
While it is generally accepted that RNF20 and RNF40 form a heterodimer in vivo, both
the RNF20 homodimer and the RNF40 homodimer have ligase activity in vitro. Thus,
although not yet observed in vivo, it is theoretically possible that RNF20 and RNF40
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could form homodimers. RNF20 and RNF40 are a part of the RING class of E3 proteins,
and thus contain a C-terminal RING domain. They also have helical regions, which form
coiled coils (Foglizzo, Middleton, and Day 2016). Unlike most E3 proteins that are able
to interact with many E2 ligases, RNF20 and RNF40 have specificity for UBE2B (Kim et
al. 2009). Therefore, RNF20, RNF40, and UBE2B form a complex that specifically adds
a single ubiquitin to K120 on H2B.
For this complex to function efficiently, it undergoes liquid-liquid phase
separation (LLPS) (Fig. 3.2a). Since the RNF20-complex undergoing LLPS has only
been seen thus far in yeast, the yeast nomenclature will be used to describe the process.
Lge1 contains two domains, an intrinsically disordered domain (IDR) and a coiled-coil
domain (CC). Its IDR domain is necessary for LLPS, binding Bre1, and allowing Bre1 to
oligomerize. Even though Lge1, through its IDR domain, can undergo LLPS on its own,
Bre1 can only undergo LLPS in the presence of Lge1. Lge1 forms the core of the
condensate, while Bre1, through the CC domain of Lge1, forms a shell around the Lge1
core. Thus, Lge1 serves as a scaffold around which Bre1 forms a shell. The properties of
this shell, thickness and organization, are highly dependent on the ratio of Bre1 to Lge1
(Fig. 3.2b). Once Bre1 is present in the condensate, Rad6 and the nucleosomes can be
recruited to the inside. Thus, LLPS gathers and organizes the H2Bub1 machinery and
substrate, increasing the rate of H2B monoubiquitination. Additionally, it is hypothesize
that LLPS is necessary for the proper localization of the mark. This is supported by
experiments that eliminate LLPS. In its absence, H2Bub1 changes its localization, since it
is reduced on the gene body (Gallego et al. 2020). Therefore, LLPS is important for
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Figure 3.2 Liquid-liquid phase separation of the RNF20-complex. Adapted from
(Gallego et al. 2020). Reproduced with permission.
(A) A simplified model for how liquid-liquid phase separation occurs. Bre1 forms a shell
around the Lge1 core. Rad6 (omitted) and the histones are present on the inside.
(B) Cartoons depicting what the condensate look like with different ratios of Lge1:Bre1.
If the ratio of full length Lge1 to only the IDR domain of Lge1 is altered (effectively
altering the amount of Lge1), the ability of Bre1 to form a shell around the condensate is
altered.
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H2Bub1 because it concentrates the core components, increasing the likelihood that H2B
monoubiquitination will occur.
3.3 Histone cross talk
Chapter 2 started with the idea that chromatin marks are context dependent. This
is partially due to the fact that histone marks interact with each other. In this section,
some examples of histone marks that interact with each other will be highlighted. There
are many developmental gene promoters that contain both H3K4me3 (activating mark)
and H3K27me3 (repressive mark), which is most prevalent in ESCs. This combination of
marks on the same gene, referred to as bivalent, seems counterintuitive. In this state, they
are thought to be poised, able to be rapidly activated or inhibited based on genetic and/or
environmental cues. One study determined that there exist genes that contain both marks,
and those genes are expressed at low levels, despite the presence of H3K4me3. Further,
when these cells were differentiated, some of these genes lost H3K27me3 and became
expressed, and others lost H3K4me3 and became repressed (Bernstein et al. 2006). A
different lab came to the same conclusion using replication timing as a proxy for
chromatin accessibility, since early replicated regions are more accessible. Some
neuronal genes replicated early in ESCs, even though they are not expressed. In
differentiated non-neuronal cells, these genes replicated later. This is due to the fact that
in ESCs these genes are bivalent, but in the differentiated cell they are repressed.
Interestingly, when a component of the PRC2 complex is deleted in ESCs, neuronal
genes become expressed, which supports the idea that they are marked by H3K4me3 as
well (Azuara et al. 2006). Thus, the two opposing marks work together to allow for genes
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to quickly be able to be activated or repressed, allowing for normal developmental
progression.
Histone marks do not have to be on the same histone tail. H2Bub1 interacts with
H3K4me3 and H3K79me2. It was determined that in the absence of H2Bub1, H3K4me3
is also absent (Sun and Allis 2002; Dover et al. 2002). H2Bub1 interacts with the Set1
methyltransferase subunit of the complex that deposits H3K4me3, the COMPASS
complex (Weake and Workman 2008). More specifically, CPS35 is a component of the
COMPASS complex that only associates with the complex in the presence of H2Bub1.
Thus, H2Bub1 affects the stability of the complex. Additionally, CPS35 will only
associate with chromatin in the presence of H2Bub1. Since CPS35 is required for the
COMPASS complex’s methyltransferase function, without H2Bub1, this complex cannot
generate H3K4me3 (Lee et al. 2007). H3K4me3 being an activating mark and H2Bub1
triggering the deposition of H3K4me3, suggests that H2Bub1 and H3K4me3 cooperate to
activate genes. See section 3.4 for more details on whether H2Bub1 is an activating mark.
Similar to H3K4me3, H3K79me2 also requires H2Bub1 (Ng et al. 2002; Briggs et al.
2002). One potential mechanism is through CPS35. There is some evidence to suggest
that CPS35 and DOT1L physically interact. Thus, by interacting with the COMPASS
complex, H2Bub1 could be indirectly affecting H3K79me2 deposition in addition to
directly affecting H3K4me3 deposition (Lee et al. 2007). Additionally, there is evidence
to suggest that H2Bub1 directly stimulates DOT1L activity, likely allosterically
(McGinty et al. 2008). Thus, histone marks do not act in isolation, but rather interact with
neighboring marks, and the sum total of the marks on a gene dictates its expression level.
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3.4 H2Bub1 is deposited on the gene body and is likely activating
Now that the components of the RNF20-complex and how it interacts with the
other histone modifications have been established, the function of H2Bub1 can be
discussed. Most marks, such as H3K4me3, form a single peak upstream of the gene body
(Liang et al. 2004). However, there are some exceptions, such as H3K36me3, which is
enriched in the gene body, particularly at the 3’ end (Pokholok et al. 2005). Notably,
H2Bub1 is located on gene bodies, where it is enriched near the promoter and gradually
decreases towards the 3’ end. Thus, it does not form peaks, but rather coats the entire
gene body (Jung et al. 2012).
One open question is how the H2Bub1 coat affects the gene it is located on.
Unlike histone acetylation which alters the charge on the histone tail to change DNA
compactness, histone monoubiquitination does not. Given its large size, it was originally
proposed that H2Bub1 is merely a steric inhibitor. However, it has been demonstrated
that replacing it with another large chromatin modification (SUMO) does not allow for
H3K4 to be methylated. Since H2Bub1 has a key interaction with H3K4me3 (see section
3.3 for a full discussion), it is clear that its size is not the only aspect to its biochemical
function. One theory for how H2Bub1 affects chromatin is that it stabilizes the
nucleosome, activating the region of DNA (Chandrasekharan, Huang, and Sun 2009).
Another theory is it interferes with chromatin compaction and interactions between
fibers, keeping the surrounding DNA in an open state (Fierz et al. 2011). While there are
two biochemical theories as to how H2Bub1 affects the histones, both assume that
H2Bub1 is activating. Interestingly, genetic experiments tell a different story; they
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provide contradictory evidence as to whether this coat is activating or repressive. The rest
of this section will review this literature.
In most chromatin contexts, H2Bub1 is probably an activating mark.
H2Bub1interacts with the Set1/COMPASS methyltransferase complex, which in most
chromatin contexts creates an activating mark (Lee et al. 2007). See section 3.3 for a full
description of histone cross talk. In yeast, it was shown that H2Bub1 is required for
activating some genes and is absent from two well-established regions of repressed
chromatin (Kao et al. 2004). Further, H2Bub1 is preferentially located in the gene body
of highly expressed genes, suggesting it plays a role in keeping the genes highly
expressed (Minsky et al. 2008). This association with active genes and activating
chromatin marks, and lack of association with inactive genes supports the idea that
H2Bub1 is activating, but does not show causation. Additional lines of evidence to
support that H2Bub1 is activating is its positive association with transcription. WAC
helps couple H2Bub1 with transcription by helping the complex associate with RNA Pol
II (Zhang and Yu 2011). Additionally, RNF20 activates transcription of many genes and
interacts with transcriptional activators (P53 and P300) (Kim, Hake, and Roeder 2005).
Thus, the role of H2Bub1 as a positive regulator of transcription provides more concrete
evidence that H2Bub1 is an activating mark.
While these studies make it seem like H2Bub1 is definitely activating, it is not
that simple; there are many studies that suggest that H2Bub1is both activating and
repressive depending on the context. In Rnf40 knockouts, there are genes near regions
that lost H2Bub1 and also have increased expression, suggesting H2Bub1 can also be
repressive (Xie et al. 2017). Similarly, when RNF20 is knocked-down, there are genes
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with decreased H2Bub1 that are repressed and others that are activated (Shema et al.
2008). Thus, these data demonstrate that H2Bub1 is activating some genes, repressing
some genes, and appearing not to affect most genes. Further, Rad6 is required for
telomeric gene silencing, solidifying the role of H2Bub1 in repressing gene transcription
(Huang et al. 1997). Other studies show that the H2Bub1 deubiquitinases are required for
transcriptional activation. USP22, one such deubiquitinase, is required for transcriptional
activation (Zhang et al. 2008). Additionally, when Ubp8, another deubiquitinase, is
knocked-out, there are some genes that are activated and others that are repressed (Mutiu
et al. 2007). From these data on the activating role of histone deubiquitinases, one can
deduce that histone ubiquitination must also have an inhibitory role.
Further evidence suggests that gene activation requires both the addition and
removal of H2Bub1 (Henry et al. 2003). This was validated by yeast experiments that
show that the SAGA complex, which contains a deubiquitinase, is recruited after Rad6.
This implies that the H2Bub1 mark is added and then instantly removed (Kao et al.
2004). With these conflicting studies, the effect of H2Bub1 on transcriptional regulation
is not well understood. Likely, H2Bub1 is both activating and repressive, depending on
the chromatin context.
3.5 H2Bub1 regulates transcriptional efficiency
Another contentious matter, in addition to whether H2Bub1 is activating (detailed
in section 3.4), is how (and if) H2Bub1 affects transcriptional efficiency. There are many
lines of evidence to suggest that H2Bub1 affects transcription in a positive way. H2Bub1
is deposited co-transcriptionally and co-localizes with RNA Pol II. As a result, H2Bub1
is highly correlated with transcriptional elongation, hinting at a positive regulatory
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mechanism (Fuchs et al. 2014). Other studies show that RNF20-complex components
have direct interactions with the RNA transcriptional machinery. The N-terminal domain
of WAC recognizes RNA Pol II, which causes the RNF20-complex to associate with
RNA Pol II (Zhang and Yu 2011). This suggests, through correlation, that the RNF20complex is related to transcription. Additionally, in yeast, the Paf1 complex (positive
regulator of transcriptional elongation) has a direct and specific interaction with Bre1
(Kim and Roeder 2009). Further, the deposition of H2Bub1 is dependent on PAF. These
data together imply that RNA transcription affects H2Bub1. H2Bub1 also positively
regulates the histone chaperone FACT, which promotes transcriptional elongation (Pavri
et al. 2006). H2Bub1 stimulating a protein that promotes transcriptional elongation
solidifies the positive relationship between H2Bub1 and transcription.
Further evidence suggesting a positive role for H2Bub1 on transcriptional
elongation is the fact that many long genes are preferentially affected by loss of H2Bub1.
A simple study was done in yeast, where the ratio of acid phosphatase activity for a long
versus a short gene was calculated (a proxy for transcriptional elongation efficiency) in
several mutants to measure the transcriptional elongation efficiency. Based on this ratio,
it was determined that the transcriptional elongation efficiency was decreased in bre1
mutants (Gaillard et al. 2009). This experiment was scaled up to include all genes in
mammals. In this experiment, it was determined that long genes are more likely to
depend on RNF20 to be induced upon differentiation into neuronal cells. Interestingly,
the genes that do not depend on RNF20 for neuronal differentiation tend to be expressed
higher in induced pluripotent stem cells (iPSCs) than the RNF20 dependent ones,
suggesting that RNF20 is important for turning on genes (Fuchs et al. 2012). From these
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data, one can conclude that H2Bub1 has a positive effect on transcription, but it is not
that simple.
There is also some evidence to suggest that H2Bub1 negatively affects
transcription and different contradictory evidence that H2Bub1 does not affect
transcription at all. Some pro-oncogenic genes, located in regions of compact chromatin,
are selectively repressed by RNF20 through inhibiting recruitment of TFIIS (which
prevents RNA Pol II from stalling). By inhibiting the interaction between TFIIS and the
PAF1 complex, it effectively blocks transcriptional elongation. Interestingly, this
repression by RNF20 and TFIIS is not global, but rather on a very specific set of genes
(Shema et al. 2011). This study provides evidence that RNF20 actually inhibits
transcriptional elongation, which is in direct contrast to the previous studies described.
Interestingly, increased H2Bub1 levels, due to mutations affecting deubiquitination,
result in embryonic lethality in mice, but do not affect global RNA Pol II transcriptional
elongation in mouse embryonic stem cells (mESCs) or mouse embryonic fibroblasts
(MEFs) (Wang et al. 2021). This implies that H2Bub1 has no effect on transcription.
However, they neglected to investigate whether transcriptional elongation affects certain
classes of genes, which is the topic of section 7.4. Given these conflicting results, it is
hypothesized that the role of H2Bub1 on transcriptional elongation may be contextdependent.
3.6 Known cellular functions of H2Bub1
While the role of numerous chromatin modifiers is known in heart development,
how H2Bub1 affects heart development is largely unknown (see chapter 2 for a full
discussion on the role of histone modifiers in heart development). Even though its role in
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heart development is largely unknown, several other roles are better defined. This section
will be focused on some of the known roles H2Bub1 has outside of heart development,
such as development, DNA damage, and cancer.
H2Bub1 is important for normal development of many organisms. It is observed
as early as the late 1-cell stage in mice (Ooga, Suzuki, and Aoki 2015). Additionally,
upon differentiation into many cell types (neurons, keratinocytes, osteoblasts, adipocytes,
neurospheres and oligodendrocytes) in many organisms (human, mouse, and
Drosophila), H2Bub1 increases (Fuchs et al. 2012; Karpiuk et al. 2012; Chen et al.
2012). Both of these data together suggest a role for H2Bub1 early in development. If
Rnf20 is knocked-down, a significant number of embryos die at the blastocyst stage
(Ooga, Suzuki, and Aoki 2015). Additionally, if Rnf20 is knocked-down in stem cells,
fewer cells can differentiate. Interestingly, RNF20 is not required for maintenance of
pluripotency-related genes (Chen et al. 2012). Similar to the Rnf20 knockdowns, RNF40
is also required for human osteoblast and human adipocyte differentiation. (Karpiuk et al.
2012).This more conclusively shows that RNF20 has an essential function in early
development. Neurons derived from RNF20 knockdown stem cells have increased
expression of pluripotency genes and decreased expression of neuronal genes.
Interestingly, it was determined that neurons derived from USP44 knocked-down stem
cells have the same phenotype. This suggests that H2Bub1 turnover is necessary for
differentiation (Fuchs et al. 2012). Additional studies in neuronal development
demonstrate that RNF20 is both necessary and sufficient for astrocyte production. (Liang
et al. 2018). Looking later in development, if RNF20 levels are abnormal in human cell
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lines, the Hox genes are also misregulated (Zhu et al. 2005). Thus, the RNF20-complex
and H2Bub1 are required at many stages of development.
H2Bub1 is also known to function in the DNA damage and cell death pathways.
H2Bub1 occurs at double stranded breaks and RNF20 is recruited to these sites. Further,
if H2Bub1 levels are reduced, less double stranded break repair occurs and there are
defects in homologous recombination repair. Together, this indicates a role for chromatin
remodeling in double stranded break repair (Shiloh et al. 2011; Chernikova et al. 2010;
Moyal et al. 2011; Nakamura et al. 2011). Another cause of double stranded breaks is
altered mRNA processing. Rnf20 or Rnf40 depletion causes issues with mRNA
processing, and therefore might cause double stranded breaks and DNA damage
(Chernikova et al. 2012). Another cause of DNA damage is unequal chromosome
segregation, which H2Bub1 also regulates. H2Bub1 is responsible for centromeric
chromatin maintenance in S. pombe and human cells. A transient amount of centromeric
H2Bub1 promotes noncoding transcription, which regulates centromere integrity and
chromosomal segregation. Thus, H2Bub1 deficient cells have unequal chromosome
segregation, which causes DNA damage (Sadeghi et al. 2014). One effect of DNA
damage is cell death through autophagy or apoptosis. Rnf40 depletion leads to decreased
cell growth, increased apoptosis, and increased micronuclei (Chernikova et al. 2012).
Additionally, in yeast, Bre1 prevents apoptosis by conferring protection from hydrogenperoxide related cell death. Deletion of bre1 promotes cell death and a reduced lifespan
(Walter, Matter, and Fahrenkrog 2010). Thus, one function of H2Bub1 is to keep DNA
damage low to prevent apoptosis. Interestingly, under starvation, USP44 decreases
H2Bub1 levels, which causes autophagy to occur through activation of autophagy related
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genes (Chen et al. 2017). Therefore, by altering H2Bub1 levels, apoptosis or autophagy
can occur.
RNF20 is also known to function in cell size and cancer. In S. cerevisiae, it was
determined that Rad6, Bre1, and Lge1 regulate cell size (Hwang et al. 2003). In
mammals, RNF20 and RNF40 are known to regulate spindle assembly and cell
proliferation, which indirectly affects cell size (Duan et al. 2016; Wang et al. 2013).
Since cell size and proliferation are pathways involved in cancer, it is unsurprising that
RNF20 and RNF40 have been implicated in several cancers, such as breast carcinomas,
mixed-lineage leukemia, HER2-positive breast cancer, and colorectal cancer. The
mechanisms behind how RNF20 causes cancer are related to spindle assembly,
proliferation, actin-cytoskeleton dynamics, inflammation, and overexpression of protooncogenes (Duan et al. 2016; Wang et al. 2013; Wegwitz et al. 2020; Tarcic et al. 2016;
Shema et al. 2008). In conclusion, even though there is a lot of information regarding the
role of RNF20 in basic cellular processes, there is still a lot that is unknown.
3.7 Variants in RNF20-complex components are significantly enriched in congenital
heart disease patients
Now that the well-defined roles of the RNF20-complex have been described, this
section and the next section will describe the little that is known about its role in heart
development. The idea that RNF20 could have a function in heart development comes
from its connection to CHD. There is at least one variant that is correlated with CHD in
every core component of the RNF20-complex (Jin et al. 2017; Homsy et al. 2015; Zaidi
et al. 2013) (Fig. 3.3a). All of these variants are absent from the gnomAD database,
which indicates that these specific mutations are absent from the general population.
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Figure 3.3 Variants affecting the RNF20-core complex are identified in patients with
congenital heart disease (Robson et al. 2019). No permission needed to reproduce.
(A) 3 patients with variants in the RNF20-core complex were identified. An outline of the
genes identified, the mode of inheritance, the variant in the gene, and the patient
phenotypes are displayed. CAVC, complete atrioventricular canal; HLHS, hypoplastic
left heart syndrome; L-TGA, levo-transposition of the great arteries; PA, pulmonary
atresia; RAA, right aortic arch; RAI, right atrial isomerism; TAPVR, total anomalous
pulmonary venous return; TOF, tetralogy of Fallot.
(B) Diagram of the location of the patient variants (indicated by the red arrows) in the
genes.
(C) Transmission electron microscopy of tracheal cilia from the patient with the RNF20
variant (top) and of control tracheal cilia (bottom). Outer dynein arms (indicated by the
blue arrows) and inner dynein arms (indicated by the red arrows) are shown.
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Thus, it can be inferred that having one of these mutations is likely disease-causing. The
variants in the RNF20 and RNF40 genes are predicted to be loss of function variants, and
the UBE2B variant is a point mutation at the predicted interaction site with RNF20
(Foglizzo, Middleton, and Day 2016; Robson et al. 2019) (Fig. 3.3b, 3.4). An additional
analysis of the role of the 45 proteins that the RNF20-complex interacts with in CHD was
performed. The de-novo expectation analysis, a test for enrichment in de-novo mutations,
showed a significant enrichment in loss of function, protein-altering, and proteindamaging mutations (loss of function and damaging missense) in CHD patients, but not
in controls (Robson et al. 2019) (Table 3.1). Overall, these data suggest an involvement
for the RNF20-complex and H2Bub1 in heart development.
As observed in CHD patients with variants in other chromatin modifiers, the
phenotypes of the patients with these variants exhibit the full range of CHD phenotypes.
Five of the fourteen patients with variants in the RNF20-complex had left-right (LR)
patterning defects (see section 3.8 for more detail on the role of RNF20 in LR
patterning). The patient with the RNF20 variant had heterotaxy, where some or all of the
organs are located on the wrong side of the body (Fig. 3.3a). This patient had non-cardiac
phenotypes as well, such as chronic respiratory failure and absence of inner dynein arms
in tracheal cilia (Robson et al. 2019) (Fig. 3.3c). This indicates that while RNF20 is
necessary for heart formation in human patients, it also functions in other organs.
Together, these data illustrate that further studies are needed to investigate the role of
RNF20 in heart development.
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Figure 3.4 Crystal structure of the RNF20-complex. A model of where the
components of the RNF20-complex interact. Note that RNF20 and UBE2B have a direct
interaction (Foglizzo, Middleton, and Day 2016). Reproduced with permission.
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Table 3.1 De-novo enrichment analysis of the RNF20-interactome genes. (Robson et
al. 2019). No permission needed to reproduce.

Significant enrichment is illustrated by bold red text. Syn, synonymous mutation; D-Mis,
meta-SVM damaging; Protein-damaging, loss of function and damaging missense
mutations.
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3.8 RNF20-complex components regulate left-right patterning via cilia motility
While H2Bub1 has been linked to CHD, presently, the only known cardiac roles
of H2Bub1 are in regulating cardiac situs by controlling cilia gene expression at the leftright organizer (LRO) (Robson et al. 2019) (detailed in this section and in section 7.2)
and in cardiomyocyte maturation (VanDusen et al. 2021). Given the RNF20 patient
phenotype of heterotaxy described in section 3.7, it was hypothesized that RNF20 has a
role in LR patterning. Before describing that role, LR patterning in general will be
detailed. Cilia, one key component of LR patterning, are hair-like organelles on the
surface of most vertebrate cells and function in signaling, fluid propulsion, establishing
LR asymmetry, and determining heart looping direction. In heart development, the
ciliated LRO uses motile cilia to generate directional fluid flow and immotile cilia to
sense it, which transduces a calcium signal (McGrath et al. 2003; Nonaka et al. 1998;
Yuan et al. 2015; Schweickert et al. 2007). Directional fluid flow leads to a cascade of
proteins that determine the left and right side, and ultimately determine heart looping
directionality. Since this is such an important cellular process, the ciliary proteins are
regulated by transcription factors, such as RFX3 (El Zein et al. 2009). Even though
transcription factors for ciliary proteins are known, the epigenetic regulation, particularly
by H2Bub1 was unknown until recently.
The Rnf20-complex affects LR patterning and heart looping. Through morpholino
experiments in Xenopus, it was determined that rnf20 depletion leads to heart looping
abnormalities, abnormal expression of LR asymmetry markers (pitx2c and dand5), and
decreased rotational frequency of motile cilia. These cilia either lack or have shortened
inner dynein arms, just like the patient with the RNF20 variant (Fig. 3.3c). Thus, it is
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likely that the heart looping abnormalities are caused by cilia motility defects due to
abnormal inner dynein arms. Next, it was determined how Rnf20 regulates cilia. The
ciliary transcription factor, Rfx3, is downregulated in rnf20 knockdown LROs.
Interestingly, Rfx3 partially rescues the ciliary motility defects and LR patterning defects
caused by rnf20 knockdown. Therefore, Rnf20 is upstream of Rfx3 in ciliary motility and
LR asymmetry (Robson et al. 2019).
While a lot is known about the role of RNF20 in LR pattering, prior to this body
of work, nothing was known about the role of RNF20 in cardiogenesis. While LR
patterning defects can lead to heart morphological abnormalities, it is important to
determine if the cardiac issues observed in patients with abnormal H2Bub1 are merely
the result of abnormal LR patterning or if they are the result of a combination of LR
patterning defects and abnormal cardiac development. Through the use of conditional
knockout mice, where Rnf20 is knocked-out after the LRO stage, chapter 4 provides
evidence to suggest that RNF20 functions in both the LRO and the heart itself to allow
for the creation of a normal heart.
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Part II: Experimental Results and Discussion
The research presented here aimed to unravel the mechanism by which variants in the
RNF20-complex lead to the observed phenotypes in the CHD patients that have such variants. I
explored the role of RNF20, RNF40, and UBE2B in heart development in vivo in mice and in
vitro in iPSC-derived cardiomyocytes. This is an overview of the following chapters:
Chapter 4: First, we explored the role of RNF20 in vivo in mice. Constitutive Rnf20-/- mice are
pre-implantation lethal. Mice with cardiac-specific Rnf20 deletion using Nkx2.5-Cre die by e12.5,
have incomplete septation, decreased compact myocardium, and abnormal cardiac sarcomeres.
Chapter 5: Next, we determined the role of RNF20 in vitro in iPSC-derived cardiomyocytes.
ChIP-seq for H2Bub1 demonstrated that H2Bub1 is dynamically regulated during differentiation:
there are abundant genes with H2Bub1 marks in iPSCs and mesoderm, but only a few genes
maintain their H2Bub1 mark during the transition from cardiac mesoderm to cardiac progenitors.
The set of selectively maintained genes is strongly enriched for sarcomeric calcium genes.
Chapter 6: Then, we tested the effect of downregulation of RNF20-complex components on
cardiomyocyte differentiation. Haploinsufficiency for RNF20 arrests differentiation into cardiac
mesoderm. Notably, decreased RNF20 leads to a paradoxical increase in H2Bub1 at chromatin
modifier genes. Depletion of UBE2B results in either beating cardiomyocytes or failure to
differentiate into cardiac mesoderm. RNA-seq of the UBE2B deficient cardiomyocytes shows
decreased expression of sarcomeric genes and sarcomeric calcium signaling genes.
Chapter 7: Finally, we investigated the shape of the H2Bub1 signal. H2Bub1-ChIP-seq identifies
accumulation in H2Bub1 near the center of all long genes that is UBE2B-dependent only in
sarcomeric genes, which is correlated with transcriptional elongation efficiency. Given that it is
also seen in MEFs, we predict that this is a general mechanism.
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Chapter 4: RNF20 is required for heart development in vivo
4.1 Summary
De-novo mutations affecting H2Bub1 are enriched in CHD; however, how
H2Bub1 affects heart development beyond its function in establishing left-right
asymmetry remains unknown. Here we report how RNF20 (a component of the complex
that deposits H2Bub1) affects heart development in vivo. We first show that the RNF20complex (RNF20-RNF40-UBE2B) is expressed dynamically in heart development and
that this dynamic expression affects H2Bub1 levels. We next demonstrate that Rnf20-/mice are pre-implantation lethal and Rnf20+/- mice survive to adulthood with no
discernable morphological abnormalities. Since the constitutive knockouts are not helpful
for determining the role of RNF20 in cardiogenesis, we use two different cre drivers to
create a FHF and a SHF RNF20 conditional knockout. Interestingly, we show that
RNF20 is required in the FHF and seems to be dispensable in the SHF. When Rnf20 is
knocked-out in the FHF, the result is embryonic lethality, abnormal compact
myocardium, disorganized cardiac sarcomeres lacking an H zone, altered expression of
calcium signaling genes, and ventricular septal defects. On the contrary, when Rnf20 is
knocked-out in the SHF, the mice survive to adulthood with no apparent phenotypes.
Together, these data indicate that RNF20 is required for heart development in vivo.
4.2 The RNF20-complex is expressed in the developing mouse heart
Since RNF20 variants have previously been linked to CHD both with and without
abnormal laterality, we wanted to determine the RNF20-complex expression in the
developing mouse heart. We first evaluated the spatiotemporal distribution of RNF20
protein within the heart. Analysis of RNF20 protein in mouse embryonic hearts
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demonstrated ubiquitous cardiac expression at e9.5 (Fig. 4.1a) that becomes gradually
restricted to only the epicardium at birth (Fig. 4.1b). At e11.5, RNF20 begins to form an
expression gradient in the myocardium, with higher RNF20 at the myocardial surface
compared to the lumen. At e14.5, myocardial RNF20 begins to disappear until it is
completely gone at e16.5 (Fig. 4.1c). Similarly, RNF20 becomes restricted starting at
e11.5 in the endocardium, until e16.5 when endocardial RNF20 is no longer expressed
(Fig. 4.1d). Thus, RNF20 has different expression patterns in the different layers of the
heart.
To relate the dynamic nature of H2Bub1 over mouse heart development to the
ubiquitination complex (RNF20-RNF40-UBE2B), we examined the expression of the
complex components. To do this, we first asked how the expression of the RNF20complex changes over heart development in vivo. Protein levels of RNF20-complex
components are dynamic between embryonic day 9.5 (e9.5) and adult mouse hearts.
RNF20 peaks at e11.5 and precipitously drops after birth, while RNF40 peaks at e14.5
and also precipitously drops after birth. UBE2A/B increases up until adulthood.
Importantly, changes in these complex components affect H2Bub1 deposition; H2Bub1 is
lowest at e9.5 and highest in adult mice (Fig. 4.1e). These observations suggest that the
ratio of the RNF20-complex components may play an important role in H2Bub1
deposition efficiency, which will be further explored in section 6.3. In conclusion, the
dynamic spatiotemporal distribution of RNF20, as well as the expression of the other
RNF20-complex components, supports a role for the RNF20-complex and H2Bub1 in
heart development.
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Figure 4.1 RNF20 is dynamically expressed during mouse heart development.
(A) Immunofluorescent staining for RNF20 in different sections (atrium, anterior
ventricle, and posterior ventricle) of the e9.5 wild-type mouse heart. Scale bar is 10 µm.
(B) Immunofluorescent staining for RNF20 and WT1 (epicardial marker) in e11.5, e16.5,
and P0 wild-type mouse hearts. These stages capture the major changes in RNF20
expression in the epicardial cells. Scale bar is 10 µm.
(C) Immunofluorescence staining for RNF20 in the myocardial cells in e11.5, e14.5, and
e16.5 wild-type mouse hearts. These stages capture the major changes in RNF20
expression in the myocardial cells. Scale bar is 10 µm.
(D) Immunofluorescence staining for RNF20 and CD31 (endocardial marker) in e11.5,
e14.5, and P0 wild-type mouse hearts. These stages capture the major changes in RNF20
expression in the endocardial cells. Scale bar is 10 µm.
(E) Western blot for RNF20-complex components (RNF20, RNF40, and UBE2B) and
H2Bub1 in wild-type mouse hearts (e9.5, e11.5, e14.5, e16.5, P0, P224 female, and P224
male). The loading control for the complex components is total protein (shown to the
right of the western blots) and for H2Bub1 is H2B.
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4.3 Rnf20 is required for mouse development
Given the dynamic expression of RNF20 during heart development, we next
asked how loss of RNF20 affects cardiogenesis in vivo. The human CHD-associated
variant in RNF20 is an early stop codon in a single allele, suggesting haploinsufficiency
for RNF20, so we analyzed constitutively heterozygous Rnf20 mice containing a targeted
deletion of Rnf20 by replacing all coding exons with a LacZ reporter (obtained from
KOMP2) (Fig. 4.2a) (Robson et al. 2019; Valenzuela et al. 2003). The Rnf20+/- mice are
phenotypically normal and survive to adulthood with no discernible cardiac abnormalities
(Fig. 4.2b). However, no Rnf20-/- embryos are recovered post-blastocyst stage, consistent
with previous data showing RNF20 is required for preimplantation development (Fig.
4.3a, 4.2b) (Tarcic et al. 2016).
To test whether RNF20 is required in cardiac development, we generated mice
with cardiac-specific deletions of Rnf20 using a conditional Rnf20fl allele containing loxP
sites flanking exons 2-4 of the Rnf20 gene (Xu et al. 2016). Since the heart is formed by
two waves of cell migration (FHF predominantly contributing to the atria and left
ventricle, and SHF predominantly contributing to the outflow tract, see section 1.3 for
more detail), we made FHF and SHF specific Rnf20 deletion mouse lines using Nkx2.5Cre (FHF) and Isl1-Cre (SHF) drivers (Fig. 4.2c) (Moses et al. 2001; Pfaff et al. 1996).
We evaluated timing and specificity of Cre expression by mating with ROSAmt/mg and
evaluating Cre expression (Fig. 4.3a). Rnf20fl/-::Isl1-Cre+ mice survive to at least 7
months at Mendelian ratios (Fig. 4.3a, 4.2d). They also have a normal heart/body weight
ratio and hearts appear morphologically normal by H&E staining (Fig. 4.2e, 4.2f).
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Figure 4.2 Breeding strategy and phenotypes of Rnf20 mutants
(A) Diagram illustrating the Rnf20 deletion construct. This mouse was created by
knocking out exons 2-19 (exon 1 is non-coding and exon 20 is mostly non-coding) and
replacing them with a LacZ neo cassette. The neo cassette was dropped using the LoxP
sites.
(B) Percent of each genotype of P0 mice born from the cross of two Rnf20+/- mice.
(C) Diagram illustrating the mouse breeding scheme for the conditional knockout mice.
(D) Percent of each genotype of e9.5, e12.5, P0, and P224 from the cross of Rnf20fl/fl and
Rnf20+/-::Isl1-Cre+.
(E) Heart weight/body weight ratios for 14 (6 Rnf20fl/-::Isl1-Cre-, 3 Rnf20fl/+::Isl1-Cre+, 3
Rnf20fl/+::Isl1-Cre-, and 2 Rnf20fl/-::Isl1-Cre+) adult offspring (P224) from the cross of
Rnf20fl/fl and Rnf20+/-::Isl1-Cre+. Data are shown as mean ± SEM.
(F) Example hematoxylin and eosin stained P224 wild-type (Rnf20fl/-::Isl1-Cre-) and
mutant (Rnf20fl/-::Isl1-Cre+) mouse hearts.
(G) Example hematoxylin and eosin stained e11.5 wild-type (Rnf20fl/-::Nkx2.5-Cre-) and
mutant (Rnf20fl/-::Nkx2.5-Cre+). Lower panels are higher magnification views of the
ventricles.
(H) Percent of each genotype of e9.5, e11.5, e12.25, e12.5, and P0 from the cross of
Rnf20fl/fl and Rnf20+/-::Nkx2.5-Cre+.
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Figure 4.3 Rnf20 is required for heart development
(A) Rnf20 mutant mouse survival chart for constitutive nulls, Rnf20flx/-::Nkx2.5-Cre+, and
Rnf20flx/-::Isl1-Cre+. Colored percentages indicate the observed percentage of null or
conditionally null mice (green indicates mendelian ratios, yellow indicates deviation
from mendelian ratios, and red indicates no mice). Black percentages indicate the
predicted percentages. The sample size is listed below each percentage. See Figure 4.2
for more details on these crosses. Images were taken of the cross between a Nkx2.5-Cre
positive (e8.5 (cardiac crescent), signal in cardiac crescent) or Isl1-Cre positive mouse
(e9.0 (heart tube), signal in outflow tract and atria) and a ROSAmt/mg mouse to illustrate
distribution of Cre-positive cells. Drawings indicate the expected morphology at each
stage mouse heart development. OFT – outflow tract, RV – right ventricle, LV – left
ventricle, AVC – atrioventricular canal, ECC – endocardial cushions, RA – right atrium,
LA – left atrium, A – anterior, P – posterior, L – left, R - right.
(B) Immunofluorescent staining for NKX2.5 and RNF20 in e11.5 wild-type (Rnf20fl/::Nkx2.5-Cre-) and mutant (Rnf20fl/-::Nkx2.5-Cre+) mouse hearts.
(C) Example hematoxylin and eosin stained e12.25 wild-type (Rnf20fl/-::Nkx2.5-Cre-) and
mutant (Rnf20fl/-::Nkx2.5-Cre+) mouse. Quantifications of interventricular septum length,
heart diameter, thickness of right ventricle compact myocardium, and thickness of left
ventricle compact myocardium are displayed as individual data points with a line
representing the median (n = 7 wild-type and 5 mutant hearts). Unpaired 2-tailed,
heteroscedastic t-test.
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NKX2.5 is a transcription factor initially expressed in the entire heart, and then
becomes restricted to the FHF (Moses et al. 2001). Rnf20fl/-::Nkx2.5-Cre+ embryos are
found at Mendelian ratios until e12.25, but none were recovered after e12.5 (Fig. 4.3a,
4.22h). At e11.5, the embryos and heart appear normal by H&E, including 100% normal
heart looping direction (Fig. 4.2g). By e12.25, the compact myocardium is significantly
thinned in Rnf20fl/-::Nkx2.5-Cre+ embryos irrespective of comparable diameters to
wildtype, and they exhibit large ventricular septal defects (left ventricle compact
myocardium thickness p-value = 0.009, right ventricle compact myocardium thickness pvalue = 0.004, septum length p-value = 0.0007) (Fig. 4.3c). We verified the Nkx2.5specific deletion of Rnf20 at e11.5; the RNF20 protein is in both myocardial and
epicardial cells in the Nkx2.5-Cre- embryos, but only in the NKX2.5- epicardial cells in
Nkx2.5-Cre+ embryos (Fig. 4.3b). While the majority of NKX2.5-expressing cells
become cardiomyocytes, it remains possible that the structural defect phenotype results
from a role for RNF20 in NKX2.5 expressing cardiac tissue including a subset of
endocardial cells. Together, these data indicate that RNF20 is required in heart
development in the FHF (NKX2.5-expressing cells), but is likely dispensable in the SHF
(ISL1-expressing cells).
4.4 Sarcomeres are abnormal when total H2Bub1 is reduced
The cardiomyocyte phenotype observed in the mice where RNF20 is knocked-out
in the NKX2.5+ cells led us to investigate the cardiomyocytes further by evaluating the
effect of reduced H2Bub1 on cardiac sarcomere structure in vivo. Transmission electron
microscopy revealed a missing H zone and a poorly defined I-band in e12.25 Rnf20fl/::Nkx2.5-Cre+ mouse sarcomeres (Fig. 4.4). As reviewed in section 1.5, the H zone is the
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Figure 4.4 Rnf20 is required for normal sarcomeres. Transmission electron
microscopy of e12.25 wild-type (Rnf20fl/+::Nkx2.5-Cre+, n = 2) and mutant (Rnf20flx/::Nkx2.5-Cre+, n = 2) mouse heart sarcomeres.
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region of the sarcomere that is devoid of actin filaments. At the center of the H zone is
the M band, consisting mostly of myomesin at e12.25, which functions to anchor the
filaments to titin. An abnormal M band will lead to abnormal sarcomere organization, as
observed in the Rnf20flx/-::Nkx2.5-Cre+ mice (Lange et al. 2020). In section 6.5, we will
show RNA-seq data comparing wild-type and UBE2B-/- cardiomyocytes. Interestingly,
these data show that two components of the M-band (Myomesin and Titin) and two
proteins required for regulating their alternative splicing (RBM20 and RBM24) have
decreased expression in UBE2B-/- iPSC-derived cardiomyocytes compared to the wildtype (median b value = -1.54) (Yang et al. 2014; Schneider et al. 2020). Since the M-band
proteins, particularly titin, are abnormal, it is likely that the poorly defined I-band is the
result of the myosins not being properly held in position. Together, this indicates that
H2Bub1 regulates M band proteins, which are required for normal sarcomeric structure.
Since calcium signaling is important for cardiomyocyte function (see section 1.4
for more detail), we also evaluated the expression of the embryonic sarcomeric calcium
signaling genes (Cacna1c, Ryr2, Ncx, and Serca2a) at e11.5 in Rnf20fl/+::Nkx2.5-Cre+ and
Rnf20fl/-::Nkx2.5-Cre+ embryonic hearts, prior to any visible cardiac defects (Fig. 4.5a).
We observed that the Rnf20fl/-::Nkx2.5-Cre+ have significantly lower Cacna1c and
Serca2a expression than Rnf20fl/+::Nkx2.5-Cre+ siblings (Cacna1c p-value = 0.03,
Serca2a p-value = 0.001) (Fig. 4.5b). Thus, RNF20-complex dependent H2Bub1 is
necessary for normal sarcomeric calcium gene expression in mice.
4.5 Discussion
In this chapter, we set out to determine the role of RNF20 in heart development,
independent of LR patterning. We found that mice with Rnf20 knocked-out in Nkx2.5+
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Figure 4.5 Rnf20 is required for normal sarcomeric calcium gene expression.
(A) RNF20-complex schematic illustrating the Rnf20fl/- mouse mutant. This mutation
leads to decreased total H2Bub1 levels.
(B) Quantitative RT-PCR of calcium signaling genes in e11.5 wild-type
(Rnf20fl/+::Nkx2.5-Cre+) and mutant (Rnf20fl/-::Nkx2.5-Cre+) mouse hearts for Cacna1c,
Ryr2, Ncx, and Serca2a. Levels of expression are normalized to 18s rRNA. Individual
data points are shown in black dots (n = 2). Unpaired 1-tailed, heteroscedastic t-test, * p
< 0.05, ** P < 0.01, N.S. is non-significant.
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cells die by e12.5 and have reduced compact myocardium and incomplete septation. On
the other hand, mice with Rnf20 knocked-out in Isl1+ cells survive until adulthood with
no obvious abnormalities. Importantly, none of these mice have LR patterning
abnormalities, determined by heart looping direction. Since the Cre drivers used in this
study turn on after the LRO stage, this was expected. Thus, we can conclude that the
phenotypes we observed in this study represent an additional role of RNF20 in the heart
itself and are not secondary to LR patterning abnormalities.
Interestingly, the mice where Rnf20 was deleted in the FHF have a more severe
phenotype compared to the mice where Rnf20 was deleted in the SHF. Since the SHF
contributes the majority of the cells to many specialized structures, such as the outflow
tract, this indicates that RNF20 is surprisingly not essential to their development. The big
question is why RNF20 is so important in the FHF. One easy explanation is that Rnf20 is
not expressed or expressed in a low amount in ISL1+ cells. Preliminary analysis of
previously published data indicates that this is not the case (Jia et al. 2018). This study
sorted NKX2.5+ and ISL1+ cells at e7.5, e8.5, and e9.5. While the distribution of Rnf20
expression across NKX2.5+ cells is different than ISL1+ cells, Rnf20 is not only expressed
in ISL1+ cells, but it is also equivalently expressed in NKX2.5+ and ISL1+ cells.
Therefore, that hypothesis is incorrect. Another possibility is that RNF20 is not
completely deleted in ISL1+ cells. Even though this was not rigorously tested, it is
unlikely due to the fact that the expression pattern of the Cre mice used in this study was
validated. Even if a few cells were missed by the Cre, it is very likely that the phenotype
would still be present due to lack of RNF20 in the majority of the SHF. A third possible
explanation has to do with the fact that the two heart fields do not contribute equally to
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the layers of the heart, as alluded to in section 1.3. While the FHF mostly creates
myocardium, the SHF creates myocardium, endocardium, and epicardium (Liang et al.
2013; Spater et al. 2013). We hypothesize that in the Rnf20fl/-::Isl1-Cre+ embryos, there
are enough cardiomyocytes from the FHF that express Rnf20 that the mice are able to
develop normally. In contrast, in the Rnf20fl/-::Nkx2.5-Cre+ embryos, since the FHF is the
main contributor of myocardium, the SHF is unable to compensate. It is important to note
that RNF20 is not completely gone in the Rnf20fl/-::Nkx2.5-Cre+ embryos, even in the
cells that express NKX2.5, likely due to remnants of RNF20 from before the cre turned
on or incomplete non-sense mediated decay of the shortened Rnf20 transcript. In
conclusion, while the exact reason for the phenotypic difference between the FHF and
SHF RNF20 knockout is unknown, this study highlights the importance of another
epigenetic regulator in FHF development.
We observed some key differences between the human patients and the mouse
models. Interestingly, the two models of RNF20+/- have vastly different phenotypes:
CHD patients with variants in RNF20 have major cardiac abnormalities and the Rnf20+/mice have no observable phenotype (Robson et al. 2019). Mice are not perfect models for
human disease, especially when modeling epigenetic modifications (see section 1.6 for
more details). Even though there is a lot of conservation between the species, the lack of
phenotype might be due to species-specific differences that have functional effects
(Hanna, Demond, and Kelsey 2018). While our models do not perfectly replicate the
human patient, they allowed us to deduce the role of H2Bub1 in heart development.
While no phenotype was observed in the Rnf20 heterozygotes and the Isl-Cre
knockouts, while unlikely, it is theoretically possible that a phenotype exists. Future
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experiments could determine if there is an environment that causes a phenotype to
emerge, such as exercise. Additionally, more detailed analysis on lifespan, cardiac
rhythm, cardiac calcium signaling, etc. might reveal a less apparent phenotype. In the
subsequent chapters (chapters 5-7), we follow up on the myocardial phenotype observed
in the Rnf20fl/-::Nkx2.5-Cre+ by studying iPSC-derived cardiomyocytes in vitro.
4.6 Materials and Methods
Mouse husbandry
The wild-type mouse data in figure 4.1 are on the CD1 background. The Rnf20+/-,
Rnf20fl/fl, and all of the cre lines used in this study are maintained on the C57BL/6
background. All cre mice used were validated for correct expression and penetrance by
testing their offspring with a ROSAmT/mG mouse at e8.5 for GFP and tdTomato
expression. This research complies with all ethical regulations; mouse experiments were
performed in a manner approved by the Yale University Institutional Animal Care and
Use Committee.
Immunofluorescence
Mouse embryos and hearts were fixed in 4% PFA overnight. They were placed in
30% sucrose until the tissue sank and then embedded in OCT. 12 µM sections were cut.
These slides were allowed to defrost and dry out for 3 hours on a slide warmer. The
sections were post-fixed for 10 minutes with 0.2% PFA, and then washed 4 times with
PBS for 20 minutes. The sections were either blocked in 5% BSA, 10% Goat serum, or
Fish Gelatin Blocking agent in PBT (PBS+ 0.2% Triton X100). The samples were
incubated with primary antibodies for either 4 hours at RT or overnight (Supplemental
Table 2). The samples were washed four times in PBT for about 20 minutes, incubated
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with the corresponding chromophore conjugated secondary antibody (1:500) for about 45
minutes, and then washed four times in PBT for about 20 minutes. The second to last
wash contained 1:2000 Hoechst. The samples were mounted on coverslips in ProLong
Gold (molecular probes). The samples were imaged on the Zeiss Observer Z1 equipped
with Apotome optical interference imaging.
Histology
Whole embryos or adult hearts were fixed overnight in 4% buffered
paraformaldehyde. The adult hearts were then cut in half sagittal sections. These embryos
or half hearts were dehydrated, cleared, and embedded in paraffin wax. Transverse
sections (embryonic sections were 10 µm thick and adult heart sections were 3-6 µm
thick) were cut using a microtome and were stained with hematoxylin and eosin
following standard protocols. Images were taken on a Zeiss Axiovert microscope, using
an Axiocam driven by Axiovision software. Measurements (heart size, interventricular
septum length, and compact myocardium thickness) were made using imageJ (Schneider,
Rasband, and Eliceiri 2012).
Transmission electron microscopy
The embryos were dissected in 4% PFA. A small hole was made in an atrium with
a scalpel to allow the fixative to get inside the heart. Embryonic heart tissue was fixed in
2.5% glutaraldehyde and 2% paraformaldehyde in 0.1M sodium cacodylate buffer, pH
7.4 for 1 hour at room temperature and left at 4ºC for two days. The samples were rinsed
in buffer, then post fixed in 1% osmium tetroxide and en-bloc stained in 2% aqueous
uranyl acetate for another hour. This was followed by rinsing in distilled water and
dehydrating in an ethanol series, then resin infiltration in Embed 812 (Electron
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Microscopy Sciences) and baking overnight at 60ºC. Hardened blocks were cut using a
Leica UltraCut UC7. 60 nm sections were collected on formvar/carbon coated grids and
contrast stained using 2% uranyl acetate and lead citrate. The sections were viewed in an
FEI Tencai Biotwin TEM at 80 Kv. Images were taken using Morada CCD and iTEM
(Olympus) software.
Protein extractions
Mouse hearts were dissected and the blood was removed by flushing with PBS.
The hearts were flash frozen in liquid nitrogen and homogenized on Mikro Dismembrator
II. Proteins were extracted using NE-PER Nuclear and Cytoplasmic extraction reagents
(Thermo fisher scientific 78833) supplemented with proteinase inhibitors (Roche)
according to manufacturer instructions. After the fractions were acquired, they were
combined. The proteins were analyzed by western blotting.
Histone extractions
Histones were extracted from the pellets from the protein extractions using the
total histone extraction kit (Epigentek) according to manufacturer instructions. The
extracted histones were analyzed by western blotting.
Western blots
The protein samples were evenly loaded onto 4-12% gradient Bis-Tris gels
(Invitrogen) (UBE2B) or 3-8% Tris-Acetate gels (NuPAGE) (RNF20 and RNF40),
transferred to PVDF membrane, blocked overnight in 5% dry milk in TBST, and
incubated with primary antibodies overnight rocking at 4ºC (Supplemental Table 2),
followed by washes in TBST for 1 hour, incubated with corresponding HRP-conjugated
secondary antibodies (Abcam ab6721, 1:20,000) for 1 hour at RT, washed in TBST for
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4.5 hours. Images were acquired using film and scanned in to be quantified using imageJ
(Schneider, Rasband, and Eliceiri 2012). For a loading control, we used a MiniPROTEAN TGX Stain-Free precast gel (Bio-Rad).
The histone samples were evenly loaded onto 4-12% gradient Bis-Tris gels
(Invitrogen), transferred to PVDF membrane, blocked for 1 hour in 5% dry milk in
TBST, and incubated with primary antibodies overnight rocking at 4ºC (Supplemental
Table 2). The next day, the blots were washed in TBST three times for 15 minutes,
incubated with corresponding HRP-conjugated secondary antibodies (Abcam ab6721,
1:20,000) for 1 hour at RT, washed in TBST 3 times for 15 minutes. Images were
acquired using film and scanned in to be quantified using imageJ (Schneider, Rasband,
and Eliceiri 2012). Expression was normalized to levels of H2B.
Mouse calcium qRT-PCR
e11.5 mouse hearts were dissected and flash frozen in liquid nitrogen separately.
After genotyping, 3-10 hearts were pooled together to form each sample. RNA was
extracted with the Qiagen RNeasy Plus mini kit. cDNA was synthesized with Quantabio
qScript cDNA SuperMix. qPCR was done using Quantabio PerfeCta syberGreen mix on
a CFX96 Touch Real-Time (BioRad) in biological duplicates and technical triplicates.
See Supplemental Table 1 for primers. Expression was normalized to the ribosomal
protein 18s.
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Chapter 5: H2Bub1 in iPSC-derived cardiomyocyte development shows selective
maintenance of sarcomeric calcium genes
5.1 Summary
The role of many epigenetic marks, including H2Bub1, has not been studied in a
temporal or tissue-specific manner. Based on the mouse phenotype in chapter 4, we
investigated the changes in H2Bub1 over cardiomyocyte differentiation in wild-type cells
in vitro. We first show that overall H2Bub1 levels change as an iPSC becomes a
cardiomyocyte: H2Bub1 increases from iPSC to mesoderm, remains constant from
mesoderm to cardiac mesoderm, decreases from cardiac mesoderm to cardiac progenitor,
and remains constant from cardiac progenitor to cardiomyocyte. We next demonstrate
that while many genes are decreasing in H2Bub1 occupancy between the cardiac
mesoderm and cardiac progenitor stages, there are some genes that have H2Bub1
selectively maintained. Interestingly, these selectively maintained genes are significantly
enriched in calcium signaling genes and of the 11 calcium signaling genes, 10 are
associated with cardiomyopathy through patient variants and/or mouse models. Finally,
we find patterns in H2Bub1 occupancy in cardiac mesoderm that predict gene expression
in the cardiac progenitor stage. Based on the dynamic levels of H2Bub1 occupancy and
the preference of H2Bub1 for sarcomeric calcium signaling genes in the cardiac
progenitor stage, these data imply that H2Bub1 is involved with cardiomyocyte
differentiation.
5.2 H2Bub1 is dynamically distributed during cardiomyocyte development
Based on our data showing abnormal development of compact myocardium in
response to tissue-specific Rnf20 deletion (see chapter 4), we investigated H2Bub1 during
cardiomyocyte development using in vitro differentiation of human iPSCs into
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cardiomyocytes (CMs) (see section 5.6 for more details) (Lian et al. 2013). To evaluate
the genome-wide H2Bub1 profile and subsequent transcriptional changes during CM
development, ChIP-seq of H2Bub1 and bulk RNA-seq were performed simultaneously at
five stages of CM differentiation: iPSCs, mesoderm (M), cardiac mesoderm (CMes),
cardiac progenitor (CP) and CM. The stages of differentiation were verified through
RNA-seq (Fig. 5.1a). H2Bub1 ChIP-seq peaks from iPSCs were grouped into four
clusters based on H2Bub1 occupancy (high, moderate, low, and none) (Fig. 5.2b). ChIPseq peaks from the other stages are displayed based on these clusters. The general profile
of H2Bub1 is as previously reported, with very low-occupancy at the transcription start
site (TSS) and coverage over the entire gene-body with gradual diminution from 5’ to 3’
(Jung et al. 2012). The moderate-occupancy cluster has a distinct profile compared to the
high and low-occupancy clusters. While the high and low-occupancy clusters have
constant H2Bub1 throughout the 5’ region of the gene-body, the moderate-occupancy
cluster has a drop-off in H2Bub1 occupancy (Fig. 5.2b). Further, H2Bub1 occupancy
increases between iPSC and M near the TSS, but remains constant between M and CMes.
It then decreases between CMes and CP, and again remains constant between CP and CM
(Fig. 5.2a).
We next performed DAVID gene ontology (GO) enrichment analysis on the
genes in each cluster for each cell type to obtain their biological context. The high and
moderate-occupancy clusters (Clusters 1 and 3) are enriched for general cell maintenance
terms, showing a general need for H2Bub1 in maintaining homeostasis. The nooccupancy cluster (Cluster 4) is enriched for both general cell maintenance and chromatin
assembly terms. Most interesting to us is the low-occupancy cluster (Cluster 2), which is
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Figure 5.1 H2Bub1 and mRNA expression throughout CM differentiation
(A) PCA plots of RNA-seq experiments of CM differentiation comparing all neighboring
stages (iPSC (red) v mesoderm (M) (blue), M (red) v cardiac mesoderm (CMes) (blue),
CMes (red) v cardiac progenitor (CP) (blue), and CP (red) v cardiomyocyte (CM) (blue))
for three replicates of each stage.
(B) The top 30 gene ontology (GO) terms related to development in cluster 2 (see Fig.
5.2a, 5.2b) of iPSCs. Dashed bars represent GO terms not related to heart, nervous
system, or appendages.
(C) The top 30 GO terms related to development in cluster 2 (see Fig. 5.2a, 5.2b) of CMs.
(D) One additional replicate of western blots (see Figure 5.2d) showing H2Bub1 changes
during five stages of CM differentiation (iPSC, M, CMes, CP, and CM). The loading
control is H2B.
(E) Percent of H2Bub1 peaks overlapping with the B compartment in each stage of CM
differentiation (iPSC, M, CP, and CM) comparing observed (red) and expected (blue)
values. Data are shown as mean ± SEM (n = 3). P-values comparing observed and
expected values were manually calculated by comparing the actual values to the expected
values, * p < 0.05, ** P < 0.01 (see section 5.6 for more details). P-values comparing
observed values between stages were calculated by computing a z score, * p < 0.05, ** P
< 0.01.
(F) Percent of H2Bub1 peaks on the same gene as an activating chromatin mark
(H3K4me3 shown in blue) and a repressive chromatin mark (H3K27me3 shown in red)
in iPSCs and CMs. Data are the ratio of observed to expected values. Data are shown as
mean ± SEM (n = 3). P-values comparing observed values to expected values were
calculated by Chi Square tests and adjusted for multiple comparisons,* p < 0.05, ** P <
0.01. P-values comparing observed values between stages were calculated using an
unpaired 2-tailed, heteroscedastic t-test, * p < 0.05, ** P < 0.01, N.S. is non-significant.
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Figure 5.2 H2Bub1 in iPSC-derived cardiomyocyte development shows selective
maintenance of sarcomeric calcium genes
(A) H2Bub1 surrounding the transcriptional start site (TSS) (-2 Kb, +10 Kb) in five
stages of CM differentiation (iPSC, mesoderm (M), cardiac mesoderm (CMes), cardiac
progenitor (CP), and cardiomyocyte (CM)). Genes are grouped by H2Bub1 occupancy
into four clusters. The average profile, depicted using fold enrichment against random
distribution values, across this region for each cluster in each stage is shown. This
represents the average of three replicates.
(B) The cluster breakdown for (a). Cluster 1 indicates high H2Bub1 levels, cluster 2
indicates low H2Bub1 levels, cluster 3 indicates moderate H2Bub1 levels, and cluster 4
indicates no H2Bub1.
(C) Comparison of expressed transcripts from RNA-seq data (red) to the Ensembl
transcripts near H2Bub1 peaks from ChIP-seq data (blue) at the CM stage.
(D) Western blot for H2Bub1 in five stages of CM differentiation (iPSC, M, CMes, CP,
and CM). The loading control for H2Bub1 is H2B. Numbers indicate average
quantification (imageJ) of H2Bub1 normalized to H2B over two replicates.
(E) Comparison of the number of Ensembl genes located near H2Bub1 peaks based on
ChIP-seq data from CMes (blue) to CP (red).
(F) Results of a differential binding analysis for H2Bub1-ChIP-seq across five stages of
CM differentiation (iPSC, M, CMes, CP, and CM). This depicts the number of regions
that gain and lose H2Bub1 at each transition.
(G) A heat map depicting the top 20 significant regions with increased H2Bub1
occupancy in M compared with iPSCs.
(H) The significant gene ontology terms from the genes near regions that maintain
H2Bub1 between CMes and CP. Genes associated with the calcium signaling pathway
are listed and are colored blue if they are associated with cardiomyopathy from patient
variants and/or mouse models and are colored black if they are not.
(I) Example H2Bub1 occupancy, depicted using fold enrichment against random
distribution across calcium genes (CACNA1C and RYR2, values ranging from 0 to 3) and
non-calcium genes (KDM7A and NAT10, values ranging from 0 to 8) at three stages in
CM differentiation (iPSC (blue), M (red), and CM (green)). All of the genes are oriented
5’ to 3’. Gene structure is indicated below the gene.
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enriched in development GO terms. Cluster 2 in iPSCs contains multiple types of
developmental genes (muscle, renal, eye, heart, etc.), consistent with previous studies
demonstrating RNF20 is required to exit pluripotency (Fuchs et al. 2012; Karpiuk et al.
2012). Strikingly, as cells commit to a cardiac fate (in CP and CM), H2Bub1 is retained
only on developmental genes related to heart, nervous system, or appendage development
(Fig. 5.1b, 5.1c).
Total H2Bub1 increases from CMes to CP, in contrast to the ChIP-seq data,
which shows a decrease in H2Bub1 around gene bodies during the equivalent stages of
CM differentiation. Total H2Bub1 in the other stages agree with the ChIP-seq data (Fig.
5.1d, 5.2a, 5.2d). One explanation is that H2Bub1 is decreasing in occupancy around the
gene-body, but increasing in occupancy in heterochromatic regions. To test this, we
compared the amount of H2Bub1 in the B compartment (heterochromatic compartment)
to expected values calculated by generating bootstrap replicates from previously
published data at each cell stage (see section 5.6 for more details) (Bertero et al. 2019).
We found H2Bub1 first significantly decreases in the B compartment between iPSC and
M, before significantly increasing as the cells progress through all the stages from M to
CM (p-values <1X10-5). By the CM stage, there is significantly more H2Bub1 in the B
compartment than expected by chance (p-values <1X10-5) (Fig. 5.1e). The gradual
transition of H2Bub1 from gene bodies to heterochromatin is further supported by a
significantly higher overlap of H2Bub1 and previously published H3K27me3 peaks
(heterochromatic mark) on the same gene in CMs compared to iPSCs (p-values <1X10-5),
versus no change in overlap of H2Bub1 and previously published H3K4me3 peaks
(active genes) (Inoue et al. 2017; Kazachenka et al. 2018). Further, in CMs, there is a
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significantly higher overlap of H2Bub1 and H3K27me3 peaks on the same gene than of
H2Bub1 and H3K4me3 peaks (p-value = 0.04). In iPSCs, both overlaps are equivalent
(Fig. 5.1f). We conclude that the percent of H2Bub1 marks in active regions remains
constant between iPSCs and CMs, but the percent of heterochromatic regions marked by
H2Bub1 increases between iPSCs and CMs so that there are more heterochromatic
regions marked by H2Bub1 than active regions at the CM stage. Together these data
indicate that H2Bub1 increases in heterochromatic regions, which accounts for the
discrepancy between the observed increase in total H2Bub1 from CMes to CP, while
gene-specific H2Bub1 decreases at the same stages.
5.3 H2Bub1 is selectively maintained on sarcomeric calcium genes
The distribution of many epigenetic marks is dynamic during development
(Wamstad et al. 2012; Mei et al. 2021). To determine the temporal dynamics of H2Bub1
occupancy during cardiomyocyte differentiation, differential binding analysis on the
H2Bub1 ChIP-seq data was performed during the progression from iPSCs to CMs. We
found 316 regions that have increased H2Bub1 between iPSC and M, compared to 18
regions with decreased H2Bub1. Between M and CMes, there are 2 regions with
decreased H2Bub1. The largest change in H2Bub1 happens upon transition from CMes to
CP, with a decrease in 25,748 regions, while no gene-specific changes in H2Bub1
between CP and CM were observed (Fig. 5.2f). This drop off in H2Bub1 occupancy
between CMes and CP is further shown in a Venn diagram comparing the unique CMes
Ensembl genes near H2Bub1 regions to the unique CP genes (Fig. 5.2e). This is
consistent with the overview data (Fig. 5.2a). DAVID GO enrichment analyses on
regions that change in H2Bub1 occupancy, based on the average of all three replicates,
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indicate that they are mostly cell maintenance genes (Fig. 5.2g). Since this mark is
thought to be activating, we verified expression of the genes near H2Bub1 for all cell
stages. We evaluated the overlap of ChIP-seq and RNA-seq results in the terminal CM
stage in more detail and identified 432 genes that are predicted to be direct targets of
H2Bub1 (Fig. 5.2c). Consistent with a role for H2Bub1 in CMs, DAVID GO analysis of
these 432 genes identified a significant enrichment (p-value = 0.014) in cardiac
conduction genes, including the calcium channel CACNA1C.
Given this connection between H2Bub1 and cardiac function genes, we
hypothesized that the genes that maintain their mark during the large drop off in H2Bub1
occupancy between CMes and CP are also cardiac genes. Genes that maintain H2Bub1 in
CP are enriched for calcium signaling genes (Fig. 5.2h). Interestingly, calcium signaling
genes remain constant in H2Bub1 occupancy over time, unlike housekeeping genes
which follow the general trend outlined in Fig. 5.2a (Fig. 5.2i). Further, a significantly
higher proportion of calcium signaling genes is identified within the genes that have
maintained H2Bub1 compared to genes with downregulated H2Bub1 (Z score = 4.3996,
p-value = 1.1 X 10-5). Importantly, ten of the eleven calcium signaling genes that
maintain H2Bub1 are associated with cardiomyopathy either through patient variants or
mouse models (Fig. 5.2h) (Tang et al. 2012; Knight et al. 2016; Wang et al. 2017; Wang
et al. 2016; Vasti and Hertig 2014; Xu et al. 2018; Boczek et al. 2015; Kepenek et al.
2020; Mazzarotto et al. 2021; Vasilescu et al. 2018). These include CACNA1C and RYR2
which have been linked to left ventricular non-compaction cardiomyopathy (Mazzarotto
et al. 2021; Vasilescu et al. 2018). Together, these data indicate that H2Bub1is selectively
maintained on tissue-specific genes in CMs to promote their expression.
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5.4 Patterns in H2Bub1 occupancy predict gene expression
The distribution of chromatin marks, such as H3K4me3, is known to affect gene
expression, so we wanted to determine if the same is true for H2Bub1 (Xie et al. 2017).
We next asked if we could identify patterns of H2Bub1 distribution and amount on CMes
marked genes that we could use to predict the subsequent loss of H2Bub1 and gene
expression in CP. By using a previously established method, we identified multiple
groups of genes (patterns) that have similar distribution or amount of H2Bub1 across the
gene body (Zhang and Zhang 2019) (Fig. 5.3a). Interestingly, the calcium signaling
genes were among the many genes that did not get placed into any pattern, hereafter
referred to as ‘unpatterned genes’.
We next calculated the ratio of H2Bub1 peaks that decrease in occupancy
between CMes and CP to total H2Bub1 peaks for each of these patterns. Patterned genes
have a higher ratio of peaks decreasing in occupancy than average (Fig. 5.3b). On the
contrary, some unpatterned genes, such as the calcium signaling genes, maintain their
H2Bub1 occupancy. The decreased occupancy in patterned genes corresponds to their
significantly decreased expression in CP compared to CMes (all p-values < 0.05). Thus,
if H2Bub1 only occupies a particular region of a gene body (such as in housekeeping
genes), it will likely decrease in H2Bub1 occupancy and gene expression between CMes
and CP. In contrast, if H2Bub1 is relatively even throughout the gene body (such as in
calcium signaling genes), it will instead maintain H2Bub1 occupancy and gene
expression (Fig. 5.2i, 5.3c). This implies that patterned H2Bub1 marks precede loss of
the mark and decreased expression, while evenly distributed H2Bub1 marks are retained
and predict continued expression.
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Figure 5.3 Localized regions of H2Bub1 in the cardiac mesoderm stage predict
decreased expression in the cardiac progenitor stage
(A) Patterns identified in the H2Bub1 peaks in cardiac mesoderm (CMes) and in cardiac
progenitor (CP). The graphs depict the H2Bub1 occupancy in the clusters of genes, called
patterns, over the gene body. Heat maps showing patterns based on amount are in the left
panel, and based on distribution are shown in the right panel. A pattern is defined as a
group of genes that have a similar structure to the distribution or amount of H2Bub1
across the gene body.
(B) Ratio of H2Bub1 regions lost to total H2Bub1 regions in each of the patterns (based
on amount in the left panel and based on distribution in the right panel) and the average
ratio (labeled all) between CMes and CP.
(C) Expression levels from the RNA-seq data of the genes in each pattern (based on
amount in the left panel and based on distribution in the right panel) in CMes (red) and
CP stages (blue). Data are shown as a box plot, where the center line is the median, the
box limits are the upper and lower quartiles, and the whiskers are 1.5x the interquartile
range. Paired, one-sided Wilcoxon Rank Sum Test, * p<0.05, ** p < 0.01.
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5.5 Discussion
In this chapter, we set out to determine the wild-type H2Bub1 occupancy changes
over cardiomyocyte differentiation. We found that H2Bub1 levels are dynamic
throughout cardiomyocyte differentiation, and these H2Bub1 occupancy changes are
correlated with changes in gene expression. We further demonstrate that as iPSCs
differentiate into cardiomyocytes, H2Bub1 becomes preferentially localized to
sarcomeric calcium signaling genes. These data imply that H2Bub1is unique in that it is
not added to activate genes, but instead is selectively maintained on tissue-specific genes
to promote their gene expression (see section 3.4 for details about whether H2Bub1 is an
activating mark).
Gene-specific H2Bub1 is dynamic over CM differentiation. We demonstrate,
using human iPSCs, an increase in total H2Bub1 and gene-specific H2Bub1 at the onset
of CM differentiation. Previous work has observed an increase in H2Bub1 in mESCs
differentiating into neuronal cells, mESCs differentiating into keratinocytes, and human
ESCs differentiating into neuronal cells (see section 3.6 for more detail) (Fuchs et al.
2012). It was also determined that gene-specific H2Bub1 can be grouped into four
clusters based on H2Bub1 occupancy (Robson et al. 2019; Xie et al. 2017). This is a
general mechanism that we demonstrate also applies to CM differentiation. We show that
the low-occupancy cluster contains developmental genes in the iPSCs and heart
developmental genes in the CMs. In section 7.2, we show that the low-occupancy cluster
contains cilia genes in multiciliated tissue (Robson et al. 2019). In both examples, the
low-occupancy cluster contains the tissue-specific genes and the other clusters contain
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cell-maintenance genes. Thus, the H2Bub1 profile for CM differentiation agrees with the
limited available H2Bub1-ChIP-seq data.
While this study thoroughly characterizes the dynamics of H2Bub1 over
cardiomyocyte differentiation, it is unknown how (or if) the other histone marks change
with H2Bub1. Future experiments could look at H3K4me3 and H3K79me2, since these
marks are known to interact with H2Bub1 (see section 3.3 for more details). Additionally,
this study only evaluated the role of RNF20 in the myocardium, but RNF20 is expressed
in the endocardium and epicardium as well (Fig. 4.1). With the interest of learning the
tissue-specific roles of RNF20, it is necessary to evaluate the role of RNF20 in the
endocardium and epicardium as well. In the subsequent chapters (chapters 6-7), we
continue studying the iPSC-derived cardiomyocytes to show that normal H2Bub1 levels
are necessary for heart development. In other words, in this chapter we describe the
pattern of H2Bub1 over cardiomyocyte differentiation, but in the following chapters, we
show that H2Bub1 is necessary for cardiomyocyte differentiation.
5.6 Materials and Methods
Cell lines and cardiomyocyte differentiation
PGP1 cells (gift from the Seidman lab) were maintained on matrigel with mTESR
media. Differentiation was performed in accordance with previously published work
(Lian et al. 2013). Briefly, 0.5 million cells, were plated on matrigel about four days prior
to onset of differentiation. When the cells reached 100% confluency, differentiation was
started using 12 µM of CHIR99021 in RPMI media supplemented with B-27 minus
insulin. Twenty-four hours later, the media was replaced with RPMI media supplemented
with B-27 minus insulin. Forty-eight hours later, the media was replaced with 5 µM of
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IWP4 in RPMI media supplemented with B-27 minus insulin. Forty-eight hours later, the
media was replaced with RPMI media supplemented with B-27 minus insulin. On day
eight and every 2-3 days after that, the media was replaced with RPMI media
supplemented with B-27. After the onset of beating, the cardiomyocytes (CMs) were
selected using 4 mM lactate in DMEM without glucose. A well was considered to be
beating if two distinct regions on the plate contained beating cells. Prior to the collection
of samples, mycoplasma testing was performed on all cell lines using the MycoAlert Plus
Mycoplasma Detection Kit from Lonza (LT07-703).
Histone extractions
Histones were extracted from the pellets from the protein extractions using the
total histone extraction kit (Epigentek) according to manufacturer instructions. The
extracted histones were analyzed by western blotting.
Western blots
The histone samples were evenly loaded onto 4-12% gradient Bis-Tris gels
(Invitrogen), transferred to PVDF membrane, blocked for 1 hour in 5% dry milk in
TBST, and incubated with primary antibodies overnight rocking at 4ºC (Supplemental
Table 2). The next day, the blots were washed in TBST three times for 15 minutes,
incubated with corresponding HRP-conjugated secondary antibodies (Abcam ab6721,
1:20,000) for 1 hour at RT, washed in TBST 3 times for 15 minutes. Images were
acquired using film and scanned in to be quantified using imageJ (Schneider, Rasband,
and Eliceiri 2012). Expression was normalized to levels of H2B.
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ChIP-seq
Samples were collected in triplicate, where each replicate came from a plate that
started differentiation at a different time. Samples were harvested by adding 2 mL of 1%
formaldehyde to the media for 10 minutes. The reaction was quenched by adding
664.0625 mM of glycine for 5 minutes. Two washes with ice cold PBS were done before
scraping the cells of the plate in PBS using a cell scraper. The tube was spun down at
2000 rpm for 5 minutes and flash frozen in liquid nitrogen. The frozen samples were
resuspended in 1 mL lysis buffer (10 mM Tris, 2 mM EDTA, and 0.1% SDS) for 30
minutes on ice and 1-6 wells of a 6-well plate (depending on the stage and how many
cells were in each well) from one batch of cells were combined in the same tube. The
DNA quantity was estimated by using a Qiagen PCR purification kit and the volumes
were normalized to 6.25 ng/µL. The cells continued to lyse overnight. The samples were
sonicated on a Bioruptor Pico (23 cycles of 30 seconds on and 30 seconds off) in 0.65 mL
tubes with 120 µL of sample in each tube. The DNA quantity was adjusted to 1 µg per
sample, diluted 2 parts dilution buffer to 1 part DNA with a dilution buffer, and incubated
with 4 µL of H2Bub1 antibody or Igg antibody overnight. It was then incubated with 50
µL of protein G Dynabeads (Invitrogen) for 4 hours at 4ºC while rocking. The beads were
washed twice with low salt buffer, twice with high salt buffer, twice with LiCl buffer, and
twice with TE buffer (changing tubes after the first TE wash). Each wash was three
minutes long. The immunoprecipitated chromatin was eluted from the beads in 85 µL of
elution buffer two times for 15 minutes at 70ºC. The immunoprecipitated chromatin was
then treated with RNase, underwent reverse cross-linking, and treated with proteinase K
at 65ºC overnight. The DNA was purified using a Qiagen PCR purification kit. qPCR
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was performed on these samples to verify that the immunoprecipitation worked using
Quantabio PerfeCta syberGreen mix. The samples were run on either a 7900HT Fast
Real-Time PCR Detection System (Applied Biosystems) or a CFX96 Touch Real-Time
(BioRad) in triplicate. The results were analyzed by calculating percent input. The
samples that passed quality control were sequenced at Yale Center for Genome Analysis
using NovaSeq.
Buffers
Dilution Buffer: 16.7 mM Tris pH = 8, 167 mN NaCl, 1.2 mM EDTA, 0.002% SDS,
1.1% Triton, 1X proteinase inhibitors (Roche), and 5 mM Na butyrate)
Low Salt Buffer: 20 mM Tris pH = 8, 0.1% SDS, 1% Triton, 2 mM EDTA, 150 mM
NaCl
High Salt Buffer: 20 mM Tris pH = 8, 0.1% SDS, 1% Triton, 2 mM EDTA, 500 mM
NaCl
LiCl Buffer: 10 mM Tris pH = 8, 250 mM LiCl, 1 mM EDTA, 1% NP40, 1% Nadeoxycholate
TE Buffer: 10 mM Tris pH = 8, 1 mM EDTA
Elution Buffer: 50 mM Tris pH = 8, 1 mM EDTA, 1% SDS
ChIP-seq analysis
The ChIP-seq reads were trimmed using the FASTX-Toolkit to remove poor
quality reads and were aligned to the human reference genome (hg38) using the BWA
Mem algorithm (version 0.7.17). To call peaks, Model-based Analysis of ChIP-seq
(MACS) (version 2.1.1.20160309) was used, where the input was used as the control, and
reads were normalized using fold enrichment (Zhang et al. 2008). Since H2Bub1 peaks
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are atypical, the BAMPE option, the no model option, and the broad option (with a cutoff
of 0.2) were used. The presence of H2Bub1 near the TSS (-2 Kb, + 10 Kb) was computed
using “computeMatrix” in deepTools (version 2.5.0.1) and the genes were divided into
four clusters using kmeans clustering based on the iPSC peaks (Fig. 5.2a, 5.2b) (Ramirez
et al. 2016). Four clusters were selected unbiasedly by implementing the elbow method in
Python (version 2.7.13). The plots that were generated in deepTools represent the average
of the three replicates. To determine the differentially bound sites between samples, the
“DiffBind’ package in R (version 3.6.1) was used with the following parameters:
maximum q value of 0.05 and minimum absolute fold change of 1.5 (Stark and Brown
2011; R Core Team 2019). These differentially bound sites were matched to the nearest
gene using the “ChIPseeker” package in R (UCSC hg38) (R Core Team 2019; Yu, Wang,
and He 2015). The heat maps were made by selecting the most differentially bound
regions in each gene ontology (GO) term using the “pheatmap” package in R (Kolde
2015; R Core Team 2019). The Venn Diagrams were made using the R package
VennDiagram (Chen and Boutros 2011; R Core Team 2019). GO enrichment analysis
was done in DAVID (version 6.8) (Huang da, Sherman, and Lempicki 2009b, 2009a).
The gene traces were visualized in the Integrative Genomics Viewer (version 2.4.5)
(Thorvaldsdottir, Robinson, and Mesirov 2013).
RNA-seq
Samples were collected in triplicate, where each replicate came from a plate that
started differentiation at a different time. Each replicate consisted of two wells of a 6-well
plate that were differentiated at the same time. Total RNA was extracted using a Qiagen
RNeasy mini kit with the RNase-Free DNase Set. The mRNA-seq libraries were prepared
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using a KAPA mRNA HyperPrep Kit (cat no. 08098123702). Samples were sequenced at
Yale Center for Genome Analysis using NovaSeq.
RNA-seq analysis
The RNA-seq reads were trimmed using the FASTX-Toolkit to remove poor
quality reads and were aligned to the human reference genome (hg38) using Kallisto
(version 0.45.0) in R (version 3.6.1) (Bray et al. 2016; R Core Team 2019). Differential
expression analysis was done using the Wald test in Sleuth (version 0.30.0) in R with the
following parameters: maximum q value of 0.05 and minimum absolute fold change of
1.5 (R Core Team 2019; Pimentel et al. 2017). BiomaRt (version 3.13) was used to match
the transcripts with genes (Durinck et al. 2005; Durinck et al. 2009; R Core Team 2019).
Analysis of compartment data
H2Bub1 peaks that overlapped by greater than or equal to 20 positions to a
compartment interval, based on previously collected compartment data, were considered
to be part of that interval (Bertero et al. 2019). Intervals that had a positive value were in
the “A” compartment, and intervals that had a negative value were in the “B”
compartment. The three ChIP-seq replicates were compared to the compartment data
separately and then mean and SEM were calculated.
To calculate expected values, 1000 bootstrap replicates were created for each
stage of CM differentiation. A bootstrap replicate was created by sampling the
compartment file with replacement until the bootstrap replicate file had the same number
of rows as the H2Bub1 peak file. By doing this, we generated a “random” collection of
intervals from the “A” and “B” compartment that was of the same length as the H2Bub1
peak files. The mean and SEM were calculated on these files to get the expected values.
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To calculate p-values between observed and expected, the following equation was
used for each replicate:𝑝 =

∑𝑛
1 𝐸𝑛 > 𝑂
𝑛

, where E is the expected percentage, O is the

observed percentage, and n is the bootstrap replicate number. A sample was considered
significant if every replicate had a p-value less than 0.05.
To calculate p-values between observed values of different stages, the following
equation was used to calculate a z-score between these two percentages:𝑧 =

𝑝1 −𝑝2
𝑆𝐸

, where

p1 and p2 are the percents and SE is the standard error. The z distribution was used to
calculate a p-value from the z-score. All of this analysis was done in R (version 3.6.1) (R
Core Team 2019).
Analysis of histone marks
H3K27me3 and H3K4me3 peaks were downloaded from the Encode Consortium
and generated by the Bernstein lab (Inoue et al. 2017; Kazachenka et al. 2018).
Previously collected data on other histone marks from iPSC and CM stages, as well as the
H2Bub1 data from the iPSC and CM stages, were matched to the nearest gene using the
“ChIPseeker” package in R (UCSC hg38) (R Core Team 2019; Yu, Wang, and He 2015;
Inoue et al. 2017; Kazachenka et al. 2018). See the table below for which ENCODE files
were used. For each replicate of every mark at each stage, the presence or absence of a
peak in a gene was recorded in a data frame (1 indicated presence, and 0 indicated
absence). A 2X2 contingency table was created to record how many genes contained both
marks, how many genes had one mark, and how many genes had neither mark.
To calculate expected values, fixed row and column sums were used. For
𝑚𝑘

example, in a 2X2 contingency table, the expected value of position (2,2) is 𝐸(2,2) 𝑡𝑜𝑡𝑎𝑙,
where m is the column sum and k is the row sum (Fu and Adryan 2009). The graph was
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made by plotting the mean ratios of the observed values to the expected values. Chi
Square test was done to calculate p-values between observed values and expected values.
P-values comparing observed values between stages were calculated using an unpaired 2tailed, heteroscedastic t-test. All analyses were done in R (version 3.6.1) (R Core Team
2019).
Experiment

Bedfile

Target

Tissue

ENCSR864LRY

ENCFF289NJD

H3K27me3

cardiac muscle originated
from RUES2

ENCSR000ALU

ENCFF296RYM

H3K27me3

Human h1-hESC

ENCSR652QNW

ENCFF905NTT

H3K4me3

cardiac muscle originated
from RUES2

ENCSR000AMG

ENCFF668YOE

H3K4me3

Human h1-hESC

Analysis of patterns
We wanted to investigate the drop off in H2Bub1 on gene bodies between the
CMes and CP stages. Previously, a program was developed that used matrix factorization
to investigate patterns in ChIP-seq and RNA-seq data (Zhang and Zhang 2019). Briefly,
matrices are created where the rows are genes and the columns are positions along the
gene. The matrices (one for each condition, in this case CMes and CP) get factored into
two matrices, see diagram below. These two matrices when multiplied together yield the
original matrix. The numbers get rearranged in each of these two submatrices such that
genes with similar signals get grouped together.
𝒈𝟏 , 𝒑𝒐𝟏
[ ⋮
𝒈𝒏 , 𝒑𝒐𝟏

⋯
⋱
⋯

𝒈𝟏 , 𝒑𝒐𝒏
𝒈𝟏 , 𝒑𝒂𝟏
⋮ ]= [ ⋮
𝒈𝒏 , 𝒑𝒐𝒏
𝒈𝒏 , 𝒑𝒂𝟏

⋯ 𝒈𝟏 , 𝒑𝒂𝒏
𝒑𝒂𝟏 , 𝒑𝒐𝟏
⋱
⋮ ]∗ [
⋮
⋯ 𝒈𝒏 , 𝒑𝒂𝒏
𝒑𝒂𝒏 , 𝒑𝒐𝟏

where g is a gene, po is a position along the gene, and pa is a pattern.
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⋯
⋱
⋯

𝒑𝒂𝟏 , 𝒑𝒐𝒏
⋮
],
𝒑𝒂𝒏 , 𝒑𝒐𝒏

It is unclear if the amount of H2Bub1 at a particular location is important, or
whether the presence of H2Bub1 at a particular location is important. Therefore, we
created two versions of these matrices.
Version one considers both distribution and amount. To create this version, we
used “computeMatrix” in deepTools (version 2.5.0.1) (Ramirez et al. 2016). We used the
scale regions option to be able to analyze the entire gene. We limited our search from 2
Kb upstream of the TSS to 2 Kb downstream of the TES. We used 5000 for the region
body length, which gave us 900 bins. We combined the three replicates together by
averaging in R (version 3.6.1) (R Core Team 2019).
Version two considers only distribution. To create this version, we went line by
line in the H2Bub1 peak files using R (version 3.6.1) code (R Core Team 2019). For each
peak, we used interval searching to search through the ENSEMBL genes (this file was
sorted by chromosome and the genes were in order based on position on the
chromosome) to find all of the ENSEMBL genes each peak overlapped with. We divided
each ENSEMBL gene into 100 bins of equal size. A peak was considered to be in a bin if
it overlapped with more than a quarter of the bin. This created a 3d matrix, where the
rows were genes, the columns were positions along the gene, and the third dimension was
the replicates. To combine the replicates, a peak was considered present if it was present
in a given bin of a given gene in at least two replicates.
We ran these four matrices (CMes version 1, CMes version 2, CP version 1, and
CP version 2) through the previously published pipeline. After some tweaking of the K
values to get a K value that is more representative of the global minimum, we decided to
make K go from 2-8 for version 1 and K go from 2-7 for version 2. K represents the
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number of patterns. The K values were manually checked. In both cases, no common
patterns emerged. The K value for CMes was seven and for CP was five in version 1. The
K value for CMes was six and for CP was four in version 2. This program produced the
graphs in Fig. 5.3a. To create Fig. 5.3b, the genes in each pattern from CMes in each
version were compared to the differentially occupied genes identified using diffbind.
To create Fig. 5.3c, the genes in each pattern were combined with the RNA-seq
data. The transcript with the highest expression level in the CMes stage for a given gene
was used for both the CMes stage and the CP stage. Expression levels for each gene in
each pattern at both stages were recorded in a matrix in R (version 3.6.1) (R Core Team
2019). The box and whisker plots were plotted using ggplot2 (R Core Team 2019;
Wickham 2016).
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Chapter 6: Precise stoichiometric ratios of RNF20-complex components lead to
normal cardiomyocyte development
6.1 Summary
De-novo mutations affecting the RNF20-core complex (RNF20-RNF40-UBE2B)
have been implicated in CHD and cardiomyocyte formation in mice; however the
mechanism by which these proteins affect cardiomyocyte differentiation is unknown.
Here we report that RNF20 and UBE2B are required for normal cardiomyocyte
differentiation in vitro. We first show that UBE2B-/- iPSC form cardiomyocytes some of
the time, while RNF20+/- iPSCs do not form cardiomyocytes. We next demonstrate that
UBE2B-/- cells have decreased total H2Bub1, while RNF20+/- cells have a paradoxical
increase in total H2Bub1. From these data, we conclude that H2Bub1 is sensitive to the
stoichiometric ratios of the RNF20-complex components. Thus, by decreasing RNF20,
we increase the efficiency of the complex. Through RNA and ChIP-seq, we determine
that many of the genes with increased H2Bub1 and increased expression in RNF20+/iPSCs are chromatin modifier genes. On the contrary, the genes with decreased H2Bub1
and decreased expression in UBE2B-/- cardiomyocytes are calcium signaling genes. This
calcium signaling phenotype agrees with the mouse phenotype from chapter 4 and the
selectively maintained genes from chapter 5. Together, these data indicate that precise
ratios of RNF20-complex components are necessary for normal H2Bub1 levels and
cardiomyocyte formation; altering the ratio of components positively or negatively
affects the rate of H2Bub1 deposition, which affects cardiomyocyte differentiation
ability.
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6.2 Mutations in the RNF20-complex affect cardiomyocyte differentiation
Since H2Bub1 is selectively maintained on sarcomeric calcium signaling genes
linked to cardiomyopathy, along with the known link between ubiquitinase complex
members (RNF20 and UBE2B) and CHD, we next asked how defective H2Bub1 impacts
CM development. To address this, we first established iPSC lines with mutations
affecting RNF20, and evaluated how the mutations impact the capacity for iPSCs to
differentiate into CMs. In each of two independent CRISPR experiments, we created one
RNF20+/- iPSC line. The two independent iPSC lines have different mutations, and are
both predicted to be functionally haploinsufficient trans-heterozygotes. For simplicity, we
will be referring to these iPSC lines collectively as RNF20+/- (Fig. 6.6a) (see section 6.7
for more details). RNF20 knockdown was verified by western blotting for RNF20 (Fig.
6.4i, 6.5d).
RNF20+/- and wild-type iPSCs were then simultaneously differentiated into CMs
(Lian et al. 2013). At iPSC, M, and CM stages (when the cells are relatively
homogenous),we performed immunofluorescence for markers of pluripotency (OCT4), M
(Brachyury), CMes (NKX2.5), CP (ISL1), and CM (cardiac troponin T, TNNT) (Lian et
al. 2013). At the iPSC stage, both wild-type and RNF20+/- cells express OCT4, indicating
that haploinsufficiency for RNF20 does not affect pluripotency (Fig. 6.1a). At the M
stage, again both wild-type and RNF20+/- cells express Brachyury, but only wild-type
cells lose their OCT4 expression, suggesting the RNF20+/- cells have a delay in exiting
pluripotency (Fig. 6.1b).
Wild-type CMs beat, no longer express Brachyury, and instead express NKX2.5,
ISL1, and TNNT. However, most cells in both RNF20+/- lines continue to express
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Figure 6.1 Differentiation trajectory for RN20 complex mutants
(A) Immunofluorescence staining for marker genes for each of five stages in CM
differentiation (iPSC: OCT4 (red), mesoderm (M): Brachyury (green), cardiac mesoderm
(CMes): NKX2.5 (red), cardiac progenitor (CP): ISL1 (green), and cardiomyocyte (CM):
TNNT (green)) in each of the mutants (wild-type, RNF20+/-1, RNF20+/-2, UBE2B-/-1, and
UBE2B-/-2) at the iPSC stage. One representative scale bar is shown, which represent 20
µm.
(B) Immunofluorescence staining for marker genes for each of five stages in CM
differentiation (iPSC: OCT4 (red), M: Brachyury (green), CMes: NKX2.5 (red), CP:
ISL1 (green), and CM: TNNT (green)) in each of the mutants (wild-type, RNF20+/-1,
RNF20+/-2, UBE2B-/-1, and UBE2B-/-2) at the M stage. One representative scale bar is
shown, which represents 20µm.
(C) Immunofluorescence staining for marker genes for each of five stages in CM
differentiation (iPSC: OCT4 (red), M: Brachyury (green), CMes: NKX2.5 (red), CP:
ISL1 (green), and CM: TNNT (green)) in each of the mutants (wild-type, RNF20+/-1,
RNF20+/-2, UBE2B-/-1, and UBE2B-/-2) at the CM stage. Since these mutants form
beating CMs some of the time, staining was done for beating and non-beating samples for
each genotype, except RNF20+/-2 since it never forms beating CMs. One representative
scale bar is shown, which represents 20 µm.
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Brachyury, and have no NKX2.5 or TNNT expression. Interestingly, the RNF20+/- cells
do express ISL1, a pan-cardiac marker, despite not expressing NKX2.5 (Fig. 6.1c). Since
ISL1 is expressed in all CP cells, this may indicate that RNF20+/- cells are in a less
mature state (Prall et al. 2007; Dorn et al. 2015). Importantly, unlike wild-type cells, most
RNF20+/- cells fail to beat (even by day 20) (Fig. 6.2). In conclusion, the RNF20+/- cell
lines fail to differentiate into normal CMes, and thus ultimately fail to make beating CMs.
To further investigate the possible role for the RNF20-complex on CM
differentiation, we also established iPSC lines with mutations affecting UBE2B, and
evaluated how the mutations impact the capacity for iPSCs to differentiate into CMs. In
each of two independent CRISPR experiments, we created one UBE2B-/- iPSC line. Since
UBE2A and UBE2B are more than 95% identical at the protein level, these knockouts
were validated by sequencing the cDNA (Fig. 6.3a) (see section 6.7 for more detail)
(Sarcevic et al. 2002). Mutant and wild-type iPSCs were then simultaneously
differentiated into CMs (Lian et al. 2013). As with the RNF20+/- iPSCs, UBE2B-/- iPSCs
mirror wild-type, but by M stage, most UBE2B-/-cells gain Brachyury expression, while
retaining OCT4 expression (Fig. 6.1a, 6.1b).
In contrast to the RNF20+/- cell lines, about a third of UBE2B-/- cells (UBE2B-/-1
25/72, UBE2B-/-2 24/69) beat at the CM stage (Fig. 6.2). Given this heterogeneity, we
evaluated both beating (lactate selection) and non-beating (no lactate selection) cells at a
time corresponding to the wild-type CM stage (see section 6.7 for more details). The
beating UBE2B-/- cells are mostly Brachyury negative, and NKX2.5, ISL1, and TNNT
positive, while the non-beating UBE2B-/- cells are mostly Brachyury and ISL1 positive,
and NKX2.5 and TNNT negative (Fig. 6.1c). These data indicate that UBE2B-/- iPSCs
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Figure 6.2 Reduced total H2Bub1 levels lead to abnormal cardiomyocytes. The
percent of each 6 well plate of iPSC-derived cardiomyocytes that beats by day 20 is
shown with colored dots (WT (n = 12) is blue, RNF20+/- (mutant 1: n= 8, mutant 2: n =
11) is red, and UBE2B-/- (mutant 1: n = 18, mutant 2: n = 11) is green). Data are shown as
individual data points and a blue line representing the median. Unpaired 2-tailed,
heteroscedastic t-test, * p<0.05, ** p < 0.01, N.S. is not significant.
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Figure 6.3 Characteristics of the UBE2B-/- mutant
(A) Diagram of the UBE2B protein with its catalytic site, shown in blue, and where the
created UBE2B mutations are located (with a star). Lower three panels are sequencing
traces of the wild-type and two independent UBE2B-/- iPSC lines demonstrating CRISPRgenerated mutations.
(B) PCA plots of RNA-seq experiments comparing wild-type (red) and both UBE2B-/mutants (green and blue) at the cardiomyocyte stage (n = 3).
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can differentiate into beating CMs, but do so at a reduced efficiency compared to wildtype iPSCs. Additionally, non-beating UBE2B-/- cells are phenotypically equivalent to
RNF20+/- cells. Collectively, these data demonstrate a requirement for the RNF20complex in normal CM differentiation.
6.3 RNF20-complex component dosage determines level of H2Bub1 deposition
To relate the dynamic nature of H2Bub1 over CM differentiation and mouse heart
development to the ubiquitination complex (RNF20-RNF40-UBE2B and the scaffolding
protein WAC), we examined the expression of the complex components. The expression
of the RNF20-complex components and H2Bub1 levels in wild-type mice were already
shown, and the data suggest that the ratio of the RNF20-complex components may play
an important role in H2Bub1 deposition efficiency (Fig 4.1). This section will follow up
on that data with the iPSCs containing mutations in RNF20 and UBE2B.
We then determined the trajectory of RNF20-complex mRNA during CM
differentiation using RNA-seq data. UBE2B and RNF40 are relatively constant over CM
differentiation, while WAC reaches a maximum and RNF20 reaches a minimum at the CP
stage (Fig. 6.4a). Protein levels do not directly correlate with mRNA; RNF20, RNF40,
and UBE2A/B proteins all peak at the CP stage, before falling to very low levels at the
CM stage (Fig. 6.4b, 6.5a). The differences in mRNA and protein levels could be
secondary to persistence of long-lived protein from earlier developmental time points, or
from post-transcriptional regulation. In addition, UBE2B levels reflect both UBE2B and
UBE2A, which are >95% identical at the protein level, and cannot be discriminated by
Western blotting (Sarcevic et al. 2002). The dynamic levels of RNF20-complex
components and lack of concordance of any individual complex component to the
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Figure 6.4 H2Bub1 level is determined by ratios of RNF20-complex components
(A) RNA-seq data for RNF20-complex components (RNF20, RNF40, UBE2B, and WAC)
in five stages of CM differentiation (iPSC, mesoderm (M), cardiac mesoderm (CMes),
cardiac progenitor (CP), and cardiomyocyte (CM)) in wild-type cells. Data are shown as
mean ± SEM (n = 3). Numbers indicate average ratio of RNF20 to WAC mRNA over
three replicates.
(B) Western blot for RNF20-complex components (RNF20, RNF40, and UBE2B) in five
stages of CM differentiation in wild-type cells. The loading control is GAPDH. The
upper numbers indicate average quantification (imageJ) of the ratio of RNF20
normalized to GAPDH over UBE2B normalized to GAPDH for three replicates. The
lower numbers indicate average quantification (imageJ) of the ratio of RNF20
normalized to GAPDH over RNF40 normalized to GAPDH for three replicates.
(C) Quantified western blots (imageJ) for H2Bub1 normalized to H2B in five stages of
CM differentiation in wild-type cells. Data are shown as the mean (n = 2).
(D) Schematic depicting predicted ratio of the complex components (based on protein
level for RNF20, RNF40 and UBE2B/A and mRNA level for WAC all determined by
mean of three replicates) at the stage where H2Bub1 is the lowest (iPSC) and at the stage
where H2Bub1 is the highest (CP) and the corresponding H2Bub1 levels. RNF20-red,
RNF40-green, UBE2A/B blue, WAC-purple.
(E) Western blot for RNF20-complex components (RNF20, RNF40, and UBE2B) in
wild-type and UBE2B-/- mutant iPSC and M cells. The loading control is GAPDH. The
upper numbers indicate average quantification (imageJ) of the ratio of RNF20
normalized to GAPDH over UBE2B normalized to GAPDH for three replicates. The
lower numbers indicate average quantification (imageJ) of the ratio of RNF20
normalized to GAPDH over RNF40 normalized to GAPDH for three replicates.
(F) Quantified western blots (imageJ) for H2Bub1 normalized to H2B in wild-type and
UBE2B-/- mutant iPSC and M cells. Data are shown as the mean (n = 3).
(G) Schematic depicting predicted ratio of the complex components (based on protein
level for RNF20, RNF40 and UBE2B/A all determined by mean of three replicates;
WAC is assumed based on WT data) at the iPSC stage in the UBE2B-/- cells and the
corresponding H2Bub1 level. RNF20-red, RNF40-green, WAC-purple.
(H) RNA-seq data for RNF20-complex components (RNF20, RNF40, UBE2B, and WAC)
in wild-type and RNF20+/-1 mutant iPSC and M cells. Data are shown as mean ± SEM (n
= 3). Numbers indicate average ratio of RNF20 to WAC mRNA in the RNF20+/-1 mutant
cells over three replicates.
(I) Western blot for RNF20-complex components (RNF20, RNF40, and UBE2B) in wildtype and RNF20+/- mutant iPSC and M cells. The loading control is GAPDH. The upper
numbers indicate average quantification (imageJ) of the ratio of RNF20 normalized to
GAPDH over UBE2B normalized to GAPDH for three replicates. The lower numbers
indicate average quantification (imageJ) of the ratio of RNF20 normalized to GAPDH
over RNF40 normalized to GAPDH for three replicates.
(J) Quantified western blots (imageJ) for H2Bub1 normalized to H2B in wild-type and
RNF20+/- mutant iPSC and M cells. Data are shown as the mean (n = 3).
(K) Schematic depicting predicted ratio of the complex components (based on protein
level for RNF20, RNF40 and UBE2B/A and mRNA level for WAC all determined by
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mean of three replicates) at the iPSC stage in the RNF20+/- cells and the corresponding
H2Bub1 level. RNF20-red, RNF40-green, UBE2A/B blue, WAC-purple.
(L) Western blot for RNF20-complex components (RNF20, RNF40, and UBE2B) in
e12.25 wild-type (Rnf20fl/-::Nkx2.5-Cre- and Rnf20fl/+::Nkx2.5-Cre+) and mutant (Rnf20fl/::Nkx2.5-Cre+) mouse hearts. The loading control is alpha-tubulin. The upper numbers
indicate quantification (imageJ) of the ratio of RNF20 normalized to alpha-tubulin over
UBE2B normalized to alpha-tubulin. The lower numbers indicate quantification (imageJ)
of the ratio of RNF20 normalized to alpha-tubulin over RNF40 normalized to alphatubulin.
(M) Quantified western blot (imageJ) for H2Bub1 normalized to H2B in e12.25 wildtype (Rnf20fl/-::Nkx2.5-Cre- and Rnf20fl/+::Nkx2.5-Cre+) and mutant (Rnf20fl/-::Nkx2.5Cre+) mouse hearts.
(N) Schematic depicting predicted ratio of the complex components (based on protein
level for RNF20, RNF40 and UBE2B/A; WAC is assumed based on WT data) at e12.25
in Rnf20fl/-::Nkx2.5-Cre+ and the corresponding H2Bub1 level. RNF40-green, UBE2A/B
blue, WAC-purple.
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Figure 6.5 Analysis of RNF20-complex components and H2Bub1
(A) Two additional replicates of western blots (see Figure 6.4b) showing RNF20complex components changing during CM differentiation. Western blot for RNF20,
RNF40, and UBE2B in five stages of CM differentiation (iPSC, mesoderm (M), cardiac
mesoderm (CMes), cardiac progenitor (CP), and cardiomyocyte (CM)). The loading
control is GAPDH.
(B) Two additional western blot replicates (see Figure 6.4e) depicting RNF20-complex
components (RNF20, RNF40, and UBE2B) in iPSC and M stages comparing wild-type
and UBE2B-/- cells. The loading control is GAPDH.
(C) Three western blot replicates (See Figure 6.4f for the quantification) depicting
H2Bub1 in iPSC and M stages comparing wild-type and UBE2B-/- cells. The loading
control is H2B.
(D) Two additional western blot replicates (see Figure 6.4i) depicting RNF20-complex
components (RNF20, RNF40, and UBE2B) in iPSC and M stages comparing wild-type
and RNF20+/- cells. The loading control is GAPDH.
(E) Three western blot replicates (See Figure 6.4j for the quantification) depicting
H2Bub1 in iPSC and M stages comparing wild-type and RNF20+/- cells. The loading
control is H2B.
(F) RNA-seq data for RNF20-complex components (RNF20, RNF40, UBE2B, and WAC)
in wild-type and RNF20+/-2 mutant iPSC and M cells. Data are shown as mean ± SEM (n
= 3).
(G) One western blot replicate (See Figure 6.4m for the quantification) depicting H2Bub1
in e12.25 wild-type (Rnf20fl/-::Nkx2.5-Cre- and Rnf20fl/+::Nkx2.5-Cre+) and mutant
(Rnf20fl/-::Nkx2.5-Cre+) mouse hearts. The loading control is H2B.
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resulting H2Bub1 levels suggest that deposition efficiency may depend on the ratio of the
components, as it does in yeast. Previous work demonstrated that a higher amount of
Lge1 relative to Bre1 leads to a better complex condensate, and is predicted to more
efficiently deposit H2Bub1 (Gallego et al. 2020). Therefore, we would predict that at the
CP stage, when WAC is most highly expressed, H2Bub1 would be the highest, consistent
with our observation (Fig. 5.1d, 5.2d, 6.4c). Our data both confirm and expand these
findings to mammalian cells. In conclusion, as the ratios of the complex components
change, total H2Bub1 changes in response (Fig. 6.4d).
To test this further, we asked how global H2Bub1 deposition changes in our iPSC
and mouse RNF20-complex mutants. Analysis of the RNF20+/- cell lines was limited to
the iPSC and M stages, since they fail to differentiate further. As expected RNF20+/iPSCs have decreased RNF20 mRNA and protein, but also have upregulated RNF40
mRNA and protein, and decreased WAC, perhaps to attempt to correct the abnormal ratio
(Fig. 6.4h, 6.4i, 6.5d, 6.5f). Interestingly, these cells also have a paradoxical increase in
total H2Bub1 (Fig. 6.4j, 6.5e). We propose that the abnormal ratio of complex
components may increase the efficiency of the complex, leading to the paradoxical
increase in the amount of H2Bub1 (Fig. 6.4k). By M stage, RNF20 mRNA is restored to
normal levels in RNF20+/- cells, but RNF20 protein remains decreased compared to wildtype (Fig. 6.4h, 6.4i, 6.5d, 6.5f) (see section 6.4 for more detail). As in the RNF20+/iPSCs, WAC mRNA is also decreased (Fig. 6.4h, 6.5f). Thus, the levels of the RNF20complex components are altered in response to decreased RNF20.
UBE2B-/- cell lines have reduced RNF20 and RNF40 levels at both iPSC and M
stages, possibly due to decreased H2Bub1 on these genes, resulting in transcriptional
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downregulation (Fig. 6.4e, 6.5b). As expected, loss of UBE2B results in decreased total
H2Bub1 at the iPSC and M stages (Fig. 6.4f, 6.5c). The small amount of residual
H2Bub1 is likely retained in UBE2B-/- cell lines due to the presence of UBE2A, which
has been shown to be partially redundant with UBE2B with regard to H2Bub1 (Kim et al.
2009; Sarcevic et al. 2002). Partial compensation of UBE2A by UBE2B is also supported
by the observation that Ube2b-/- and Ube2a-/- mice have abnormal fertility, but can
survive to adulthood (Roest et al. 2004; Roest et al. 1996), while Rnf20-/- mice are preimplantation lethal.
Next we asked how H2Bub1 changes in e12.25 embryonic mouse hearts in
response to FHF-specific deletion of Rnf20 (Rnf20fl/-::Nkx2.5-Cre+). Both RNF20 and
H2Bub1 are reduced in Rnf20fl/-::Nkx2.5-Cre+ mouse embryo hearts. The residual
H2Bub1 and RNF20 is perhaps due to the heterogeneity of the whole heart tissue, which
includes both NKX2.5+ (Rnf20-null) and NKX2.5- (Rnf20-wild-type) cells (Fig. 6.4l,
6.4m, 6.5g).
Together, our data suggest that partial and complete loss of RNF20 differentially
affect H2Bub1. RNF20 haploinsufficiency raises the RNF20-complex efficiency, which
results in increased H2Bub1 (Fig. 6.4k). Complete loss of either RNF20 or UBE2B leads
to a failure to form a functional RNF20-complex, and reduction in total H2Bub1 (Fig.
6.4g, 6.4n). Thus, we propose that dynamic changes in ratios of the RNF20-complex
components over developmental time create a mechanism to precisely modulate H2Bub1
patterns and temporally regulate H2Bub1-dependent gene transcription (Fig. 6.4d).

118

6.4 Haploinsufficiency for RNF20 increases H2Bub1 occupancy in iPSCs
We evaluated the genome-wide H2Bub1 binding profile and gene expression in
RNF20+/- iPSCs (6.6b). Consistent with the increased total H2Bub1 levels in the
RNF20+/- iPSCs, H2Bub1 near gene bodies is also increased (Fig. 6.4j, 6.5e, 6.7a, 6.7c).
The ChIP-seq and RNA-seq data together show that the H2Bub1 changes correlate with
transcriptional effects (Fig. 6.7b). DAVID GO enrichment analysis on genes with
increased H2Bub1 occupancy and mRNA expression indicate that many of these genes
are involved with transcription, splicing, and/or DNA and protein modifications (Fig.
6.7d). Since these classes of genes broadly affect downstream transcription,
haploinsufficiency for RNF20 likely leads to pleiotropic effects.
It was previously mentioned that RNF20 mRNA is restored to normal levels in
RNF20+/- M cells (see section 6.3). This suggests attempted autoregulation of RNF20,
since RNF20 itself has increased H2Bub1in both RNF20+/- iPSC lines compared to wildtype iPSCs. The genome-wide H2Bub1 binding profile and gene expression in RNF20+/M cells indicate that there are pleiotropic responses to haploinsufficiency of RNF20 upon
exiting pluripotency. While on average there is decreased H2Bub1 occupancy in the
RNF20+/- lines compared to wild-type cells, there are few genes that have significant
differential H2Bub1 occupancy between each RNF20+/- line and wild-type, and even
fewer in common between the lines (Fig. 6.6c, 6.6d). By the time the RNF20+/- cells
reach the M stage, their H2Bub1 levels deviate so far from normal levels that there is
catastrophic dysregulation of gene expression, which prevents the cells from continuing
to differentiate.
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Figure 6.6: Characteristics of the RNF20+/- mutants
(A) Diagram of the RNF20 protein with its domains (Ring-Finger domain is shown in
blue) and where the created RNF20 mutations are located (with a star). Lower four panels
are sequencing traces of the wild-type and two independent RNF20+/- iPSC lines
demonstrating CRISPR-generated mutations.
(B) PCA plots of RNA-seq experiments comparing wild-type (red) and both RNF20+/mutants (green and blue) at iPSC and mesoderm (M) stages (n = 3).
(C) H2Bub1 surrounding the transcriptional start site (TSS) (-2 Kb, +10 Kb) in the wildtype and RNF20+/- mutants at the M stage. Genes are grouped by H2Bub1 levels into four
clusters. The average profile, depicted using fold enrichment against random distribution
values, across this region for each cluster in each stage is shown. This represents the
average of three replicates.
(D) Regions with differential H2Bub1 in each RNF20+/- mutant compared to wild-type at
the M stage. These Venn Diagrams depict the overlap between the regions that have
increased H2Bub1 in RNF20+/- mutants compared to wild-type and the regions that have
decreased H2Bub1 in both RNF20+/- mutants compared to wild-type. RNF20+/- line 1 is
in blue, RNF20+/- line 2 is in red.
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Figure 6.7 Haploinsufficiency for Rnf20 increases total H2Bub1 in iPSCs and
arrests differentiation into cardiac mesoderm
(A) RNF20-complex schematic illustrating the RNF20+/- iPSC mutant, and the associated
increased total H2Bub1 levels.
(B) Genes with differing H2Bub1 occupancy (red) and gene expression (blue) when
compared to wild-type that are shared between the two independent RNF20+/- cell lines at
the iPSC stage. A significant number of these genes overlap (Fisher’s exact test, n = 3).
(C) H2Bub1 surrounding the transcriptional start site (TSS) (-2 Kb, +10 Kb) in the wildtype and RNF20+/- mutants at the iPSC stage. Genes are grouped by H2Bub1 levels into
four clusters. The average profile, depicted using fold enrichment against random
distribution values, across this region for each cluster in each stage is shown. This
represents the average of three replicates.
(D) Gene ontology analysis of genes with differing H2Bub1 occupancy between wildtype and both independent RNF20+/- cell lines at the iPSC stage. Many of these genes are
related to transcription, splicing, and/or DNA/Protein modifications. Expression and
H2Bub1 occupancy levels for example genes in each category are shown. Gene ontology
(upper panel) is in gray scale; ChIP data (middle panel) and mRNA expression data
(lower panel) are shown as heat maps.
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6.5 Total H2Bub1 reduction decreases sarcomeric calcium signaling gene expression
in vitro
In contrast to RNF20+/- cells, the UBE2B-/- cells have decreased total H2Bub1 and
are able to form beating CMs. To understand how reduced H2Bub1 could alter CM gene
expression, we performed RNA-seq analysis of beating UBE2B-/- CMs, and compared
them to time-matched wild-type iPSC-derived CMs (Fig. 6.3b, 6.8a). Differential
expression analysis identified 1393 downregulated and 1555 upregulated transcripts that
are shared between both independent UBE2B-/- cell lines compared to wild-type. To
obtain a biological context for the genes with decreased expression, we did DAVID GO
enrichment analysis. About half of the significant GO terms (37/76) are related to
sarcomeric calcium genes, sarcomere genes, and/or cardiomyopathy genes. Most notably,
two genes with decreased expression, CACNA1C and RYR2, are also amongst the genes
with selectively maintained H2Bub1 upon wild-type transition from CMes to CP (Fig.
6.8b). Interestingly, the Rnf20fl/-::Nkx2.5-Cre+ mice also have reduced expression of
calcium signaling genes (Fig. 4.5b). Thus, RNF20-complex dependent H2Bub1 is
necessary for normal sarcomeric calcium gene expression in iPSC-derived CMs and in
mice.
6.6 Discussion
In this chapter, we set out to determine the phenotype of altered H2Bub1 on
cardiomyocyte differentiation and which H2Bub1 marks are RNF20-complex dependent.
It was determined that haploinsufficiency for RNF20 leads to increased total H2Bub1 and
inability to differentiate into cardiomyocytes, while deletion of UBE2B leads to decreased
total H2Bub1 and less efficient differentiation into cardiomyocytes. The genes with
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Figure 6.8 Sarcomeric calcium signaling gene expression is reduced in cells with
decreased total H2Bub1 levels
(A) RNF20-complex schematic illustrating the UBE2B-/- iPSC mutant. This mutation
leads to decreased total H2Bub1 levels.
(B) Gene ontology analysis on genes with differing gene expression levels comparing
wild-type to both independent UBE2B-/- cell lines at the cardiomyocyte stage. Many of
these genes are related to sarcomere, cardiomyopathy, and/or calcium signaling.
Expression levels for example genes in each category are shown. Stars indicate genes
shared with maintained H2Bub1 marks upon transition to CPs shown in Fig. 2h. Data
represent three RNA-seq replicates. Gene ontology (upper panel) is in gray scale; mRNA
expression data (lower panel) is shown as a heat map.
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increased H2Bub1 occupancy in RNF20+/- iPSCs tend to be chromatin modifiers, which
likely cause the observed global gene expression dysregulation. The genes with decreased
H2Bub1 occupancy in UBE2B-/- cardiomyocytes tend to be related to calcium signaling
and sarcomeres. Calcium signaling and sarcomeric genes appearing in many analyses in
all of the chapters thus far show increased support for the hypothesis that H2Bub1 has a
role in calcium signaling in heart development.
We analyzed several different RNF20-complex mutants in human models, and
observed some key differences between them. Interestingly, the two models of RNF20
heterozygotes have vastly different phenotypes: CHD patients with variants in RNF20
have major cardiac abnormalities and RNF20+/- iPSCs arrest differentiation into CMes
(Robson et al. 2019). While the cell culture system allows for experiments to be done in
human cells, it is not a perfect system, since it is artificial (see section 1.6 for more
detail). One issue with this system is the cells do not receive signals from other types of
cells, which could make the phenotype more severe. Additionally, the first step of
differentiation involves a strong GSK3 inhibitor (by inhibiting GSK3, Wnt signaling is
activated), which certainly does not mimic how stem cells exit pluripotency in vivo (Lian
et al. 2013). Additionally, in this artificial system, it was determined that differentiation
ability is highly dependent on cell cycle stage (Laco et al. 2018). Based on preliminary
results, these mutant iPSCs have altered cell cycle rates. Thus, these cells might
differentiate differently in this in vitro system compared to the human body purely
because they have abnormal cell cycles.
It is also interesting that RNF20+/- cells at a time consistent with CMs do not beat,
while UBE2B-/- CMs beat only one third of the time. As described in the previous
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paragraph, differentiation ability is dependent on cell cycle stage and confluency at the
onset of differentiation (Laco et al. 2018). Based on preliminary data, these cells reach
confluency at different rates than their wild-type counterparts. It is possible that whether
or not the cells beat is due to a hypersensitive to these factors. In other words, whether
any iPSC differentiates is based on cell cycle stage and confluency, but the UBE2B-/iPSCs might have a narrower range of acceptable conditions. While the iPSC-derived
cardiomyocyte system is not a perfect system, it still provides a window into H2Bub1
function in cardiomyocyte development.
While this study thoroughly characterizes the phenotypes and genomic changes
that occur in RNF20-complex mutants, the effect of these changes on cardiomyocyte
function remains unknown. Future experiments could insert an inducible-promoter in
front of RNF20 to determine the effects of different RNF20-complex ratios at different
stages of development. This would allow for the determination of the effect of altered
RNF20-complex ratios at every stage of cardiomyocyte differentiation, instead of just at
the iPSC stage. We also hypothesize that by altering the ratios, we might be able to push
the cardiomyocytes to differentiate further, since H2Bub1 has such a critical role in
cardiomyocyte development. Additionally, this study only evaluated the expression of
calcium signaling and sarcomeric genes, but how altered H2Bub1 affects calcium
signaling and force remains unknown. In the next chapter, we continue to dissect the
molecular mechanism by which H2Bub1 functions by analyzing the shape of the signal
on the gene body.
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6.7 Materials and Methods
Cell lines and cardiomyocyte differentiation
Differentiation was performed accordance with previously published work (Lian
et al. 2013). To initiate differentiation, 0.5 million cells (or 0.7 million cells in the
UBE2B-/- mutants), were plated on matrigel about four days prior to onset of
differentiation. Since lactate selection is a metabolic selection, it can only work if the
cells are CMs. Therefore, if a well was not beating, no lactate selection was done and the
subsequent analyses were done on the non-selected cells. See section 5.6 for complete
details.
CRISPR-Cas9 editing of human iPSCs
Guides were created using MIT’s CRISPR tool (http://crispr.mit.edu/) to create
mutations in RNF20 and UBE2B (2 each) near the transcriptional start site. These guides
and the other necessary sequence were synthesized as gblocks and cloned using the
TOPO TA cloning kit. Two different protocols were used to create knockouts. UBE2B-/-1,
RNF20+/-1, and RNF20+/-2 were created using the Lonza Nucleofector 2b with the
Human Stem Cell Nucleofector Kit 2 according to the manufacturer’s protocol. 1 million
cells were nucleofected using program B020 with 2 µg of a plasmid containing Cas9
(PX459 Addgene) and 2 µg of a plasmid containing the sgRNA. UBE2B-/-2 was created
by adding 10 µg of Cas9 plasmid and 10 µg of sgRNA plasmid to 1 million cells using
the Bio-Rad Gene Pulser XCell Eukaryotic System with a homemade nucleofection
solution (5 mM KCl, 5 mM MgCl2, 15 mM Hepes, 102.94 mM Na2HPO4, 47.06 mM
NaH2PO4 monohydrate, pH = 7.2) according to previously published work. The
following parameters were used: 250 V, 500 µF, and a 0.4 cm cuvette (Chen et al. 2015).
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These cells grew for two days with mTESR supplemented with 5 µM of Y27632. Then,
selection for receiving the Cas9 plasmid occurred for 2 days using 400 µg of puromycin.
About a week after transfection, individual colonies were picked and screened for
mutations using primers flanking the sgRNA (Supplemental Table 1). If there was a
possibility of a mixed colony, individual colonies got picked from that colony and these
subcolonies got screened. This process was repeated until colonies were pure.
Additionally, the DNA was cloned into TOPO TA cloning it (RNF20) or Zero Blunt
TOPO Cloning Kit (UBE2B) and sequenced to verify the ratio of the two different alleles
was 1:1.
Guide

Sequence

Cell Line(s) Developed

RNF20_1

ACAGTGGAAACAATTAAGCT

RNF20+/-1 and RNF20+/-2

RNF20_2

GTGGAAACAATTAAGCTAGG

N/A

UBE2B_1

AATCCCGCATGAGCCTCCTC

UBE2B-/-1

UBE2B_2

ATCCCGCATGAGCCTCCTCC

UBE2B-/-2

Surrounding sequence to the gRNA
TGTACAAAAAAGCAGGCTTTAAAGGAACCAATTCAGTCGACTGGATCCGGTA
CCAAGGTCGGGCAGGAAGAGGGCCTATTTCCCATGATTCCTTCATATTTGCAT
ATACGATACAAGGCTGTTAGAGAGATAATTAGAATTAATTTGACTGTAAACA
CAAAGATATTAGTACAAAATACGTGACGTAGAAAGTAATAATTTCTTGGGTA
GTTTGCAGTTTTAAAATTATGTTTTAAAATGGACTATCATATGCTTACCGTAA
CTTGAAAGTATTTCGATTTCTTGGCTTTATATATCTTGTGGAAAGGACGAAAC
ACC (Guide)
GTTTTAGAGCTAGAAATAGCAAGTTAAAATAAGGCTAGTCCGTTATCAACTT
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GAAAAAGTGGCACCGAGTCGGTGCTTTTTTTCTAGACCCAGCTTTCTTGTACA
AAGTTGGCATTA
Immunofluorescence of cells
iPSCs and M cells were passaged using accutase. 650 µL of accutase was added
to each well of a 6 well plate for 5-7 minutes at 37ºC until the cells started to come off
from the plate. After spinning down at 1000 rpm for 5 minutes, the cells were plated on
coverslips. A 0.1% w/v solution of gelatin had been added to these coverslips overnight
at 37ºC. The next morning, these coverslips were rinsed with PBS, a 1/400 solution of
matrigel in media was added for 1 hour, rinsed with PBS, and then the passaged cells
were added. The media the cells were grown in while they were on the coverslips was
normal cell culture media for the respective stage with 5 µM of Y27632.
CMs were passaged using Trypsin-EDTA (0.25%). 2 mL of Trypsin was added to
each well of a 6 well plate for 5 minutes at room temperature. After spinning down at
1000 rpm for 5 minutes, the cells were plated on coverslips. A 0.1% w/v solution of
gelatin had been added to these coverslips overnight at 37ºC. The next morning, these
coverslips were rinsed with PBS, and then the passaged cells were added. These cells
were grown in RPMI20 (RPMI with 20% FBS) with 5 µM of Y27632 as per previous
work (Lian et al. 2013).
After 2 days of culturing the iPSC, M, or CMs on coverslips, they were fixed in
4% PFA for 10 minutes. Extreme caution was taken when adding and removing liquids to
not cause the cells to come off the coverslips. The coverslips were rinsed 4 times for 20
minutes with PBS. The sections were either blocked in 5% BSA or 10% Goat serum in
PBT (PBS+ 0.2% Triton X100). The samples were incubated with primary antibodies for
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either 4 hours at RT or overnight (Supplemental Table 2). The samples were washed
four times in PBT for about 20 minutes, incubated with the corresponding chromophore
conjugated secondary antibody (1:500) for about 45 minutes, and then washed four times
in PBT for about 20 minutes. The second to last wash contained 1:2000 Hoechst. The
coverslips were mounted on slides in ProLong Gold (molecular probes). The samples
were imaged on the Zeiss Observer Z1 equipped with Apotome optical interference
imaging.
Protein extractions
Cells were removed from the plates using accutase (for iPSC and M cells) or
Trypsin-EDTA 0.25% (for CMs). Proteins were extracted using NE-PER Nuclear and
Cytoplasmic extraction reagents (Thermo fisher scientific 78833) supplemented with
proteinase inhibitors (Roche) according to manufacturer instructions. After the fractions
were acquired, they were combined. The proteins were analyzed by western blotting.
Histone extractions
Histones were extracted from the pellets from the protein extractions using the
total histone extraction kit (Epigentek) according to manufacturer instructions. The
extracted histones were analyzed by western blotting.
Western blots
The protein samples were evenly loaded onto 4-12% gradient Bis-Tris gels
(Invitrogen) (UBE2B) or 3-8% Tris-Acetate gels (NuPAGE) (RNF20 and RNF40),
transferred to PVDF membrane, blocked overnight in 5% dry milk in TBST, and
incubated with primary antibodies overnight rocking at 4ºC (Supplemental Table 2),
followed by washes in TBST for 1 hour, incubated with corresponding HRP-conjugated
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secondary antibodies (Abcam ab6721, 1:20,000) for 1 hour at RT, washed in TBST for
4.5 hours. Images were acquired using film and scanned in to be quantified using imageJ
(Schneider, Rasband, and Eliceiri 2012). For a loading control for the iPSCs, we used
GAPDH (Fig. 6.4, 6.5). For a loading control for the RNF20 mutant mice, we used alphatubulin (Fig. 6.4, 6.5).
The histone samples were evenly loaded onto 4-12% gradient Bis-Tris gels
(Invitrogen), transferred to PVDF membrane, blocked for 1 hour in 5% dry milk in
TBST, and incubated with primary antibodies overnight rocking at 4ºC (Supplemental
Table 2). The next day, the blots were washed in TBST three times for 15 minutes,
incubated with corresponding HRP-conjugated secondary antibodies (Abcam ab6721,
1:20,000) for 1 hour at RT, washed in TBST 3 times for 15 minutes. Images were
acquired using film and scanned in to be quantified using imageJ (Schneider, Rasband,
and Eliceiri 2012). Expression was normalized to levels of H2B.
ChIP-seq
See section 5.6 for the protocol.
ChIP-seq analysis
See section 5.6 for the protocol and below for some additional details. The
presence of H2Bub1 near the TSS (-2 Kb, + 10 Kb) was computed using
“computeMatrix” in deepTools (version 2.5.0.1) and the genes were divided into four
clusters using kmeans clustering based on the wild-type peaks (Fig. 6.6c, 6.7c) (Ramirez
et al. 2016). Four clusters were selected unbiasedly by implementing the elbow method in
Python (version 2.7.13). Importantly, a gene was only considered differentially bound
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(between the mutants and the wild-type cells) if there was a differentially bound region in
the gene in both mutants.
RNA-seq
See section 5.6 for the protocol.
RNA-seq analysis
See section 5.6 for the protocol and below for some additional details. As with
ChIP-seq, a gene was only considered to be differentially expressed (between the mutants
and the wild-type cells) if there was a differentially expressed transcript for the gene in
both mutants. The heat maps were made by selecting the most differentially expressed
regions in each GO term using the “pheatmap” package in R (R Core Team 2019; Kolde
2015). GO enrichment analysis was done in DAVID (version 6.8) (Huang da, Sherman,
and Lempicki 2009b, 2009a). The gene traces were visualized in the Integrative
Genomics Viewer (version 2.4.5) (Thorvaldsdottir, Robinson, and Mesirov 2013).
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Chapter 7: Accumulation of H2Bub1 near the center of tissue-specific genes is
correlated with enhanced efficiency of transcriptional elongation
7.1 Summary
H2Bub1 is known to affect transcriptional elongation, but whether it activates or
represses it is unknown. Here we set out to determine the role of H2Bub1 on
transcriptional elongation in several tissues (multiciliated cells of the oviduct,
cardiomyocytes, and MEFs). We first compare H2Bub1 marks between multiciliated
(oviducts) and nonmulticiliated (liver) cells. We determine that the oviduct-specific
H2Bub1 marks are enriched in cilia genes. Interestingly, cilia genes tend to be long
genes. We next analyze H2Bub1 occupancy in wild-type and UBE2B-/- cardiomyocytes,
and discover an accumulation in H2Bub1 near the center of the gene on sarcomeric
calcium signaling and sarcomeric genes in wild-type cardiomyocytes that is reduced or
absent in UBE2B-/- cardiomyocytes. We then ask whether there is a loss of 3’ end
transcripts in UBE2B-/- cardiomyocytes in the genes with H2Bub1 accumulation, to
assess transcriptional elongation efficiency. From these data, we discover that the
UBE2B-dependent H2Bub1 accumulation is correlated with transcriptional efficiency.
Similar to the cilia genes identified in the oviduct cells, the sarcomeric calcium signaling
and sarcomeric genes are also long genes. Finally, we use previously published data for
H2Bub1 in MEFs and draw the same conclusion as we did with the UBE2B-/cardiomyocytes. Together, these data indicate that UBE2B-dependent H2Bub1
accumulation near the center of long tissue-specific genes is correlated with increased
transcriptional elongation efficiency.
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7.2 H2Bub1 marks are enriched at cilia genes in multiciliated tissue
We first investigated the role of transcriptional elongation efficiency in heart
development at the LRO stage. H2Bub1 has been shown to have a role in LR patterning
by affecting cilia motility (see section 3.8 for more details). Here, we aim to determine
which genes are marked by H2Bub1 in the LRO. Unfortunately, given its small size,
performing ChIP-seq on the LRO is quite challenging. Thus, we used the oviduct as a
proxy tissue, since it also contains multiciliated cells and expresses RNF20. To examine
the tissue-specificity of H2Bub1 marks, we performed ChIP-seq in multiciliated tissue
(oviduct) and nonmulticiliated tissue (liver) in mice. The oviduct ChIP-seq peaks were
grouped into four clusters based on H2Bub1 occupancy (high, moderate, low, and none)
and the liver ChIP-seq peaks are displayed according to these clusters (Fig. 7.1). To
understand these clusters in a biological context, gene ontology (GO) enrichment analysis
was performed on the genes in each cluster. The no-occupancy cluster contains nonoviduct specific genes. The high and moderate-occupancy clusters are enriched in
transcription and protein ubiquitination genes. The low-occupancy cluster is enriched in
cilia genes. Upon further examination of this cluster, there are many genes that have
differing amounts of H2Bub1 occupancy comparing oviduct and liver (Fig. 7.1).
We next performed a differential binding analysis with the H2Bub1 ChIP-seq data
to determine which regions of the genome have differing H2Bub1 occupancy comparing
oviduct and liver. We found 1,067 regions that have increased binding in liver and 836
regions that have increased binding in oviduct. GO enrichment analysis on the regions
that had increased binding in liver indicates that these regions are adjacent to liverspecific genes. Unlike the regions enriched in liver, the genes near the enriched regions in
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Figure 7.1 A heat map of H2Bub1 ChIP-seq. H2Bub1 surrounding the transcriptional
start site (TSS) (-1 Kb, +10 Kb) in the oviduct and liver. Genes are grouped by H2Bub1
levels into four clusters. The average profile, depicted using fold enrichment against
random distribution values, across this region for each cluster in each stage is shown.
This represents the average of three replicates. The heat map on the right is a zoom-in of
the low-occupancy cluster.
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oviducts do not contain oviduct-specific genes. Instead, it contains 89 cilia genes, such as
Kif3a (important ciliary transport protein) and Rfx3 (Fig. 7.2a). GO enrichment analysis
confirms that cilia genes are enriched in this data set: eight of the top twenty GO terms
are related to cilia and one is related to LR patterning (Fig. 7.2b).
We see two different patterns of H2Bub1 marks in cilia genes that are enriched in
oviducts, compared with liver. Some genes, such as Rfx3 and Kif3a, are enriched in the
gene region, and others are enriched only at or near the 5’ region of a gene (Fig. 7.2c,
7.3). It is of note that not all cilia gene regions have H2Bub1 marks, including Dnah7a,
an inner arm dynein (Fig. 7.2c). Interestingly, the H2Bub1 marks at both Rfx3 and Kif3a
are enriched at the gene body compared to the surrounding regions, and this enrichment
gradually decreases from 5' to 3' as has been observed previously (Jung et al. 2012).
These data identify higher levels of H2Bub1 marks at a subset of cilia genes in ciliated
tissue and point to H2Bub1 as a novel transcriptional regulator of ciliary genes.
7.3 Accumulation of H2Bub1 near the center of tissue-specific genes correlates with
enhanced efficiency of transcriptional elongation
Strikingly, while loss of UBE2B leads to decreased total H2Bub1 levels, ChIP-seq
of CMs comparing H2Bub1 between wild-type and UBE2B-/- cells demonstrates that
gene-specific H2Bub1 is only decreased in 8 Ensembl genes (Fig. 6.4f, 6.5c, 7.4a). To
identify differences in H2Bub1 patterns between UBE2B-/- and wild-type CMs, we
identified calcium and/or sarcomeric genes with reduced mRNA in UBE2B-/- CMs, along
with calcium signaling genes that selectively maintain H2Bub1 between CMes and CP.
We then created metagenes by combining our selected genes’ ChIP-seq data and
averaging the replicates, allowing us to visualize common features of H2Bub1 for those
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Figure 7.2 H2Bub1 marks are enriched at cilia genes in multiciliated tissue.
(A) The top 20 regions that have significantly higher H2Bub1 occupancy in multiciliated
tissue compared to nonmulticiliated tissue. Bolding denotes cilia genes.
(B) The top 20 significant gene ontology terms based on the genes that have significantly
higher H2Bub1 occupancy in multiciliated tissue compared to nonmulticiliated tissue.
Blue text denotes gene ontology terms related to cilia.
(C) Example H2Bub1 occupancy, depicted using fold enrichment against random
distribution across example cilia genes (RFX3, KIF3a, and DNAH7a, values ranging
from 0 to 10) in two tissue types (oviduct (red) and liver (blue)). Gene orientation is
indicated by the black arrow. Gene structure is indicated below the gene.
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Figure 7.3 Example H2Bub1 ChIP-seq cilia gene traces. Example H2Bub1 occupancy,
depicted using fold enrichment against random distribution across the eight most
significant cilia genes (2410089E03Rik, Sgce, Hk1, Spata6, Esp8, Ccdc88a, Tszh3, and
Apt2b4, values ranging from 0 to 10) in two tissue types (oviduct (red) and liver (blue)).
Gene orientation is indicated by the black arrow. Gene structure is indicated below the
gene.
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Figure 7.4 UBE2B-/- mutant ChIP-seq.

(A) H2Bub1 surrounding the transcriptional start site (TSS) (-2 Kb, +10 Kb) in the wildtype and UBE2B-/- mutants at the cardiomyocyte stage. Genes are grouped by H2Bub1
levels into four clusters. The average profile, depicted using fold enrichment against
random distribution values, across this region for each cluster in each stage is shown.
This represents the average of three replicates.
(B) Metagene plot for H2Bub1 levels in wild-type (blue) and UBE2B-/- mutants (green
and red) across all of the short genes (less than 100 bp) (n = 3).
(C) Metagene plot for H2Bub1 levels in wild-type (blue) and UBE2B-/- mutants (green
and red) across all of the long genes (greater than 10 Kb) (n = 3). The * indicates the
accumulation near the center of the gene.
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gene sets (calcium genes n = 28, sarcomere genes n = 70). Wild-type cells have an
accumulation of H2Bub1 near the center of the metagenes, but this accumulation is either
reduced or completely absent in UBE2B-/- cells (Fig. 7.5a, 7.5b). To validate that this
accumulation is not a technical artifact, we generated 30 sets of “random” quantity and
sized-matched gene sets for both the calcium and sarcomeric genes. To control for the
expression differences in these genes, we chose an even distribution of genes sets that
were upregulated, downregulated, or unchanged between both mutants compared to wildtype. While accumulation is present near the center of some of these metagenes, none of
them show differential H2Bub1 occupancy at the accumulation region between mutant
and wild-type cells. We provide one representative graph (Fig. 7.5c). We next determined
whether this phenomenon is true for all genes, or just tissue-specific long genes by
producing metagene plots for all short genes (less than 100 bp) and all long genes
(greater than 10 Kb). We conclude that H2Bub1 accumulation near the center of genes is
present in all long genes, but UBE2B-dependent accumulation is unique to tissue-specific
long genes (Fig. 7.4b, 7.4c). Therefore, the H2Bub1 accumulation near the center of the
gene is specific only to certain gene classes, including calcium and sarcomeric genes.
Since the RNF20-complex is known to be involved in transcriptional elongation
and H2Bub1 is found on long tissue-specific genes during left-right patterning of the
heart, we hypothesized that the accumulation of H2Bub1 near the center of long genes
may support their transcriptional elongation (median length of all genes is 31 Kb,
compared to 456 and 69 Kb for calcium signaling and sarcomeric genes, respectively).
To test this hypothesis, we asked whether there was loss of the 3’ end of transcripts in
UBE2B-/- CMs compared to wild-type. When comparing the ratio of mutant to wild-type
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Figure 7.5 Accumulation of H2Bub1 near the center of tissue-specific genes is
correlated with enhanced efficiency of transcriptional elongation in cardiomyocytes.
(A) Metagene plot for H2Bub1 levels in wild-type (blue) and UBE2B-/- mutants (green
and red) across the calcium signaling genes that are differentially expressed between
wild-type and UBE2B-/- mutants and/or selectively maintained between cardiac
mesoderm and cardiac progenitor stages (n = 3). The * indicates the accumulation near
the center of the gene.
(B) Metagene plot for H2Bub1 levels in wild-type (blue) and UBE2B-/- mutants (green
and red) across the sarcomeric genes that are differentially expressed between wild-type
and UBE2B-/- mutants (n = 3). The * indicates the accumulation near the center of the
gene.
(C) Example metagene plot for H2Bub1 levels in wild-type (blue) and UBE2B-/- mutants
(green and red) across “randomly” selected quantity and size-matched genes to the
calcium gene set (n = 3). 30 “random” metagene plots were created from the calcium
gene set and 30 “random” metagene plots were created from the sarcomere gene set: 10
from genes that are upregulated between wild-type and both UBE2B-/- cell lines, 10 that
are non-regulated between wild-type and both UBE2B-/- cell lines, and 10 that are downregulated between wild-type and both UBE2B-/- cell lines.
(D) Log2 of fold change in transcript abundance between wild-type and UBE2B-/mutants is shown at each position along the genes. The genes being shown are the
calcium signaling genes describe in (a).
(E) Log2 of fold change in transcript abundance between wild-type and UBE2B-/mutants is shown at each position along the genes. The genes being shown are the
sarcomeric genes described in (b).
(F) Log2 of fold change in transcript abundance between wild-type and UBE2B-/- mutants
is shown at each position along the genes. The genes being shown are “randomly”
selected quantity and size-matched genes to the calcium signaling genes described in (c).
(G) Example log2 of fold change gene traces for calcium genes (CACNA1C and RYR2)
that have accumulation of H2Bub1 near the center of the gene and decreased
transcriptional elongation efficiency. 5’ on the left of the diagram.
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RNA in both the calcium and sarcomeric gene sets, transcripts are less abundant in
UBE2B-/ cells in the most 3’ 20% of the gene, indicating inefficient transcription
elongation in the mutants; example transcript traces for CACNA1C and RYR2 are shown
(Fig. 7.5d, 7.5e, 7.5g). To validate this conclusion, we repeated the same analysis on our
“random” gene sets, which only had transcriptional efficiency drop-off in the last 5-10%
of the 3’ end. We provide one representative graph (Fig. 7.5f). Thus, these data support
the conclusion that accumulation of H2Bub1 near the center of calcium and sarcomeric
genes is UBE2B dependent and correlates with enhanced transcription elongation
efficiency.
7.4 Accumulation of H2Bub1 exists near the center of tissue-specific genes in mouse
embryonic fibroblasts
We next asked if this H2Bub1 accumulation is unique to CMs. To address this,
we used previously published H2Bub1-ChIP-seq data of wild-type mESCs and MEFs
(Wang et al. 2021). We determined the MEF-specific genes by identifying differentially
expressed genes between MEFs and mESCs; they are enriched in adhesion (n = 143),
extra-cellular matrix (ECM) (n = 130), and ions (n = 160) GO terms. Similar to the CM
tissue-specific genes, these genes are also long (median length is 43 Kb for adhesion, 48
Kb for ECM, and 50 Kb for ions). The metagene plots generated for adhesion and ECM
show an accumulation of H2Bub1 near the center of the gene, similar to the calcium and
sarcomeric genes in CMs. Additionally, this accumulation was higher in the tissue with
increased expression of the differentially expressed genes (MEFs), as expected (Fig.
7.6a, 7.6b). As in CMs, all of the quantity and size-matched “random” genes sets
generated show no accumulation of H2Bub1 near the center of the gene, as shown in one
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Figure 7.6 Accumulation of H2Bub1 near the center of tissue-specific genes exists in
MEFs.
(A) Metagene plot for H2Bub1 levels in wild-type MEFs (teal) and wild-type mESCs
(red) across the ECM genes that are differentially expressed between wild-type MEFs
and wild-type mESCs. The * indicates the accumulation near the center of the gene.
(B) Metagene plot for H2Bub1 levels in wild-type MEFs (teal) and wild-type mESCs
(red) across the adhesion genes that are differentially expressed between wild-type MEFs
and wild-type mESCs. The * indicates the accumulation near the center of the gene.
(C) Example metagene plot for H2Bub1 levels in wild-type MEFs (teal) and wild-type
mESCs (red) across “randomly” selected quantity and size-matched genes to the
adhesion gene set. 20 “random” metagene plots were created from the adhesion gene set
and 20 “random” metagene plots were created from the ECM gene set.
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representative graph (Fig. 7.6c). The CM and MEF data collectively suggest that
accumulation of H2Bub1 near the center of tissue-specific long genes is a general
mechanism for regulation of transcriptional elongation efficiency. In CMs, central
H2Bub1 accumulation and efficient transcription of sarcomeric and calcium signaling
genes depend on UBE2B, providing a mechanism to explain the cardiac phenotype in the
Rnf20fl/fl::Nkx2.5-Cre mouse model.
7.5 Discussion
In this chapter, we set out to determine the effect of H2Bub1 on transcriptional
elongation efficiency. We first find that H2Bub1 marks are not only tissue-specific, but
that they are also located on long tissue-specific genes. We next find that the shape of the
signal differs between long and short genes: long genes have an accumulation of H2Bub1
near the center, which is absent in short genes. Then, we demonstrate that this
accumulation is UBE2B-dependent only in tissue-specific genes. Finally, we correlate the
accumulation in tissue-specific long genes with transcriptional elongation efficiency.
Through the use of three different models, we come to the conclusion that
H2Bub1 does not affect global transcriptional elongation, but rather enhances the
efficiency of transcriptional elongation of tissue-specific long genes. Thus, as addressed
in section 3.5, H2Bub1 likely positively affects transcriptional elongation of some genes
and negatively affects transcriptional elongation of other genes (Fuchs et al. 2014; Zhang
and Yu 2011; Kim and Roeder 2009; Pavri et al. 2006; Gaillard et al. 2009; Fuchs et al.
2012; Shema et al. 2011; Wang et al. 2021). It is hypothesized that these long genes need
extra help being transcribed and this accumulation of H2Bub1 near the center helps to
ensure that these genes will be full transcribed. We speculate that H2Bub1 deposition on
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tissue-specific genes is related to the ratio of complex components affecting the
complex’s efficiency (see sections 6.3 and 8.3 for more detail). We propose that this is a
general mechanism that cells use to obtain tissue-specific expression of long genes.
While it has been shown that accumulation of H2Bub1 near the center of the gene
is correlated with transcriptional elongation efficiency, it remains to be demonstrated that
this accumulation causes altered transcriptional elongation efficiency. Future experiments
could do RNA Pol II ChIP-seq to determine if RNA Pol II is present less often at the
3’end of tissue-specific transcripts in UBE2B-/- cardiomyocytes compared to wild-types.
While this would provide more evidence to support this hypothesis, this would also not
determine a causative relationship. The only conceivable way would be to alter the level
of H2Bub1 only near the center of a given gene, instead of globally altering H2Bub1.
This could involve using a nuclease dead cas9 to target USP44 to that region. While this
study does not prove causation, it does provide a lot of support for a model whereby
H2Bub1 accumulation near the center of tissue-specific long genes leads to increased
transcriptional elongation efficiency.
7.6 Materials and Methods
Cell lines and cardiomyocyte differentiation
Differentiation was performed accordance with previously published work (Lian
et al. 2013). To initiate differentiation, 0.5 million cells (or 0.7 million cells in the
UBE2B-/- mutants), were plated on matrigel about four days prior to onset of
differentiation. See section 5.6 for complete details.
CRISPR-Cas9 editing of human iPSCs
See section 6.7 for the protocol.
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ChIP-seq
See section 5.6 for the protocol for the iPSC-derived CMs. The oviducts and
livers used the following protocol. Mouse oviducts and livers were collected from 6-week
old virgin females. The samples were fixed in 1% formaldehyde using truChIP
Chromatin Shearing Kit (Covaris) according to manufacturer instructions. Prepared tissue
samples were flash frozen in liquid nitrogen. The frozen samples were ground into a
powder and resuspended in 1x Lysis buffer (Covaris) and processed according to the
manual. The samples were sonicated on focused ultrasonicator S220 (intensity 5%, duty
cycle 5, 6 min). 6 µg of the sonicated chromatin were diluted 1:3 with a dilution buffer
and incubated with H2Bub1 (cell Signaling) antibody overnight, incubated with protein G
Dynabeads (Invitrogen), 50 µl/sample, for 4 hours at 4ºC. The beads were washed and
eluted using the protocol in section 5.6. Primers are listed below.
Primers:
Gene
Forward
Reverse
GAPDHp GAAATGAGAGAGCCCAGCT
ACCAGGGAGGGCTGCAGTCC
GAPDHc GTATGTAGGCAGTGGGGAGAC GGCCATCCACAGTTCTTCTGG
ChIP-seq analysis
See section 5.6 for the protocol and below for some additional details (for the
iPSC-derived CMs). The presence of H2Bub1 near the TSS (-2 Kb, + 10 Kb) was
computed using “computeMatrix” in deepTools (version 2.5.0.1) and the genes were
divided into four clusters using kmeans clustering based on the wild-type peaks (Fig.
7.4a) (Ramirez et al. 2016). Four clusters were selected unbiasedly by implementing the
elbow method in Python (version 2.7.13). Importantly, a gene was only considered
differentially bound (between the mutants and the wild-type cells) if there was a
differentially bound region in the gene in both mutants.
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The oviducts and liver used the following protocol. The ChIP-seq reads were
aligned to the mouse reference genome (mm10) using the BWA Mem algorithm (Li and
Durbin 2009). To identify significant peaks, Model-based Analysis of ChIP-seq (MACS)
(version 2.1.0) was used, where the input was used as the control, and the peaks were
normalized using fold enrichment (Zhang et al. 2008). The average signal of H2Bub1
peaks near the TSS (-2Kb, +10Kb) was computed using "computeMatrix" in deepTools
(version 2.5.0.1) and divided into four clusters using k-means clustering based on the
oviduct peaks (Ramirez et al. 2016). Four clusters were chosen by implementing the
elbow method in the "factoextra" package in R (version 3.4.2) (Kassambara and Mundt
2017; R Core Team 2019). Since the median standard error of the mean (SEM) between
the two replicates among all of the values produced by ComputeMatrix was 5%, these
values from the two replicates were averaged and visualized using the "plotHeatmap"
function in deepTools (Ramirez et al. 2016). Differentially bound sites were obtained
using the "DiffBind" package in R, with a maximum q value of 0.05 and a minimum
absolute fold change of 1.5 (R Core Team 2019; Stark and Brown 2011). The nearest
genes to the differentially bound sites were obtained using the "ChIPseeker" package in R
(UCSC mm10) (R Core Team 2019; Yu, Wang, and He 2015). The heat map was made
using the "pheatmap" package in R (Kolde 2015; R Core Team 2019). GO enrichment
analysis was done in DAVID (version 6.8) (Huang da, Sherman, and Lempicki 2009b,
2009a). The gene traces were visualized in the Integrative Genomics Viewer (version
2.4.5) (Thorvaldsdottir, Robinson, and Mesirov 2013).
RNA-seq
See section 5.6 for the protocol.
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RNA-seq analysis
The RNA-seq reads were trimmed using the FASTX-Toolkit to remove poor
quality reads and were aligned to the human reference genome (hg38) using Kallisto
(version 0.45.0) in R (version 3.6.1) (Bray et al. 2016; R Core Team 2019).
Metagene analysis
We first assembled a list of regions. We decided to focus on calcium signaling
genes and sarcomeric genes, since those are the genes that are differentially expressed
between the ChIP-seq and RNA-seq data. We combined the sets of genes that were
selectively maintained and differentially expressed into two bed files (one for calcium
signaling genes and one for sarcomeric genes). We used the R package metagene2
(version 1.8.0) to create the plots with the following parameters: normalize with RPM,
alpha = 1, and paired_end is true (R Core Team 2019; Fournier et al. 2021).
To generate “random” set of genes, we fit the lengths of the genes in the calcium
signaling bed file and the sarcomeric gene bed file to the poisson function in R (version
3.6.1) (R Core Team 2019). We then generated random numbers (the same number as
there are lines in each bed file) from that distribution. For each random number, we found
all of the down regulated genes in UBE2B-/-1 that are within 10% of that number. We
then kept picking a gene at random until one was downregulated in both mutants. We
repeated the procedure for upregulated and non-regulated genes. We created 10 sets of
each (upregulated calcium signaling, downregulated calcium signaling, non-regulated
calcium signaling, upregulated sarcomeric genes, downregulated sarcomeric genes, and
non-regulated sarcomeric genes). To verify that there was no accumulation near the
center, these 60 graphs were manually inspected.
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Transcriptional efficiency
To calculate transcriptional efficiency, we used the R package CoverageView
(version 1.30.0) (R Core Team 2019; Lowry 2021). We modified the source code of
draw.heatmap to produce a pdf file to make it compatible with the machine it was being
run on. We used 100 windows, normalized with RPM, and presented the graph as a
log2ratio. We produced one graph per replicate per mutant. Since all of the replicates
look similar and both mutants look similar, we show one representative image. We used
the same set of “random” genes generated for the metagene analysis. We manually
inspected the 360 resulting graphs (ten replicates of “random” genes for three classes of
genes (upregulated, downregulated, and non-regulated), for two bed files (calcium
signaling genes and sarcomeric genes) for three replicates of two mutant cell lines). The
gene traces were visualized in the Integrative Genomics Viewer (version 2.4.5)
(Thorvaldsdottir, Robinson, and Mesirov 2013).
mESC and MEF analysis
We downloaded the raw data from previously published work and put it through
our ChIP-seq and RNA-seq pipelines described in the ChIP-seq and RNA-seq analysis
sections (Wang et al. 2021).To determine the tissue-specific genes for the MEFs, we used
the Wald test in Sleuth (version 0.30.0) (maximum q value of 0.05 and minimum
absolute fold change of 1.5) to compare the wild-type MEFs to the wild-type mESCs (R
Core Team 2019; Pimentel et al. 2017). BiomaRt was used to match the transcripts with
genes (Durinck et al. 2005; Durinck et al. 2009; R Core Team 2019). GO enrichment
analysis was done using DAVID (version 6.8) on the genes upregulated in the MEFs
compared to the mESCs (Huang da, Sherman, and Lempicki 2009b, 2009a). The GO
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terms were related to ions, adhesion, and/or ECM. Thus, we created metagenes for genes
in those three categories following the pipeline described in the metagene section. Since
this group did not knockout a component of the RNF20-complex, we did not think it was
necessary to create “random” genes representing the upregulated, downregulated, or nonregulated genes. Therefore, we created 20 “random” gene sets for ions, 20 “random” gene
sets for adhesion, and 20 “random” gene sets for ECM.
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Chapter 8: Commentary on the function of RNF20 in heart development
8.1 Proposed model for how H2Bub1 functions
Together, our data support a requirement for tight control of H2Bub1 levels in
cardiac development. Increased total H2Bub1 leads to failure to form CMs, while
decreased total H2Bub1 reduces the efficiency of CM differentiation in vitro, and leads to
reduced expression of calcium signaling genes and structural abnormalities of the cardiac
sarcomere, including a deficient H zone, in vivo (Fig. 8.1a). H2Bub1 is highly dynamic
during CM differentiation: early, the mark is increased and then decreased on
housekeeping genes, and later the mark is selectively maintained on calcium signaling
genes, while it shifts from euchromatic to heterochromatic regions (Fig. 8.1b). Finally,
we show that the shape of the H2Bub1 signal changes between wild-type and UBE2B-/CMs. The profile of H2Bub1 on short genes is as previously reported, with coverage over
the entire gene-body, higher at the 5’ end than the 3’ end of the gene (Jung et al. 2012).
Notably, long genes have a vastly different profile: there is tissue-specific UBE2Bdependent H2Bub1 accumulation near the center of the gene, which correlates with
efficient transcriptional elongation (Fig. 8.1c).
8.2 Location of H2Bub1 within a gene is important
H2Bub1 is an enigmatic chromatin mark localizing to the entire gene body,
instead of discreet promoter and enhancer regions. At the onset of CM differentiation, we
highlight an increase in both the total and gene-specific H2Bub1, as seen previously in
neuronal cells and keratinocytes (Fuchs et al. 2012). H2Bub1 has been linked to
transcriptional elongation, but how it affects transcriptional elongation is unclear (see
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Figure 8.1 Working Model
(A) When H2Bub1 levels are misregulated by altering levels of complex components,
cardiomyocytes do not form normally. When total H2Bub1 levels are increased by
haploinsufficiency of RNF20, cardiomyocytes do not form. When total H2Bub1 levels
are decreased by creating UBE2B-/- or Rnf20fl/-, sarcomeres do not form normally and
calcium signaling genes have reduced expression.
(B) During wild-type CM differentiation, housekeeping genes and heterochromatic
regions have dynamic H2Bub1 levels. H2Bub1 is sparsely maintained during the
transition from cardiac mesoderm to cardiac progenitor. Notably, selectively maintained
genes are enriched for sarcomeric calcium genes.
(C) Genes that are short in length have an increase in H2Bub1 at the 5’ end of the gene
that decreases towards the 3’ end. However, longer tissue-specific genes have an
accumulation in H2Bub1 near the center of the gene in wild-type cells and not in UBE2B/. In the mutants when this accumulation is absent, the transcriptional efficiency is
reduced.
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section 3.5 for more details) (Fuchs et al. 2014; Kim et al. 2009; Kim, Hake, and Roeder
2005; Pavri et al. 2006; Sadeghi et al. 2014; Shema et al. 2011; Wang et al. 2021). We
observe accumulation of H2Bub1 near the center of a subset of long genes. Interestingly,
it was previously determined that RNA Pol II exhibits a similar accumulation at the
center of all expressed genes (Young et al. 2011). Since H2Bub1 co-localizes with RNA
Pol II, the published RNA Pol II distribution is in concordance with the H2Bub1
distribution (Fuchs et al. 2014). We propose that H2Bub1 enhances transcriptional
elongation of long tissue-specific genes. This conclusion is supported by previous work
finding that long genes are more likely to depend on RNF20 to be induced upon
differentiation into neuronal cells (Fuchs et al. 2012). Further evidence is the presence of
H2Bub1 on cilia genes (which have an average length of 73 Kb) in the multiciliated cells
of oviducts (which require expression of long motile cilia genes), but not in the liver
cells, which do not (Robson et al. 2019). Combined with our data analyzing CMs and
MEFs, we propose that targeted H2Bub1 accumulation is a more general mechanism
regulating tissue-specific transcriptional elongation efficiency on long genes.
8.3 Stoichiometry of the RNF20-complex
Ratios of RNF20-complex components affect the efficiency of H2Bub1
deposition. We show that if Rnf20 is deleted, total H2Bub1 decreases; if RNF20 is
haploinsufficient, total H2Bub1 paradoxically increases; if UBE2B is deleted in the
presence of normal UBE2A, total H2Bub1 decreases. The varying levels of H2Bub1
resulting from altered levels of distinct RNF20-complex components support an existing
hypothesis, whereby the exact stoichiometric ratios of the complex components affect its
efficiency (Gallego et al. 2020). Thus, missing a component will yield the expected
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results of no H2Bub1, but having less of a component will affect the ratios of the
complex components, altering the efficiency.
We suggest that iPSCs normally maintain complex components in a less efficient
ratio to constrain the level of H2Bub1 to maintain pluripotency. We hypothesize that
different regions of the genome are easier to monoubiquitinate than others, possibly due
to openness of DNA; the easier regions always get ubiquitinated, but the harder regions
only get ubiquitinated if the ratio of the RNF20-complex components is more optimal.
For example, H2Bub1 marks being deposited at the center of tissue-specific genes (see
chapter 7 for more detail) is thought to occur because those regions are able to be
monoubiquitinated based on the efficiency of the complex and the non-tissue-specific
regions are not able to be monoubiquitinated. Thus, we predict that the tissue-specific
H2Bub1 marks are produced by changes in the ratio of the RNF20-complex components,
which affect the efficiency of H2Bub1 deposition.
8.4 H2Bub1 does not activate or repress genes, but rather makes genes competent to
be expressed
There is a lot of debate in the literature as to the role H2Bub1 has on gene
expression (see section 3.4 for more details) (Lee et al. 2007; Kao et al. 2004; Minsky et
al. 2008; Zhang and Yu 2011; Kim, Hake, and Roeder 2005; Xie et al. 2017; Shema et al.
2008; Huang et al. 1997; Zhang et al. 2008; Mutiu et al. 2007; Henry et al. 2003). Many
of these studies did not compare H2Bub1 levels during a developmental progression, so
they missed a key piece of data. Given that calcium signaling genes have constant
H2Bub1 occupancy from the iPSC stage all the way through the CM stage, H2Bub1
cannot be an activating or a repressive mark. We propose that having H2Bub1 present
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makes the gene competent to be expressed. At the iPSC stage, many different types of
genes have H2Bub1. We posit that this is due to the fact that the cell has not committed
to a fate yet, so it is allowing many genes to be able to be expressed. As cells commit to a
cardiac fate, the number of genes marked by H2Bub1 is drastically reduced (from cardiac
mesoderm to cardiac progenitor). We propose that this is because H2Bub1 is being lost
on non-cardiac genes to prevent them from being able to be expressed. We hypothesize
that H3K4me3 or H3K79me2 (the histone marks that are known to be associated with
H2Bub1, see section 3.3 for more details) only get added to regions that contain H2Bub1,
and once the second modification is added, the gene becomes activated. Therefore, our
data support a model where tissue-specific transcriptional effects are determined by the
retention, instead of deposition, of H2Bub1 on tissue-specific genes.
8.5 Concluding remarks: RNF20, structural heart defects, congenital heart disease,
and calcium signaling
We propose that heart development is exquisitely sensitive to H2Bub1 dosage.
Since RNF20 is required to exit pluripotency, the presence of H2Bub1 on a subset of
genes is crucial for this process to occur. Once the cells exit pluripotency, these marks
become restricted to heart-specific genes. If there is an abnormal amount of H2Bub1
upon exiting pluripotency, the cells are unable to fully differentiate. Our data indicate that
RNF20-complex-dependent H2Bub1 is necessary for normal cardiac development
through regulating the transcriptional elongation efficiency of cardiac calcium signaling
and sarcomeric genes during CM differentiation and development.
It cannot be forgotten that these experiments were prompted by three patients with
variants in the RNF20-core complex. The phenotypes of these patients encompassed the
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full range of CHD, not limited to laterality abnormalities. Thus, it is important to
investigate the role of RNF20 in both LR patterning and in the heart itself, which is what
this body of work accomplished. This study helps clinicians to understand what went
wrong during the development of these patients and what the patients might be more
susceptible to later in life. CHD cannot be cured; even after an operation, patients are still
at risk for heart problems and may need additional operations (Warnes 2005). From the
experiments presented here, it can be concluded that patients with variants in proteins that
affect H2Bub1 are more susceptible to cardiomyopathy and calcium signaling
abnormalities. Thus, these results can be directly translated to the clinic in the form of
patient monitoring.
The question remains how H2Bub1 affects development of cardiac structure,
since both human patients with variants affecting H2Bub1 and mouse embryos with
cardiac-specific deletion of Rnf20 have structural heart defects. A possible link to the
observed structural heart defects in mice is that altered expression of calcium signaling
genes and abnormal sarcomeric structure observed in Rnf20fl/-::Nkx2.5-Cre+ mouse
embryos led to defective cardiac function during embryonic development, and that the
resulting hemodynamic derangement affects structural cardiac morphogenesis. Extensive
evidence supports interdependence between embryonic hemodynamics and valve
development, cardiac trabeculation, myocardial proliferation and formation of the
epicardium (Andres-Delgado and Mercader 2016). Genomic studies of human CHD
patients are beginning to provide further evidence of an overlap between genes classically
linked to cardiomyopathy, and patients presenting with structural CHD. For example,
dominant mutations affecting myosin heavy chain 6 (MYH6) are associated with
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cardiomyopathy and atrial septal defects (Ching et al. 2005; Hershberger et al. 2010),
while recessive mutations in MYH6 are found in 11% of patients with Shone syndrome,
characterized by valve defects and multiple levels of left ventricular obstruction (Jin et al.
2017). The essential role of H2Bub1 in CM development and cardiac morphogenesis in
mouse and human provide further support for genetic overlap between cardiac structure
development and myocardial function, and suggest that a subset of patients with
structural heart defects caused by genetic defects affecting cardiomyocytes may be more
vulnerable to myocardial dysfunction. Although there are likely variations in the absolute
H2Bub1 levels required for normal iPSC-derived CM development, mouse embryo, and
human heart development, our observations in iPSC-derived CMs and mouse embryos
indicate a shared requirement for precise control of H2Bub1 in the heart.
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Appendix
Supplemental Table 1: Primers A list of all of the primers used in this study and their
application.
Primer Name
18s F
18s R
Cacna1cF1
Cacna1cR1
Ncx F2
Ncx R2
Ryr2 F2
Ryr2 R2
Serca2a F3
Serca2a R3
GAPDH Exon F
GAPDH Exon R
GAPDH Promoter F
GAPDH Promoter R
RNF20 F
RNF20 R
RNF20 Sequence
UBE2B F
UBE2B R
UBE2B Sequence
+/Rnf20 F Null allele
+/Rnf20 F WT allele
+/Rnf20 R Null allele
+/Rnf20 R WT allele
UBE2B F
UBE2B R

Sequence
Species
CTTAGAGGGACAAGTGGCG
Mouse
ACGCTGAGCCAGTCAGTGTA
Mouse
CCTAATGGGTTCGTTTCAGAAGT
Mouse
TCCGGTTACCTCCAGGTCA
Mouse
AGATCAAGCATCTGCGTGTG
Mouse
CTCCACAACTCCAGGAGAGC
Mouse
CCTTGCCTGAGTGCAGTTG
Mouse
TTGAGGTATCAACAGGTTGTGG
Mouse
GGGCAAAGTGTATCGACAGG
Mouse
TCAGCAGGAACTTTGTCACC
Mouse
GCAGGCCGGATGTGTTC
Human
AGAACAGTGAGCGCCTAGT
Human
GGGCTCTCCAGAACATCATC
Human
CAGTGAGCTTCCCGTTCAG
Human
ACGACTGTCTTCTTCTGCCA
Human
ACCACCTTCCCAGATTCTCG
Human
GCTTCCCCATACTCCAGAAA
Human
ACGTCATTGCAGGGTTGTTT
Human
CGGCAAAGCTTATGGGAGTA
Human
GGCCCTTACCGCTTGAAATC
Human
CCATTACCAGTTGGTCTGGTGTC
Mouse
GACCTTCACCTCAAGTCTAGCAGAG Mouse
TCCTCACTATGTTCTCTCGCTACTG Mouse
TCCTCACTATGTTCTCTCGCTACTG Mouse
CAGCTGCGGAGCATGTCG
Human
CAACAATGGCCGAAACTCTT
Human

Application
Calcium qRT-PCR Experiment
Calcium qRT-PCR Experiment
Calcium qRT-PCR Experiment
Calcium qRT-PCR Experiment
Calcium qRT-PCR Experiment
Calcium qRT-PCR Experiment
Calcium qRT-PCR Experiment
Calcium qRT-PCR Experiment
Calcium qRT-PCR Experiment
Calcium qRT-PCR Experiment
Control for H2Bub1 ChIP-seq
Control for H2Bub1 ChIP-seq
Control for H2Bub1 ChIP-seq
Control for H2Bub1 ChIP-seq
Genotyping iPSC Mutants
Genotyping iPSC Mutants
Genotyping iPSC Mutants
Genotyping iPSC Mutants
Genotyping iPSC Mutants
Genotyping iPSC Mutants
Mouse genotyping
Mouse genotyping
Mouse genotyping
Mouse genotyping
Sequencing cDNA
Sequencing cDNA

1

Designed by (Gomez-Ospina et al. 2013)
Designed by (Santulli et al. 2015)
3
Designed by (Chung et al. 2019)
2
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Supplemental Table 2: Antibodies A list of all of the antibodies used in this study, their
species, their dilution, and their application.
Antibody
H2Bub1
Igg
Brachyury
Cardiac Troponin T
ISL1
NKX2.5
OCT-4a
CD31
NKX2.5
RNF20
WT1
alpha-tubulin
GAPDH
H2B
H2Bub1
RNF20
RNF40
UBE2B

Catalogue Number
Cell Signaling 5546s
Cell Signaling 2729s
R&D systems AF2085-SP
Invitrogen MA5-12960
DSHB 39.4D5 supernatant
Santa Cruz sc-8697
Cell Signaling 2840S
BD biosciences 550274
Santa Cruz sc-8697
Cell Signaling 11974
Novus 6f-h2
Invitrogen 62204
Invitrogen MA515738HRP
Millipore 07-371
Cell Signaling 5546s
Cell Signaling 11974
Abcam ab191309
GenTex GTX100416
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Species
Rabbit
Rabbit
Goat
Mouse
Rat
Goat
Rabbit
Rat
Goat
Rabbit
Mouse
Mouse
Mouse
Rabbit
Rabbit
Rabbit
Rabbit
Rabbit

Dilution
4 µL
4 µL
1:20
1:200
1:10
1:200
1:200
1:500
1:100
1:200
1:250
1:1000
1:20,000
1:12,000
1:200,000
1:500
1:1000
1:500

Application
ChIP
ChIP
IF cells
IF cells
IF cells
IF cells
IF cells
IF sections
IF sections
IF sections
IF sections
Western
Western
Western
Western
Western
Western
Western

